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Abstract 
The occurrence of diverse colony morphotypes of Pseudomonas aeruginosa is a 
common finding in the chronically infected cystic fibrosis (CF) lung. A previous study 
from our laboratory showed that the isolation of P. aeruginosa Small Colony Variants 
(SCVs) could be correlated with parameters revealing poor lung function and the use of 
inhalative antibiotics. Among the heterogenous group of clinical SCVs, recently a 
subgroup of hyperpiliated SCVs that exhibited autoaggregative growth behaviour and 
enhanced ability to form biofilms was identified. Role of these variants in the 
pathogenesis is poorly understood.   
 
In this study we compared the ability of these SCVs to survive harsh conditions like 
iron limitation and hydrogen peroxide induced oxidative stress compared to their 
corresponding wild types. The autoaggregative SCV 20265 showed better growth and 
survival under iron limiting and oxidative stress conditions compared to the clonal wild 
type. In agreement with these functional characteristics extensive comparative proteome 
analysis of SCV 20265 was indicative of a better adaptation to oxidative stress and iron 
limitation as compared to the corresponding wildtype, WT 20265. Proteome profile of 
SCV 20265 showed differential expression of some oxidative stress combat proteins 
like peroxidases, superoxide dismutases and iron acquisition related proteins like FeoB, 
HasAp, FpvA.  
 
Since occurrence of anaerobic biofilms in the CF lung is known, differential adaptation 
of SCV and WT 20265 to anaerobic mode of growth using nitrate was tested. Results 
indicate that SCV 20265 grows better than the WT 20265 under this condition. 
Proteome analysis of anaerobically grown cells revealed the differential regulation of 
some key genes involved in the anaerobic mode of growth using nitrate. 
 
Membrane and supernatant sub proteomes of morphotypes of strain 20265 were 
subjected to a gel-less proteome analysis using nanoflow LC/MS to obtain an overview 
of the expression differences and pick up candidates for more detailed analysis. 
Accordingly, expression of a putative ferrous iron transporter (PA 4358) was further 
monitored using real time PCR analysis and its differential expression confirmed at a 
transcription level too. As an interesting offshoot from the main study, polyadenylation 
of mRNAs of Pseudomonas aeruginosa has been reported in this study for the first 
time. DNA microarray analysis of log phase RNA preparation of strain PAO1 has 
revealed that up to 42% of the expressed mRNA was polyadenylated. 
 
Taken together our data suggest that some SCVs like the SCV 20265, represent clonal 
variants which are especially adapted to oxidative stress and iron limitation, conditions 
which are likely to be encountered in the CF lung. It is speculated that polyadenylation of a 
significant number of expressed mRNAs might have some significance in the post-
transcriptional modification and mRNA stability. 
 
Key words: Small colony variant (SCV), Cystic fibrosis, Pseudomonas aeruginosa, 
iron, proteome analysis, H2O2, Polyadenylation 
 
 
 
Kurzfassung 
Das Auftreten verschiedener Kolonie-Morphotypen von Pseudomonas aeruginosa ist ein 
häufiger Befund bei der chronisch infizierten Lunge von Patienten mit Cystischer 
Fibrose(CF). Frühere Untersuchungen unseres Labors haben gezeigt, dass das Vorkommen 
so genannter „P. aeruginosa Small Colony Variants“ (SCVs) mit schlechter 
Lungenfunktion und inhalativer Antibiotikatherapie korreliert. Aus dieser heterogenen 
Gruppe klinischer SCVs wurde unlängst eine Untergruppe hyperpilierter SCVs 
identifiziert, die ein autoaggregatives Wachstumsverhalten und eine erhöhte Fähigkeit zur 
Biofilm-Bildung aufwiesen. Über die Rolle dieser Varianten in der Pathogenese ist nur 
wenig bekannt. 
 
In dieser Arbeit wurden die Auswirkungen verschiedener Faktoren, wie Eisen-Mangel und 
durch Wasserstoffperoxid ausgelöster oxidativer Stress, auf das Überleben der SCVs mit 
denen der entsprechenden Wildtypen verglichen. Die autoaggregative SCV 20265 zeigte 
ein besseres Wachstum und Überleben unter diesen Bedingungen im Vergleich zum 
klonalen Wildtyp. Diese funktionellen Charakteristikan wurden durch umfangreiche 
Proteom-Analysen der SCV 20265 unterstützt, die ebenfalls auf eine bessere Anpassung 
der SCV an oxidativen Stress und Eisen-Mangel im Vergleich zum entsprechenden 
Wildtyp deuten. Das Proteom-Profil der SCV 20265 zeigte eine unterschiedliche 
Expression einiger Schutzproteine gegen oxidativen Stress, wie Peroxidasen und 
Superoxid-Dismutase und einiger Proteine, die bei der Eisen-Aufnahme eine Rolle spielen, 
wie FeoB und HasAp. 
 
Da bekannt ist, dass anaerobe Biofilme in der CF-Lunge auftreten, wurde die 
unterschiedliche Anpassung von SCV und WT 20265 an anaerobe 
Wachstumsbedingungen in gegenwart von Nitrat untersucht. Die Ergebnisse weisen darauf 
hin, dass die SCV 20265 besser als der WT 20265 unter diesen Bedingungen wächst. 
Proteom-Analysen von unter anaeroben Bedingungen gewachsenen Zellen zeigten eine 
unterschiedliche Regulation einiger Schlüsselgene, die bei der Nitrat-Nutzung unter 
anaeroben Wachstumsbedingungen involviert sind. 
 
Membranen und sezernierte proteinen von Morphotypen des Stammes 20265 wurden 
mittels eines Gel-unabhängigen Proteom-Analyse Verfahrens namens Nanoflow LC/MS 
untersucht, um eine Übersicht über Expressionsunterschiede zu erhalten und um mögliche 
Kandidaten für eine ausführlichere Analyse zu finden. Folglich wurde die Expression eines 
vermeintlichen Fe2+-Eisen-Transporters (PA 4358) mittels RT-PCR genauer untersucht, 
wodurch seine unterschiedliche Expression auch auf Transkriptionsebene bestätigt werden 
konnte. Als interessantes „Nebenprodukt“ dieser Studie wurde eine Polyadenylierung der 
mRNA in Pseudomonas aeruginosa gezeigt. DNA-Mikroarray Analysen von isolierter 
RNA aus der exponentiellen Wachstumsphase des sequenzierten Stammes PAO1 haben 
gezeigt, dass bis zu 42% der exprimierten mRNA polyadenyliert war. 
 
Letztlich deuten unsere Ergebnisse darauf hin, dass einige SCVs, wie die SCV 20265, 
klonale Varianten bilden, die besonders gut an oxidativen Stress und Eisen-Mangel 
angepasst sind; eben solchen Bedingungen, wie sie in der CF-Lunge vorherrschen. 
Polyadenylierung des grössten Teils der mRNA könnte eine entscheidende Rolle bei 
posttranskriptionalen Modifikationen und bei der Stabilität der mRNA haben. 
 
Schlagworte: Small Colony Variants (SCV), Cystische Fibrose, Pseudomonas aeruginosa, 
Eisen, Proteom-Analyse, H2O2, Polyadenylierung 
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1. Introduction 
1.1 Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a gram-negative rod shaped bacterium having polar flagella 
belonging to the group of α-proteobacteria (Olsen et al., 1994). The genus Pseudomonas 
belongs to the γ-subclass of the Proteobacteria and contains more than 140 species 
including fluorescent Pseudomonads such as Pseudomonas putida, Pseudomonas 
fluorescens, Pseudomonas chlororaphis, Pseudomonas aeruginosa, phytopathogenic 
species like Pseudomonas syringae, Pseudomonas cichorii, Pseudomonas marginalis and 
Pseudomonas tolaasii as well as non-fluorescent Pseudomonads like Pseudomonas 
stutzeri, Pseudomonas mendocina or Pseudomonas alcaligenes.  
 
Most pseudomonads are saprophytic organisms and are well known for their broad 
metabolic and physiological versatility. They are free-living ubiquitous bacteria that are 
frequently found in soil, aquatic habitats or associated with host organisms like plants and 
animals and play an important role in decomposition, biodegradation, carbon and nitrogen 
cycles and disease production. Unlike other Pseudomonads, P. aeruginosa has the capacity 
to cause disease in humans, because of its large repertoire of virulence factor (Stover et al., 
1983). It can cause serious infections in immuno-suppressed patients such as burn victims, 
cancer and intensive care unit patients. P. aeruginosa infections of the respiratory tract are 
the major cause of death in cystic fibrosis patients. P. aeruginosa causes  bacteraemia in 
burn victims, urinary-tract infections in catheterized patients, and hospital-acquired 
pneumonia in patients on respirators (Bodey et al., 1983).  
 
 
 
 
 
 
 
Fig 1.1.1 Pseudomonas aeruginosa morphology in a Scanning Electron Micrograph (A) and streaks on agar 
plates (B). (Illustration adopted from  http://www.pseudomonas.com (A) and von Götz (2003) (B)) 
 
Today, in the era of genome sequencing and whole genome analysis, the genome of one 
Pseudomonas strain, P. aeruginosa PAO1 has been completely sequenced (Stover et al., 
2000). The sequencing project of P. putida KT2440 was started in 1998, five more 
A B 
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Pseudomonas sequencing projects are currently underway, including three P. fluorescens 
and two P. syringae strains (Bernal, 2001). During the last 15 years, physical and genetic 
chromosome maps were constructed for a number of Pseudomonas species shedding 
additional light on the genome structure and variability of Pseudomonads (Romling and 
Tummler, 2000; Wechter et al., 2002; Rainey and Bailey, 1996) 
 
1.2 Pseudomonas aeruginosa in Cystic Fibrosis  
CF is the most common genetic disease among the Caucasians. The affected gene encodes 
for a 1480 amino acid chloride channel called the Cystic Fibrosis Transmembrane 
Conductance Regulator (CFTR). 70% of the patients are affected with EF 508 (Phenly 
alanine deletion) in a critical portion of the protein that leads to its being misfolded and 
retained in the endoplasmic reticulum (ER), where it seems to be pulled out of the ER 
membrane and degraded on proteosomes.  
 
Thus these patients suffer from lack of any chloride channels in the membrane because 
they have been degraded before they ever became functional in the membrane. A large 
number of mutations have been described. In general, there is a direct correlation between 
severity of disease symptoms and the severity of the effect on chloride channel 
function.The opportunistic pathogen P. aeruginosa being a key etiological agent of 
hospital acquired infections in the immunocompromised host, is also responsible for 
chronic lung infection in cystic fibrosis (CF) patients (Gilligan, 1991; Lyczak et al., 2002; 
Govan & Deretic, 1996; Breitenstein et al.,1997).  
 
Once CF patients become colonized by P. aeruginosa, there is a subsequent gradual 
deterioration in lung function, which determines the course and prognosis in most CF 
patients. In normal individuals, the function of airway epithelia is to promote proper 
transport of Cl-, Na+ and water from the basolateral to the apical surface (Fig. 1.2.1). A 
major role of CFTR is to transport Cl- across the apical surface of secretory cells. Thus, a 
major defect in CF is either little or no Cl- transport across the apical surface. This can 
occur as a result of either (i) no CFTR produced, (ii) mutated CFTR, (iii) or mutated and 
truncated CFTR. Without CFTR, Na+, Cl- and water are reabsorbed in an unopposed and 
accelerated fashion. The fact that goblet cells in CF airway disease secrete mucus to the 
apical surface despite the failure to clear mucus from the airway surface further 
exacerbates the disease process (Fig. 1.2.1).  
                                                                                                                              Introduction 
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Figure 1.2.1. Model of ion transport in normal (left) and CF (right) absorptive (A) and secretory (C) 
epithelia. Transepithelial Cl- transport occurs through movement of Cl- through the basolateral membrane 
Na+ K+ 2Cl- co-transporter, and across the lumenal (apical) membrane by Cl- channels. This model shows 
that CFTR is activated by increased intracellular cAMP through protein kinase A, and alternative Cl- 
channels, as well as the amiloride-sensitive sodium channel, ENaC. The basolateral membrane contains the 
Na+/K+ ATPase and basolateral membrane calcium and cAMP activated K+ channels. K+ channels help drive 
Cl- across the cell. Tight junctions provide a transepithelial resistance to the movement of other ions and 
molecules. In CF, CFTR mutants have altered unit conductance, or altered trafficking, maturation or stability. 
ENaC activity is increased in CF, leading to hyper-absorption of sodium. This leads to a decrease in the 
airway surface liquid volume, and thickened mucus. This thickened mucus layer, plus oxygen-consuming 
metabolism of airway epithelia and bacteria, provides a hypoxic environment ideal for anaerobic growth of 
P. aeruginosa. (Illustration adopted from Hassett et al., 2002) 
 
The cilia that beat freely and efficiently on normal epithelia are matted down by the thick 
mucus and either do not beat or beat inefficiently. Thus, the thickened, poorly cleared 
mucus becomes a veritable breeding ground for opportunistic pathogens in CF that include 
P.aeruginosa, Staphylococcus aureus, Hemophilus influenzae, Burkholderia cepacia, and 
other opportunists, as well as some true pathogens (e.g. Mycobacterium tuberculosis). 
However, with progression of CF airway disease, P. aeruginosa predominates and its 
mode of growth in vitro is dramatically different from that in vivo. The in vivo mode of 
growth in CF airway disease has been termed a ‘biofilm’(Singh et al., 2000).  
 
The lung infection with P. aeruginosa is regarded as one of the major causes of health 
decline in patients with cystic fibrosis (CF). The CF host response to the persistent 
bacterial antigen load in the endobronchiolar lumen is characterized by a pronounced 
humoral response, local production of cytokines, influx of neutrophils into the lung and a 
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protease-protease inhibitor imbalance predominantly sustained by released neutrophil 
elastase. The epidemiology of the infection with P. aeruginosa, investigated by 
quantitative macro restriction fragment pattern analysis, revealed that the distribution and 
frequency of clones found in CF patients match that found in other clinical and 
environmental aquatic habitats, but the over-representation of specific clones at a CF clinic 
indicates a significant impact of nosocomial transmission. Most patients remain colonized 
with the initially acquired P. aeruginosa clone. According to direct sputum analysis the 
majority of patients carry a single clonal variant at a concentration of 107-109 CFU. Co-
colonization with other species or other clones is infrequent (Tummler et al., 1997). 
Independent of the underlying genotype, the CF lung habitat triggers a uniform, genetically 
fixed conversion of bacterial phenotype. Most CF P. aeruginosa strains become non-
motile, mucoid, LPS-, pyocin- and phage-deficient, secrete less virulence determinants and 
shift the production of cytokines evoked in neutrophils. On the other hand, other properties 
such as antimicrobial susceptibility or adherence to bronchial mucins remain highly 
variable reflecting the capacity of P. aeruginosa to adapt to ongoing changes in the CF 
lung habitat. 
 
1.3 Virulence Factors of Pseudomonas  aeruginosa  
Pseudomonas aeruginosa has several virulence factors. They fall into two broad 
categories: either cell associated or secreted virulence factors. Cellular appendages 
including motility structures like flagella and adhesive structures like Type IV pili and 
other nonpilus adhesins are important for attachment and establishment of infection in the 
epithelial cells (de Bentzmann et al., 1996; Feldman et al., 1998), which are the frontlines 
in the host-pathogen interaction. The inherent ability of P. aeruginosa to adapt a biofilm 
mode of growth is also considered as a virulence trait (Watnik and Kolter, 2000). 
 
Secreted virulence factors include exotoxins, type III toxins, elastases, alkaline metallo 
proteases, siderophores and hemolysins. These virulence factors are secreted out of the 
bacteria by one of the four types of secretion pathways (Type I–IV) known in gram-
negative bacteria. Some of them like the exotoxin A are secreted by Type II secretion 
system. Exotoxin A (ExoA), ADP ribosylates elongation factor 2 (EF–2), which stops the 
protein synthesis and elicits apoptosis of the affected cells. Secretion of ExoA by the Type 
II secretion mechanism is common to most if not all gram-negative. The secretion can be 
described as the Sec dependent export of ExoA into the periplasmic space followed by 
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folding of the polypeptide chain. Uptake of ExoA by epithelial cells is by the alpha 2- 
macroglobulin / LDL receptor. Mechanism of entry to the cytosol in other cells is very 
similar to that of the cholera toxin. Once toxin is internalised, it is transported backwards 
through the secretory pathway: endosomes, golgi apparatus and endoplasmic reticulum 
(from where the catalytic portion of the toxin is transported to the cytosol). Regulation of 
gene (toxA) is under the control of environmental iron levels (low iron means increased 
toxA). Inspite of being a potential cytotoxin, it seems to have relatively minor role in 
virulence in the airways. Folded ExoA is then recognized by a specifically assembled 
secretion machinery consisting in part of the Xcp genes and the pil genes (pil B,C,D). 
Thus, Type II secretion and Type IV pili are interconnected. Some components of the Type 
II secretion machinery, XcpT,U,V,W are exported by prepilin type signal peptides to be 
assembled into a supramolecular structure in the periplasmic space. Assembly of pilA into 
Type IV pili requires all the xcp genes. One component of the secretion machinery XcpP 
has a homolog in Type II secretion mechanisms of Salmonella, Shigella, Helicobacter, 
Yersinia, E.coli and others. This protein seems to form a 12 mer in the outer membrane 
that functions as a gated channel. It is presumed that all Type II and Type II secreted 
proteins as well as the type IV pili must pass the outer membrane through a similar type of 
channel.   
 
Elastases  (LasA and LasB) break down elastin, an important connective tissue protein in 
the lungs (maintains lung elasticity so that recoil occurs properly during exhalation). LasB 
is not strictly an elastase, but a Zinc metalloprotease (i.e., needs some Zn in the solution) 
that is somewhat non-specific but also works on elastin. LasA is a serine protease that 
nicks elastin but does not degrade it. Over all, Las A and LasB operate together to behave 
as an elastase, even though they have different individual functions. The concerted activity 
of two enzymes, LasB elastase and LasA elastase, is responsible for elastolytic activity 
(Galloway, 1991). Early damage to lungs may occur from LasA and LasB, which also 
degrade complement components and a protease inhibitor (which prevents damage due to 
neutrophil-produced proteases). Thus, LasA and LasB will inhibit immune cell response 
and could also enhance activity of neutrophil elastase.  
 
Metalloproteases in bacterial-conditioned medium, as well as purified alkaline protease 
and elastase, degrade human RANTES, monocyte chemotactic protein-1 (MCP-1), and 
epithelial neutrophil-activating protein-78 (ENA-78) (Leidal, 2003). Neuraminidase is an 
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enzyme that works on sialic acid (neuraminic acid), leading to increased amounts of asialo-
GM1 and endash GM2 on surfaces of airway cells, which will then likely bind increased 
numbers of bacteria. Neuraminidase production is regulated by osmolarity of medium 
(increases with higher osmolarity), and it has been proposed that the luminal airway 
surface liquid (ASL) has a higher than normal NaCl and osmolarity in CF than in normal 
individuals. Phospholipase C (plcS) and alkaline protease (apr) are also virulence genes.   
 
In general, all type III toxins are ineffective when they are applied to the outsides of cells, 
indicating that they must gain access into the cells to bring about cytotoxicity. Exoenzyme 
S (ExoS) is an ADP ribosylase. It targets include Ras and perhaps related G proteins Rap, 
Ral and Rab, but not Rho and ARF and it also works on vimentin, an intermediate filament 
protein. The toxin is produced as an aggregate of two immunologically related proteins 
ExoS (53 KDa) and ExoT (49 KDa). Although these proteins share about 75% amino acid 
homology, ExoT has a catalytic defect and operates at < 1% of the ADP-ribosyl transferase 
activity of ExoS. ExoS is involved in virulence. 
 
Siderophores are the most important virulence factors. Iron chelated to the P. aeruginosa 
siderophore pyochelin enhances oxidant-mediated injury to pulmonary artery endothelial 
cells by catalyzing hydroxyl radical (HO*) formation (DeWitte, 2001).  Pyoverdine, the 
yellow-green, water-soluble, fluorescent pigment of the fluorescent Pseudomonas species, 
is a powerful iron (III) scavenger and an efficient iron (III) transporter. As a fluorescent 
pigment, it represents a ready marker for bacterial differentiation and, as a siderophore, it 
plays an important physiological function in satisfying the absolute iron requirement 
(Meyer, 2000 ). Pyoverdin competes directly with transferrin for iron and that it is an 
essential element for in vivo iron gathering and virulence expression in P. aeruginosa 
(Meyer, 1996). Pyocyanin, produced by P. aeruginosa, has many deleterious effects on 
human cells that relate to its ability to generate reactive oxygen species (ROS), such as 
superoxide and hydrogen peroxide (O'Malley, 2003 ). Other virulence factors include LPS, 
pilin assembled into type IV pili and possibly other not so well described iron uptake 
systems. 
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1.4 Iron and  Pseudomonas aeruginosa   
Iron is a first row transition metal that under physiological conditions, mainly exists in one 
of the two readily inter-convertible redox states: the reduced Fe2+(Ferrous) and the 
oxidised Fe3+(Ferric). It can also adopt different spin states (high or low) in both the ferric 
and ferrous form, depending on its ligand environment. These properties make iron an 
extremely versatile prosthetic component for incorporation into proteins as a biocatalyst or 
electron carrier. Iron is considered to be absolutely required for life of all forms (except for 
a few exceptions like the Lactobacilli, Borrelia burgdorferi).  It participates in many major 
biological processes, such as photosynthesis, N2 fixation, methanogenesis, H2 production 
and consumption, respiration, the trichloroacetic acid (TCA) cycle, oxygen transport, gene 
regulation and DNA biosynthesis. With the evolution of oxygenic photosynthesis (about 
2.2 to 2.7 billion years ago), the predominant form of iron switched from the relatively 
soluble (0.1M at pH 7.0) ferrous state to the extremely insoluble (10-18M at pH 7.0) ferric 
form. Thus, this valuable minor nutrient upon which life is now so dependent became 
scarce and growth limiting within many ecological niches.  Iron limitation has profound 
consequences for all but a few microbial organisms so far identified on our planet. There is 
always a paucity of soluble, biologically useful iron in aerobic environments. Bacterial 
cells each contain 105 to 106 iron ions, which are essential for many metabolic pathways. 
Typical bacterial organisms require approx. 0.3 – 1.8 µM of iron for optimal growth, 
whereas the concentration in the soil is < 0.1 µM and only 10-9 in mammalian host (Vasil 
and Ochsner, 1999). P. aeruginosa is found in a remarkable variety of environments, 
which furnish a variety of exigencies, both in terms of how to obtain iron from its 
surroundings and how to deal with potentially toxic levels once it starts to increase its 
uptake. Consequently, in comparison with many other frank pathogens that need to acquire 
iron only from the limited ecological niches to which they are restricted, i.e. a human host, 
P. aeruginosa has to use an assortment of strategies for accessing iron and for regulating 
its intake (refer Table 1.4.1). 
 
Siderophores are the chief iron scavengers. They are highly efficient in chelating Ferric 
iron from a variety of sources. Pyoverdin and pyochelin are the two siderophores of P 
aeruginosa. P. aeruginosa is also capable of utilizing heterologous siderophores 
(siderophores produced by other microbes) and henceforth expresses cognate receptors for 
these too apart from the ferripyoverdine and ferripyochelin receptors. 
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Table.1.4.1. Iron uptake systems of Pseudomonas aeruginosa 
 
Iron source Protein Function  References 
 
 
Haemoglobin / 
Haemin 
 
PhuR 
 
 
PhuSTUVW 
 
 
HasRADEF 
 
Heme/Hb OM receptor 
 
 
Heme ABC transport system 
 
Heme receptor, hemophore, ABC 
transporter for HasA export 
 
 
(Ochsner et al., 2000)) 
 
 
(Ochsner et al., 2000) 
 
 
(Ochsner et al., 2000) 
 
 
 
Reduced iron -  
Fe(II) 
 
FeoAB 
 
 
Fe2+ 
 
(Vasil and Ochsner, 1999) 
 
 
 
 
 
Siderophores – 
Fe(III) 
 
FptA 
 
 
FpvA 
 
 
FiuA 
 
PfeA 
PirA 
 
PiuA, PfuA, 
UfrA 
 
Ferric Pyochelin OM receptor 
 
 
Ferric pyoverdine OM receptor 
 
 
Ferrioxamine OM receptor 
 
Ferric enterobactin OM receptor 
 
 
Unknown OM receptor 
 
 
(Ankenbauer, 1992) 
 
 
 
(Poole et al, 1993) 
 
 
 
(Ochsner and Vasil, 1996) 
 
 
( Dean  et al, 1993; Ochsner 
and Vasil, 1996) 
 
 
(Ochsner and Vasil, 1996) 
 
 
Haemophores are found to enhance the efficiency of haem uptake by100 folds (Letoffe et 
al., 1999). P. aeruginosa has two distinct haemophore mediated iron uptake systems 
namely, Haem Acquisition System (Has) and Pseudomonas Haem Uptake (Phu) system 
(Ochsner et al., 2000) apart from siderophore mediated iron uptake systems. Figure 1.4.1 
shows a schematic outline of the various iron uptake systems of a gram-negative bacteria 
such as P. aeruginosa along with the sub cellular localization of their components. The 
ferrous iron uptake systems of  P. aeruginosa are not well studied even though genome 
sequencing has revealed the occurrence of homologues of known ferrous iron uptake 
systems of E. coli such as feoAB. 
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Fig. 1.4.1. Bacterial iron transport. A schematic view of iron uptake systems of Gram-negative bacteria is 
shown. Under low-iron stress, many bacteria secrete siderophores to bind Fe3+ and take it up by specific 
receptors (R) that are energized by the Ton complex (T). Some pathogenic bacteria are able to use 
lactoferrin- or transferrin-bound iron either with the help of their siderophores or with specialized receptors 
in their outer membranes (OM). Often, these bacteria have additional systems to utilize the haem-bound iron 
of their host either by secreting a special haem-binding protein, a hemophore, or through specific receptors 
for haem, hemoglobin, or hemopexin, which are able to extract the haem and transport it across the outer 
membrane. All these different substrates – ferric iron from transferrin, haem, and Fe3+-siderophores – are 
transported by specialized ABC transporters (ABC) across the cytoplasmic membrane (CM). In the 
cytoplasm (C), Fe3+-siderophore reductases or haem oxygenases help to mobilize the iron for cell 
metabolism. FeoB is a transporter, which can either utilize the more-soluble Fe2+ or possibly obtain Fe2+ from 
mostly uncharacterized reductive processes (labeled Red in the figure) at the cell surface or in the periplasm 
(P). FeoA and FeoC might take part in Fe2+ transport and mobilization and Fe2+ transport is not as well-
characterized as Fe3+ transport is. (Illustration adopted from Hantke, (2003)) 
 
 
The central role in the control of iron-regulated genes has been assigned to the ‘ferric 
uptake regulator’ (Fur) protein, which acts as an iron responsive, DNA binding repressor 
protein. A widely accepted model of how Fur regulates iron acquisition genes is 
schematically depicted in figure1.4.2. The genetics, biochemistry and biology of Fur and 
the Fur regulated alternative sigma factor (PvdS) are discussed elsewhere in detail (Escolar 
et al., 1999;Vasil et al., 1998; Vasil and Ochsner, 1999;Visca et al., 2002; Wilson et al., 
2001). These regulatory proteins directly or indirectly regulate a substantial number of 
other genes encoding proteins with remarkably diverse functions. These genes include: (I) 
other regulatory genes, (II) genes involved in basic metabolic processes, (III) genes 
required to survive oxidative stress (e.g. superoxide dismutase), (iv) genes necessary for 
scavenging iron (e.g. siderophore biosynthesis genes and their cognate receptors) or genes 
that contribute to virulence (e.g. exotoxin A) of this opportunistic pathogen. Despite a 
recent expansion of knowledge about the response of P. aeruginosa to iron, many 
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significant biological issues need to be addressed. Virtually nothing is known about which 
of the distinct iron acquisition mechanisms P. aeruginosa deploys outside the laboratory, 
whether it be in soil, in a pipeline, on plants or in the lungs of the cystic fibrosis patients.   
 
 
 
 
 
Figure.1.4.2 Schematic representation of the generally accepted model of Fur mediated gene 
expression of iron uptake genes. Iron acquisition genes are repressed by the binding Fur-Fe during 
conditions of high iron availability. On the contrary, under low iron conditions, the amount of Fe available 
for complex formation with Fur is so low that most of the Fur occurs as apo-Fur (unconjugated to Fe). This 
prevents effective binding of Fur (repressor) to the promoters of the iron acquisition genes. This results in 
expression of the iron acquisition genes. (Illustration adopted from Andrews et al., (2003))   
 
 
1.5 Oxidative stress and Pseudomonas aeruginosa  
Pseudomonas aeruginosa gains its greatest metabolic energy through aerobic respiration. 
To counter the production of ROIs, the organism possesses two SODs, with either iron 
(Fe2+; encoded by sodB (Hassett et al., 1993; Hassett et al., 1995) or manganese (Mn2+; 
encoded by sodA (Hassett et al., 1993; Hassett et al., 1995)) as cofactor and whose 
function is to disproportionate *O2 to H2O2 and O2 (McCord and Fridovich, 1969). To 
remove H2O2, P. aeruginosa possesses three catalases, KatA (Brown et al., 1995; Hassett 
et al., 1992) KatB (Brown et al., 1995; Hassett et al., 1992) and KatC (Pathogenesis 
Corporation and the Cystic Fibrosis Foundation, 1999). KatA activity is the major catalase 
activity detected in all phases of growth (Brown et al., 1995; Hassett et al., 1992). In 
contrast, KatB activity is detectable in bacteria exposed to H2O2 or paraquat, the latter of 
which generates a constant flux of H2O2 through SOD-catalyzed dismutation of *O2 
(Brown et al., 1995). Unlike KatA and KatB, little is known of the biological role of KatC 
in P. aeruginosa. In fact, the putative katC gene was only recently discovered fortuitously 
via the Pseudomonas Genome Project (Pathogenesis Corporation and the Cystic Fibrosis 
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Foundation, 1999). Most bacterial catalases are multimers (typically dimers, tetramers, or 
hexamers) that require heme b or heme d for catalytic activity. The final step of heme 
synthesis is catalyzed by ferrochelatase, which condenses Fe2+ into protoporphyrin IX. 
Little is known of the cellular source of iron required for haem assembly. One protein that 
could provide iron for such a process is bacterioferritin A (BfrA, also known as 
cytochrome b1 or b557), the major iron storage protein in P. aeruginosa (Moore et al., 
1994). Actually, there is evidence in P. aeruginosa for two Bfr proteins (BfrA and BfrB), 
which differ in their N-terminal amino acid sequences (Moore et al., 1994).  BfrA is a 
complex of 24 subunits capable of binding 700 iron atoms (Moore et al., 1994). It also 
binds 3 to 9 haem groups per 24 subunits in vivo and 24 haem groups in vitro(Kadir and 
Moore,1990). Recently, a bfr gene encoding a bacterioferritin was identified in the related 
organism P. putida; this gene was located downstream of a gene encoding a group III 
catalase (Kim et al., 1997). 
 
Bacterial aerobic respiration involves a four-electron reduction of molecular oxygen (O2) 
to water. Depending upon the environmental conditions, aerobic respiration can be 
extremely dangerous to the cell. Such is the case when aberrant electron flow from the 
electron transport chain or cellular redox enzymes to O2 leads to the production of reactive 
oxygen intermediates (ROIs). These include superoxide (*O2 ), hydrogen peroxide (H2O2), 
and hydroxyl radical HO*. The unchecked production of each of these species can lead to 
cell damage, mutations, or death. The production of HO*, the most destructive of the above 
compounds, is dependent in part upon the presence of a transition metal, such as iron or 
copper, and either *O2 or H2O2. Relief from ROIs is provided by various defense systems, 
including antioxidant enzymes (superoxide dismutase [SOD]), catalase, and peroxidase), 
DNA repair enzymes and binding protein (e.g., Dps [DNA binding protein from starved 
cells (Martinez, 1997), and free-radical-scavenging agents (Imlay and Linn, 1987). 
Although it is clearly important for bacteria to secure the iron supplies required for growth, 
it is equally important to ensure that their intracellular iron is maintained in a safe, non 
toxic form (Andrews, 2003). This requires that cellular iron is not allowed to interact with 
reactive oxygen species in an unrestricted manner. Reactive oxygen species are partially 
reduced derivatives of molecular oxygen that are produced as a natural consequence of 
aerobic metabolism (Fridovich, 1995). The one- and two-electron-reduction products of 
oxygen, namely superoxide and hydrogen peroxide, are only mildly reactive 
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physiologically. However, iron interacts with these species to generate the highly reactive 
and extremely damaging hydroxyl radical. The key reactions are shown below: 
Iron reduction   O2- + Fe3+              Fe2+ + O2                          (1) 
Fenton reaction   Fe2+ + H2O2                  Fe3+ + OH- + HO*          (2) 
Haber – Wiess reaction, (1) + (2): O2- + H2O2      Fe catalysis       HO* + OH- + O2 
 
In vivo superoxide concentrations are considered to be too low (at ~10-10 M) to cause iron 
reduction, but can be sufficiently high to damage the exposed [4Fe-4S] clusters of 
dehydratase-lyase family members (e.g. aconitase and α,β-dihydroxyacid dehydratase) 
which in turn leads to release of free iron. The relevant in vivo mediator of iron reduction 
during iron-induced redox stress appears to be flavins (Woodmansee, 2002). Because of 
this, redox stress is enhanced by factors that favor the accumulation of reduced flavins 
(such as inhibition of respiration (Woodmansee, 2002). The role of iron as a major 
protagonist in redox stress is indicated by the increased sensitivity of bacteria to redox 
stress agents following growth under iron-rich conditions (Abdul-Tehrani, 1999). In 
addition, inactivation of the fur gene (resulting in deregulation of iron metabolism) 
increases sensitivity to redox stress, an effect that can be reversed by iron chelation, a tonB 
mutation (blocking iron uptake) or by increasing iron storage capacity through over 
expression of the ferritin (ftnA) gene (Touati, 2000). Also, the impairment of E.coli 
superoxide dismutase mutants can be suppressed by further mutations that raise the 
intracellular concentrations of the iron chelator, dipicolinate (Maringanti, 1999). It is 
probable that the enhanced sensitivity of E. coli and P. aeruginosa fur mutants to redox 
stress is a direct consequence of increased cellular free iron. This notion is supported by 
the observation that fur mutants, which express iron transport systems constitutively (with 
respect to iron), have low levels of iron storage proteins and have increased free iron levels 
(Keyer, 1996) (although total cellular iron levels are actually reduced). These findings 
suggest that Fur regulates the concentration of intracellular free iron through modulation of 
iron acquisition and iron consumption (e.g. iron storage), and that, in the absence of Fur, 
iron uptake and consumption are improperly balanced such that free iron levels become 
excessive. 
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1.6 Microaerobic/Anaerobic growth of Pseudomonas aeruginosa  
 
Most of the known aspects of anaerobic respiration have been extensively reviewed 
(Moreno-Vivian C, 1999; Stewart, 1998). It should be noted, however, that the well-
studied E. coli genes and products involved in anaerobic nitrate reduction have not been 
well studied in P. aeruginosa, although many have been identified by homology from the 
Pseudomonas genome project. It is clear that both the metabolic background of P. 
aeruginosa and its denitrification pathway are very different from that of E. coli and no 
general extrapolations should be made without experimental proof. There are also 
significant differences in the components and metabolic strategies involved in the first rate-
limiting step, nitrate reduction, of the denitrification pathway transport of P. aeruginosa 
relative to E. coli. Based on microscopic examination of thin sections of airways removed 
from CF patients that received lung transplants, it has been reported that in contrast to the 
prevailing surface attachment model of biofilm formation, P. aeruginosa is typically seen 
localized to the epithelial cell surface in CF airway disease where the bacteria are 
embedded in the thickened, highly inspissated airway mucus. Worlitzsch et al., (2002) 
have recently shown that there are ‘‘steep hypoxic gradients’’ in the mucus lining the CF 
airways. 
 
P. aeruginosa are seeded onto the mucus surface by inhalation and the bacteria can 
penetrate the mucus actively (presumably via flagellar, twitching or swarming motility) 
and/or passively (due to mucus turbulence) into hypoxic zones within the mucus.               
P. aeruginosa adapts to such confines by undergoing a rapid transition from aerobic to 
anaerobic metabolism, the latter process involving utilization of the alternative electron 
acceptors, nitrate (NO3) or nitrite (NO2), that are present in CF airway mucus. It has been 
recently shown that nitrate stabilizes the mucoid P. aeruginosa form during anaerobic 
respiration and prevents mucoid-to-nonmucoid conversion under aerobic conditions. 
 
Macro colonies resist secondary defenses, including neutrophils and, to a far lesser extent, 
macrophages, and many first-tier antibiotics (ceftazidime, tobramycin, ciprofloxacin, etc.), 
setting the stage for chronic infection. The presence of increased macro colony density 
and, to a lesser extent, neutrophils, renders the now mucopurulent mass anaerobic. Because 
of the tendency for CF mucus to become anaerobic, especially during chronic infection, a 
description of the machinery involved in anaerobic respiration by P. aeruginosa and 
regulation of this process for optimal survival and growth is presented in the following 
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subsection. Unlike humans, P. aeruginosa is capable of luxuriant growth under both 
aerobic and anaerobic conditions. The latter is either rapid growth via anaerobic 
respiration, using an inorganic terminal electron acceptor, or very slow growth by substrate 
level phosphorylation using arginine. Anaerobic respiration requires the presence of NO3, 
NO2, or nitrous oxide (NO) as alternative terminal electron acceptors. The reduction of 
NO3 can occur via two routes, through an assimilatory pathway, where NO3 is reduced to 
ammonia and subsequently used as a nitrogen source, or by a dissimilatory pathway, where 
NO2 is reduced to nitrogen gas for respiration. While assimilation occurs under both 
aerobic and anaerobic conditions, dissimilatory NO3 reduction occurs only under anaerobic 
conditions and involves the sequential reduction of NO3 →NO2 → nitric oxide (NO) → 
nitrogen gas (N2).  Loci important in the first step involving reduction of NO3 to NO2 are 
termed the nar (nitrate reduction) genes. Those involved in reduction of NO2 to NO are 
termed nir (nitrite reductase).  
 
 
Fig.1.6.1. Model of dissimilatory NO3 reduction and localization of critical enzymes in P. aeruginosa. 
NAR, NO3reductase; NIR, NO2 reductase; NOR, nitric oxide reductase; N OR, nitrous oxide reductase; Azu, 
azurin blue copper protein; Snr-1, electron donor to NAR; 22 NarK2, NO extrusion protein; MoCo, 
molybdenum cofactor; NarH and NarI, factors critical for NAR activity. CoQ, coenzmye Q2 (ubiquinone); 
OprF, outer membrane protein F; OprC, outer membrane protein C (Illustration adopted from Hassett et al., 
(2002)). 
 
 
Those involved in removal of NO are termed nor (nitric oxide reductase), and finally those 
involved in removal of NO are termed nos (nitrous oxide reductase). Because of the 
importance of the gene products encoded by the nar, nir, nor, and nos loci in respiration 
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and survival during the denitrification process, it is not surprising that such genes are 
localized in tightly regulated operons located throughout the genome. A model of how 
dissimilatory NO3 reduction works and the cellular localization of enzymes is presented in 
figure 1.6.1. 
 
1.7 Proteomics for analysis of microbial proteomes 
The term proteome was first coined to describe the set of proteins encoded by the genome 
(Wilkins  et al., 1996). The study of the proteome, called Proteomics, now evokes not only 
all the proteins in any given cell, but also the set of all protein isoforms and modifications, 
the interactions between them, the structural description of proteins and their higher-order 
complexes, and for that matter almost everything ‘post genomic’. In the 1970´s 
"Proteomics" solely stood for the display of large number of proteins from one organisms 
on two-dimensional polyacrylamide gels, thereby cataloging the spots to create databases 
of all expressed proteins (the so-called PROTEOME). During the 1990´s the biological 
mass spectrometry has emerged as a powerful analytical method, furthermore the complete 
genome sequences of many organisms got available. Today, "Proteomics" covers the 
functional analysis of gene products, including large-scale identification, localization and 
interaction studies of proteins. Proteomics complements other functional genomics 
approaches, including microarray based expression profiles (Shoemaker et al., 2002) 
systematic genetics (Tong et al., 2001, Hannon, 2002), systematic phenotypic profiles at 
the cell and organism level (Giaever et al., 2002, Gerlai, 2002) and small molecule based 
arrays (Kuruvilla et al., 2002) 
 
 
 
 
 
 
 
 
 
Figure.1.7.1 Schematic representation of the complementing nature of proteomics and functional genomics 
technologies to the study systems biology. (Illustration adopted from Tyers and Mann, (2003)) 
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Integration of these data sets through bioinformatics will yield a comprehensive database 
of gene function that will serve as a powerful reference of protein properties and functions, 
and a useful tool for the individual researcher to both build and test hypotheses. The main 
reasons for doing proteomics are two folds.  
 
There is no linear relationship between the genome and the proteome of a cell, however 
proteins are the ‘active agents’in cells. Genomics tells us nothing about: post-translational 
protein modifications, protein isoforms, protein expression levels and the localization of 
gene products (Görg, 2000). Protein-protein interactions and the molecular composition of 
cellular structures such as organelles can only be determined at the protein level. The 
important steps in a typical proteome analysis experiment are explained below briefly.  
 
Sample Preparation 
One of the most crucial steps in the 2D-gelelectrophoresis is obtaining and handling the 
protein sample. The E. coli chromosome contains app. 4.000 protein coding genes, but 
even the best two-dimensional gels can routinely resolve no more than 2.000 proteins. 
Therefore it is necessary to fractionise cells into organelles, intracellular proteins, 
membrane proteins or to enrich proteins of interest e.g. by antibody based affinity 
purification. In addition the multitude of working steps complicates the reproducibility of 
the method, which makes it essential to optimise and standardize growth conditions and 
sample preparation.  
 
First Dimension- Isoelectric Focussing 
The isoelectric focusing concentrates proteins at their pIs and allows proteins to be 
separated on the basis of very small charge differences. Under the influence of an electric 
field a protein moves in a pH gradient until it reaches the position where its net charge = 0 
(Isoelectric point). Proteins with a positive net charge will migrate towards the cathode and 
proteins with a negative net charge will migrate towards the anode. If a protein diffuses 
away from its pI, it immediately gains charge and migrates back. Today, pre-cast 
immobilized pH gradient strips (IPG´s) are used because of several advantages: high 
reproducibility – no drift of the pH gradient, ease in handling, high loading capacity, 
increase in the useful pH range (different ranges e.g. 3-10, 6-11, 4-7). IEF is performed 
under strictly denaturing conditions (e.g. 8 M Urea, detergents), which minimizes 
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aggregation and intermolecular interactions. The use of high voltages (e.g. 8000 V for 3 h) 
results in a high degree of resolution.  
 
Second Dimension- SDS PAGE 
During the second dimension the polypeptides are separated according to their molecular 
weights. Each spot in the resulting two-dimensional array corresponds to a single protein 
species in the sample. SDS has to be added for the following reasons: to mask the protein 
charge by forming an anionic complex with constant net negative charge per mass unit, to 
disrupt hydrogen bonds, to block hydrophobic interactions and to partially unfold the 
proteins. Reducing reagents like DTT have to be added for the following reasons: to cleave 
disulphide bonds between cysteine residues, to completely unfold proteins which results in 
‘flexible rods’ of negative charges with equal charge densities. Today the second 
dimension is often performed in a vertical electrophoresis system, where no stacking gels 
are necessary. Normally large gels (for a high resolution) and as many gels as possible per 
electrophoresis run (for a high reproducibility) are used.  
 
Analysis- Spot identification 
2D-gels can be stained by different methods. They include 
Autoradiography or phosphor imaging - most sensitive method, but sample must consist of 
radiolabeled proteins (35S, 14C, 3H or 32P) 
Fluorescent staining (e.g. SYPRO Red, Ruthenium Chelate) - rapid, simple and sensitive 
method, but very expensive dyes and additional equipment 
Silver staining - most sensitive non-radioactive method, but time consuming; many 
variables like reagent, precise timing, and water quality make quantification difficult, not 
compatible with MS 
Coomassie staining - relatively simple and more quantitative method, MS compatible, but 
50-fold less sensitive than silver staining. 
 
After the staining procedure patterns containing several hundred spots make image 
collection hardware and image evaluation necessary. The optical information is first 
captured with a transmissive scanner (densitometer) and than a software helps to 
automatically detect the spots, to correct the background, to quantify spot densities and to 
mach the spots between gels.  
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Mass spectrometry for protein identification 
Mass spectrometry is the cornerstone in Proteomics. Once interesting proteins are selected 
by differential analysis or other criteria, the proteins can be excised from gels and 
identified. The ability to precisely determine MW by mass spectrometry and to search 
databases for peptide mass matches has made high throughput protein identification 
possible. Peptides are generated by an in-gel digestion of the treated protein spot with 
enzyme like Trypsin that generates a unique set of peptides for each protein owing to its 
site-specific cleavage. The peptide mass fingerprinting is usually done with a MALDI-TOF 
(Matrix Assisted Laser Adsorption/Ionisation Time Of Flight) Mass spectrometry. Proteins 
that are not identified by MALDI TOF can be identified by sequence tagging or de novo 
sequencing using Q-TOF (Quadrapole –Time of Flight) Mass Spectrometry, where a single 
peptide is fragmented and sequenced.       
 
Proteomics approaches have been used to characterize phenotypic changes in 
Pseudomonas putida in response to surface associated growth (Sauer and Camper, 2001). 
Comparative proteome analysis has been used to compare virulent and avirulent strains of 
Brucella melitensis (Eschenbrenner et al., 2002), antibiotic sensitive and resistant strains of 
Staphylococcus aureus (Cordwell et al., 2002), Mycobacterial strains (Jungblut et al., 
1999), to study erythromycin resistance in Streptococcus pneumoniae (Cash et al., 1999). 
Eukaryotic response to Pseudomonas aeruginosa quorum sensing signals (AHL) has been 
investigated using proteomics (Mathesius et al., 2002). Several strategies for analysis of 
microbial proteomes and data exploitation have been extensively reviewed elsewhere 
(O’Connor et al., 2000; Washburn and Yates 2000; VanBogelen et al., 1999; Cash, 2000). 
Cordwell et al., (2001), have extensively reviewed comparative proteomics of bacterial 
pathogens. A preliminary reference map of the membrane subproteome of P. aeruginosa 
has been generated by gel based proteomic approaches by Nouwens et al., (2000).   
Proteomics approach has been used for characterizing transitional episodes in 
Pseudomonas aeruginosa biofilm development (Sauer et al., 2002). A detailed account of 
the application of proteomics to Pseudomonas aeruginosa is provided in the reviews by 
Nowens et al., (2003) and Sherman et al., (2001). The recent completion of the 
Pseudomonas Genome Project, in conjunction with the Pseudomonas Community 
Annotation Project (PseudoCAP) has fast-tracked our ability to apply the tools 
encompassed under the term 'proteomics' to this pathogen. Such global approaches will 
allow the research community to answer long-standing questions regarding the ability of P. 
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aeruginosa to survive diverse habitats, its high intrinsic resistance to antibiotics and its 
pathogenic nature towards humans. Proteomics provides an array of tools capable of 
confirming the expression of Open Reading Frames (ORF), the relative levels of their 
expression, the environmental conditions required for this expression and the sub-cellular 
location of the encoded gene-products. Since proteins are important cellular effectors, the 
biological questions we pose can be defined in terms of changes in protein expression 
detectable by separation to purity using two-dimensional gel electrophoresis (2-DGE) and 
relation to gene sequences via mass spectrometry. As such, we can compare strains with 
well-characterized phenotypic differences, growth under a variety of stresses, protein 
interactions and complexes and aid in defining proteins of unknown function. More 
focused approaches that target sub-cellular fractions ('sub-proteomes') prior to 2-DGE can 
provide further functional information. 
 
Tandem mass spectrometry (MS) has provided proteomics initiatives with highly selective 
methods for characterizing the dynamic state of protein mixtures responsible for biological 
function and specificity (Licklider, 2002 ). The throughput and sensitivity limits of MS-
based methods for peptide sequence analyses are tested by comprehensively identifying 
and characterizing relevant proteins from crude cellular mixtures, thereby setting 
demanding requirements upon the initial stages of purification and separation. Progress 
toward meeting these requirements has been maintained by combining relatively large-
volume methods developed to selectively isolate or resolve protein and peptide mixtures 
with low-volume capillary liquid chromatography methods performed on-line with 
automated MS/MS analyses for maximum sensitivity.  Often, excised gel bands from SDS-
PAGE are converted to proteolytic mixtures prior to sequence analysis by LC-MS/ MS 
techniques. Peptide sequence information (MS/MS spectra) is acquired with a high degree 
of automation via data-dependent software, which provides the ability to sequence five or 
more peptides independently following a single MS precursor scan to identify peptide 
parent ions. This highly sophisticated data dependent analysis can provide as many as 60 
MS/MS acquisitions per minute for high throughput in mixture analyses where thousands 
of MS/MS identifications are needed. Matching uninterrupted “raw” MS/MS spectra 
against protein and EST databases using Sequest or other database search algorithms is a 
rapid means to unambiguously identify peptide and protein sequences as well as many 
structural modifications to proteins. However, achieving fully automated analyses is a 
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challenging endeavor for nanoscale LC-MS/MS, which uses capillary columns of <100µm 
i.d. that permit flow rates of 150 nL min-1. 
 
1.8 Real Time Polymerase Chain Reaction 
 
Previously, gene quantification has been hindered by the lack of a fast, reliable and 
accurate method (Freeman et al., 1999). The traditional methods of gene expression 
quantification like Northern blotting, S1/RNase nuclease protection assay and in situ 
hybridization often work well but generally require large amount of RNA. The 
development of PCR and, in particular, reverse transcriptase PCR (RT-PCR) has made 
gene quantification easier, only a small amount of RNA being required and a large number 
of samples being analysable in one experiment (Tan and Weis 1992). The subsequent 
development of real-time PCR has greatly improved quantitative PCR and has several 
advantages over endpoint quantification. In real-time PCR, the quantification is based on 
the cycle number at which the PCR product is clearly detected rather than on the amount of 
PCR product accumulated after a fixed number of cycles. When there is a high starting 
copy number of the target present in the sample, fewer cycles are required for the 
production of a signal, and when the target copies are low, more cycles are required. In 
real-time PCR, accumulation of the product is monitored cycle by cycle.  
 
 
 
 
 
 
 
 
Figure 1.8.1 LightCycler (real time PCR equipment from Roche) 
used for the present study. (Illustration adopted from Lightcycler 
user manual, Roche).  
 
The LightCyclerTM (refer figure1.8.1) is a real-time PCR machine that allows both rapid 
PCR cycling and continuous monitoring of product formation (Wittwer et al., 1997). 
SYBR Green I, an intercalating dye that fluoresces strongly when bound to double 
stranded DNA (dsDNA), is included in the reactions so that when PCR products are 
formed, an increase in fluorescence occurs (Ririe et al., 1997). For quantitative PCR, 
standards of known concentration are included in each run. A standard curve of cycle 
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number vs. copy number is plotted; samples of unknown concentration are compared with 
this curve and their concentrations are calculated (Wittwer et al., 1997). The LightCycler 
instrument basically consists of two different components: a cycler component and a 
fluorimeter component. These components work together to simplify such complex 
applications as product analysis, quantification, and mutation analysis. The cycler 
component has been optimized for rapid PCR applications. Unlike conventional PCR, in 
which cycling programs take several hours, PCR analyses conducted with the LightCycler 
take only 20–30 min. Data obtained from fluorimetric analysis can be displayed and 
directly evaluated with the special LightCycler software. Hence, no additional tedious and 
time consuming procedures (e.g., agarose gel or Southern blotting analyses) are required to 
analyze the PCR product. Direct, uncomplicated analysis of results also reduces the 
number of sample handling steps, thus minimizing the risk of sample contamination. 
Figure 1.8.2 shows the comparison of the data output from a conventional PCR and real 
time PCR.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8.2 Comparison of data output 
from conventional PCR and real time PCR 
using Lightcycler . (Illustration adopted from 
Lightcycler user manual, Roche).  
 
 
One of the greatest advantages the LightCycler instrument offers in comparison to 
conventional thermal cyclers is that the formation of amplification products can be 
monitored in real-time. SYBR Green I is a dye that binds specifically to double stranded 
DNA. Its inherent fluorescence is enhanced when it binds to the minor groove of double-
stranded DNA. During PCR, SYBR Green I binds to DNA products as they are 
synthesized. Thus, the increase in SYBR Green I fluorescence, when measured at the end 
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of each elongation cycle, indicates the amount of PCR product formed during that cycle. 
To increase the specificity and sensitivity of SYBR Green I detection, a melting curve 
analysis is performed on the amplification reaction. Together with a melting curve 
analysis, the SYBR Green I format provides an excellent tool for specific product 
identification and quantification. Dye staining can detect from approx. 1 to 109 copies of a 
target sequence. Resolution of this amplification-detection method is limited at very low 
concentrations of template. The LightCycler measures the fluorimetric intensity of SYBR 
Green I at the end of each elongation phase. The maximum excitation of SYBR Green I 
dye occurs at 497nm. Maximal emission of DNA stained with SYBR Green I occurs at 521 
nm. SYBR Green I is stable at temperatures and pHs that occur during rapid thermal 
cycling. SYBR Green I is significantly less mutagenic than ethidium bromide.  
 
1.9 Small Colony Variants of Pseudomonas aeruginosa – State of the Art 
Pseudomonas aeruginosa occur in diverse ecological niches of natural environments as 
well as in infections of humans, animals and plants.  This ubiquitous distribution of 
P.aeruginosa indicates a remarkable degree of physiological and genetic versatility. 
However there seem to be no genetic or functional differences between environmental and 
clinical strains (Foght et al., 1996; Romling et al., 1994). The opportunistic pathogen P. 
aeruginosa being a key etiological agent of hospital-acquired infections in the 
immunocompromised host, is also responsible for chronic lung infection in cystic fibrosis 
(CF) patients (Gilligan, 1991; Lyczak et al., 2002; Govan and Deretic, 1996; Breitenstein 
et al., 1997).  
 
 
 
 
 
 
 
 
Figure 1.9.1. Morphotypes of strain 20265 grown on Columbia blood agar plates.   Small colony variant 
-in vivo isolated (A), Wildtype -in vivo isolated (B), Revertant -in vitro generated (C). (Illustration adopted 
from Haussler et al., (2003))  
 
 
 
A B C
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Despite the fact that chronically infected CF patients harbor only one or few P. aeruginosa 
genotypes (Breitenstein et al., 1997), there is significant phenotypic variation in P. 
aeruginosa isolates from the CF lung, known as ‘dissociative’ behavior (Zierdt and 
Schmidt, 1964). The chronically infected CF lung is thought to provide a habitat where P. 
aeruginosa in high cell densities faces a multiplicity of environmental challenges that lead 
to morphological diversification and the establishment of niche specialists (Oliver et al., 
2000). Apart from the best-studied mucoid P. aeruginosa phenotype and other colony 
morphotypes (Govan and Deretic,1996), it has been recognized for many years that dwarf 
colonies can be isolated from the chronically infected respiratory tract of CF patients 
(Zierdt and Schmidt, 1964).  
 
Although studies have so far been focused on the most common mucoid phenotype, other 
phenotypic variants do exist in the chronically infected CF lung, e.g. so-called SCVs, 
comprising phenotypic variants characterized by slow growth on agar plates and increased 
antibiotic resistance against a broad range of antipseudomonal agents (Haussler et al., 
1999). These dwarf or so-called small-colony variants (SCVs) of P. aeruginosa (refer 
Figure 1.9.1) isolated in our laboratory and their recovery of could be correlated with 
parameters revealing poor lung function and the use of inhaled antibiotics (Haussler et al., 
1999). Small colony variants (SCVs), slow growing subpopulations of bacterial pathogens 
have gained attention in the recent years. Staphylococcus aureus SCVs have been found to 
be associated with persistent and relapsing infections (von. Eiff et al., 2000), increased 
drug resistance (Schmitz et al., 2001) and altered biochemical profile. There is an 
increasing body of evidence about their role in exacerbation and persistence of infections.  
 
The recovery of SCVs has a strong correlation with poor lung function and 
antipseudomonal aerosol therapy. The P. aeruginosa SCVs show increased resistance to a 
broad range of antipseudomonas drugs (Haussler et. al., 1999) apart from the typical SCV 
traits like small colonial morphology and slow growth as compared to their wildtype 
counterparts. Another very distinctive feature of P. aeruginosa SCVs isolated was their 
reversion into fast growing phenotypes (revertants) with regained susceptibility patterns 
after several in vitro passages in antibiotic free medium. Also the SCVs and their 
revertants did not show any auxotrophy for haemin, menadione or amino acids. Whether 
the SCVs of P. aeruginosa are specially adapted for a hostile environment of the host lung 
needs to be investigated.  
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Recently, Deziel et al., (2001) isolated a hyperpiliated and highly adherent small 
phenotypic variant from a biofilm of P. aeruginosa strain 57RP in vitro. It was suggested 
that the occurrence of this variant within the ecological niche of the biofilm was regulated 
by a phase-variation mechanism. Similarly, a phase-variation mechanism has been 
proposed to be the cause of the phenotypic switch of an antibiotic resistant and 
autoaggregative rough SCV of P. aeruginosa strain PA14 to wild-type revertants 
(Drenkard and Ausubel, 2002).  
 
Haussler et al., (2003)  identified a subgroup of hyperpiliated P. aeruginosa SCVs isolated 
from the respiratory tract of CF patients that exhibited similar phenotypic characteristics 
such as autoaggregative growth behavior in liquid cultures and increased biofilm formation 
capacity. It was proposed that apart from the antibiotic selection pressure, which might 
favor the occurrence of SCVs, the diversity of our P. aeruginosa morphotypes could be 
due to adaptive mutations and selection, as had been described for the morphological 
diversity of P.  fluorescens phenotypic variants in the heterogeneous environment of a 
static broth (Rainey and Travisano, 1998). 
 
Wehmhöner et al., (2003) reported that proteome analysis of several clinical P. aeruginosa 
strains including the strain 20265 used in this study, revealed almost identical patterns for 
the cellular extracts, whereas interclonal diversity and intraclonal diversity were 
manifested in the secretomes of cultured P. aeruginosa. The diversity was even greater for 
the immunogenic protein patterns expressed in vivo. Proteome analysis of the P. 
aeruginosa morphotypes SCV, revertant and wild type in our laboratory has revealed the 
differential expression of haemophore HasAp (a haem acquisition protein) among these 
morphotypes. SCVs express abundant HasAp from an early log phase of growth as 
compared to the wild type. 
 
von Götz (2003) has carried out an extensive transcriptome analysis of the morphotypes of 
strain 20265 using DNA microarrays. Overall 309 differentially regulated genes were 
reported during log and stationary growth phases of growth. As a prominent pathogenicity 
factor of P. aeruginosa the type III protein secretion system and the corresponding effector 
proteins were found to be upregulated in SCV 20265. The gene expression profiles seemed 
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to indicate that SCV 20265 was arrested in a physiological state reflecting its adaptation to 
an anaerobic environment, antibiotic pressure and a biofilm mode of growth. 
 
Till now the molecular causes of the SCV phenotype among the clinical SCVs remains 
unknown. Even though lots of general functional genomics and proteomics data exist about 
the clinical SCVs used in this study, very little information on their pathogenic aspects and 
their specific adaptation to key stress conditions like iron limitation, oxidative stress and 
anaerobic stress exist. The present study aims to contribute some useful information in this 
context so as to enable a better understanding of the SCV phenotype, its molecular causes 
and role in pathogenicity.    
 
 
1.10 Objectives of the present study 
 
The major objectives of this study were as follows  
 
• To determine if there is any survival or growth advantage for SCV 20265 (a 
representative of the subgroup of autoaggregative hyperpiliated, cytotoxic SCVs) 
compared to its clonal wildtype WT 20265 under severe iron limiting conditions, 
oxidative stress conditions and anaerobic/microaerobic growth conditions. 
 
• To compare the proteome profile of these morphotypes under conditions where 
they show a differential growth response to iron limitation, oxidative stress and 
anaerobic stress. 
 
• To look for differentially expressed membrane proteins and supernatant proteins 
using a subproteomic approach. 
 
• To screen morphotypes of other member strains of the subgroup of hyperpiliated 
autoaggregative SCVs to assess the distribution of abilities to survive harsh stress 
conditions. 
 
• To obtain clues about, which selection pressures could be operating in the CF lungs 
to promote the occurrence of small colony variants.  
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2. Materials and Methods 
2.1 Chemicals and Materials 
 
2.1.1 Chemicals, Reagents and Enzymes 
Enzo BioArray Terminal Labeling Kit, 
Oligonucleotide B2, P.aeruginosa GeneChip Affymetrix 
SUPERaseIn (RNase Inhibitor) Ambion 
Immobiline-solution, IPG buffer, IEF 
(Acrylamide-Bisacrylamide Solution, T = 4%), 
Deoxynucleotides, Hybond N+ nylon 
membrane, OnePhorAll-buffer, RNase-free  
DNase l 
 
Amersham Pharmacia Biotech (Freiburg) 
Urea, Thiourea Baker (Phillipsburg, USA) 
DTT; CHAPS; Leupeptin; Pefablock Biomol (Hamburg) 
SeaKem GTG Agarose Biozym 
α-Cyano-4-hydoxy-Cinnamic acid Bruker Daltonik (Bremen) 
Agar, Bacto-Peptone Difco 
Acrylamido Buffer, Tributylphosphine Fluka (Deisenhofen) 
Agarose Gibco BRL 
Bromophenol blue, Bovine serum albumin, 
MOPS buffer, Random Primers, RNA-standard, 
Serva Blau G-250, SuperScript II Reverse 
Transcriptase, Xylene cyanol FF Invitrogen 
Formaldehyde (35%), H2O2 (30%)  
Iodoacetamide, Benzonase (Endonuclease) Merck (Darmstadt) 
Streptavidine-Phycoerythrine, SYBRGreen Molecular Probes          
Sypro ruby Protein Gel Stain Molecular Probes (Leiden, Netherlands) 
Oligodeoxynucleotides, Primers MWG-Biotech                 
DNA-ladder standards New England Biolabs      
Streptavidine Pierce Chemical 
RNase Inhibitor, Trypsin (porcine, sequencing 
grade modified) Promega 
Plasmid Spin Kit, Qia- Mini Prep plasmid kit, 
QIAquick Gel Extraction Kit, RNeasy Kit,  Qiagen 
Lumi Light Chemiluminiscene Substrate Roche Diagnostics (Mannheim) 
RBS 30 (Washing Solution); Rotipherese Gel 
30 (Acrylamide / Bis-acrylamide solution, 
T=40%); SDS; Siliconol M 100, Ethidium 
bromide, Phenol (Rotiphenol) 
 
 
Roth (Karlsruhe) 
Coomassie Brilliant Blue G-250; Coomassie 
Brilliant Blue R-250 Serva (Heidelberg) 
ASB 14; BSA (Fraction V), Paraquat, Tween 
20, H2SO4 Sigma (Deisenhofen) 
Carrier Ampholyte (Sinulyte) Sinus (Heidelberg) 
Biotin anti-Streptavidine Vector Laboratories           
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2.1.2 Equipments and other materials 
 
CCD camera LAS-1000 and intelligent Dark 
Box  
Fujifilm (Raytest) 
Electrophoresis Power supply EPS600/EPS 
3500 XL 
Amersham Pharmacia Biotech (Freiburg) 
Flat bed Scanner Powerlook III Umax Systems (Willich) 
Gel Dryer Easy Breeze Hoefer (Amersham Pharmacia Biotech) 
IPGphor Focussing System Amersham Pharmacia Biotech (Freiburg) 
Iso-Dalt Electrophoresis System Hoefer (Amersham Pharmacia Biotech) 
MALDI TOF MS Bruker Ultraflex Bruker Daltonik (Bremen) 
MilliQ water purification system Millipore  (Eschborne) 
Optima TLX ultracentrifuge Beckmann (Gladenbach) 
Photometer Spectronic 20 Genesys Spectronic Instruments (Leeds, Great Britain) 
Quadropole – MS QTOF II Micromass (United Kingdom) 
Spectramax 250 Microtiter Photometer MWG Biotech (Ebersberg) 
Trans-Blot SD Semi Dry transfer Cell Bio-Rad (Munich) 
Balance BP3100S and BP210 S   Sartorius 
Centrifuge     Hettich Universal 
Eppendorf centrifuge 5415C   Eppendorf 
Eppendorf centrifuge 5417R   Eppendorf 
pH meter 766 Calimatic    Knick 
Spectrophotometer U3000   Hitachi 
Thermocycler     Landgraf 
Thermomixer     Eppendorf 
UV- Transilluminator    Bachofer 
UV Stratalinker 1800    Stratagene 
Vacuum concentrator    Bachofer 
Voltage supply power pack 300   Bio-Rad 
 
 
 
Biomax Light Film Kodak (Stuttgart) 
Cellophane Sheets 33X38 cm Amersham Pharmacia Biotech (Freiburg) 
Chelex 100 Biotechnology grade Bio-Rad (Munich) 
GelBond-PAG-Film (FMC Bioproducts) Hoefer (Amersham Pharmacia Biotech)  
Immobiline DryStrips Amersham Pharmacia Biotech (Freiburg) 
Molecular weight standard; MW 14.4–94 Kda Amersham Pharmacia Biotech (Freiburg) 
PVDF membrane (Roti-PVDF) Roth (Karlsruhe) 
ReadyStrip IPG Strips Bio-Rad (Munich) 
SERDOLIT MB-1 Ion exchanger Serva (Heidelberg) 
ZipTipc18, ZipTipµc18 Millipore (Eschborn) 
Anaerobic chamber Anerocult Merck 
Eppendorf tubes (0.5 ml, 1.5 ml, 2 ml)  Sarstedt 
Filter paper GB003  Schleicher and Schuell 
Pasteurpipette  Sarstedt 
Petri plates 9 cm Ø  Sarstedt 
Pipette tips (1 ml, 200 µl, 10 µl)  Sarstedt 
Plastic tubes (50 ml, 15 ml)  Greiner 
Polaroid film 667  Polaroid 
X-ray film Kodak AGFA 
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2.1.3 Computer Programmes and Databanks 
 
AIDA advanced image data analyser 2.1 Raytest isotope measuring GmBH (Straubenhardt) 
Brucker Data Analysis for TOF 1.6g Brucker Daltonik (Bremen) 
Mascot  Matrix Science Ltd. 
Image reader LAS-1000 Fujifilm 
Knexus/MS  Proteometrics (Winnipeg, Mannitoba, Canada) 
SOFTmax Pro Molecular Devices (Munich) 
Sonar ProteoMetrics 
Jellyfish version 2.1  LabVelocity 
ProteomeWeaver Definiens Imaging GmbH 
Microarray Suite Affymetrix (USA) 
Microsoft Access, Excel Microsoft (USA) 
 
 
 
Gene and Protein sequences 
Annotation data- Databank 
of the Pseudomonas 
aeruginosa Genome project 
 
http://www.pseudomonas.com 
 
 
P.aeruginosa genome 
databank of the Entrez NCBI 
 
http://www.ncbi.nlm.nih.gov/database/index.html 
NCBI P.aeruginosa 
complete genome 
 
http://www.ncbi.nlm.nih.gov/cgi-
bin/Entrez/framik?db=Genome&gi=163 
‘‘SWISS-PROT’ (Protein 
Knowledgebase)’’and 
‘’TrEMBL (Computer 
annotated supplement to 
SWISS-PROT) ‘’  
http://us.expasy.org/sprot/ 
 
 
 
2.1.4 Media and Solutions  
 
Vogel Bonner (VB) medium VOGE56 
Amount/liter Component      Final concentration 
  
0.813 g  Magnesium Sulphate (MgSO4)      3.3 mM 
2.378 g  Citric acid       10 mM 
5.802 g  Sodium ammonium. Hydrogen Phosphate (NaNH4PO2) 28 mM 
8.543 g  Di-pottassium Hydrogen Phosphate(K2HPO4)  37 mM 
50.13 g  Gluconic acid (Sodium salt)    
Volume made up to 1 liter with double distilled water and pH adjusted to 7.2.  
 
VB Agar 
VB medium was solidified by adding 15 g/l agar and autoclaved. 
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Luria Broth (LB)  
Peptone 15 g/l 
Yeast Extract 5 g/l 
NaCl (10 g/l) 0.17 M 
 
LB Agar 
LB medium was solidified by adding 15 g/l agar and autoclaved. 
 
PBS (10X) 
NaCl (80 g/l) 1.37 M 
KCl (2 g/l) 27 mM 
Na2HPO4 7H2O (11.5 g/l) 4.3 mM 
KH2PO4 (2 g/l) 1.4 mM 
pH 7.3 
 
Solutions for DNA work 
 
TBE-Buffer (10X): 
Tris (108 g/l) 0.9 M 
Boric Acid (55 g/l) 0.9 M 
EDTA (7.7 g/l) 0.02 M 
pH 8.3-8.5 
 
Loading Buffer (6X): 
Ficoll 400 15% (v/v) 
Bromophenol Blue 0.25% (w/v) 
Xylene cyanol 0.25% (w/v) 
EDTA (146 g/l) 0.5 M 
pH 8.0 
  
TB Buffer: 
PIPES (3 g/l) 10 mM 
CaCl2 (1.6 g/l) 15 mM 
KCl (18.6 g/l) 250 mM 
pH adjusted to 6.7 with KOH, then MnCl2 (50mM-9.58 g/l) 
was added, sterilized by filtration and stored at 4°C. 
 
TE Buffer: 
Tris-HCl (1.2 g/l) 10 mM 
EDTA (0.38 g/l) 1 mM 
pH 8.0 
 
Solutions for RNA work 
 
RNA Lysis buffer: 
SDS 2 % (w/v) 
Sodium acetate 3 mM 
EDTA 0.1 % (w/v) 
pH 5.5 
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DNase buffer (10 x): 
Sodium acetate 500 mM 
MgCl2 6H2O (20.3 g/l) 100 mM 
CaCl2 2H2O (2.94 g/l) 20 mM 
pH 6.5 
 
MOPS buffer (10 x): 
MOPS (41.8 g/l) 200 mM 
Sodium acetate 100 mM 
EDTA (2.9 g/l) 10 mM 
pH 7.0 
 
RNA loading buffer: 
Glycerol 50 % (v/v) 
EDTA (0.29 g/l) 1 mM 
Bromophenol blue 0.25% (w/v) 
pH 6.0 
 
cDNA Reaction mixture: 
1st Strand buffer 5X  
DTT 10 mM 
dNTPs 0.5 mM 
SUPERaseIn 0.5 U/µl 
SuperScript II 25 U/µl 
 
2.2 Strains and Culture conditions 
2.2.1 Bacterial strains – propagation and  maintenance 
SCV 20265 and wildtype 20265 isolated from the same CF patient and maintained in our 
laboratory collection were used for investigation. Also used, were CF isolates Strains 10, 29, 
52, 8226 and 231 with respective SCV, revertant and wildtype morphotypes. Stable revertants 
were generated by repeated culture passage in antibiotic free medium. PAO1, a wound isolate, 
genetic reference strain (Holloway et al., 1994), was also used. TB, a CF strain capable of 
intracellular survival was also used (Tummler, 1987). For long-term storage the strains were 
stored as glycerol stocks at – 80 ºC. All bacterial cultures were maintained in LB medium 
containing 15 % glycerol (v/v) and stored at – 80 °C. For strain propagation, the glycerol 
stock was streaked on to Columbia Blood agar (sheep blood 5 %) plates to allow effective 
visual comparison of colony morphology. All plates, eppendorfs and flasks were incubated at 
37 ºC.  
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2.2.2 Depletion of iron from the medium 
 
All glasswares including media storage bottles and funnels were stripped of any traces of iron 
contamination by treating with 2 M HCl and rinsed clean with double distilled water. Sterile 
plastic pipettes were used. All the culture experiments were done with plastic tubes so as to 
avoid free iron contamination. Iron depletion was achieved by treating VB medium, with iron 
chelating resin Chelex 100 (BIORAD) at 5 g per 100 ml concentration followed by moderate 
stirring at 4 ºC for 16 hr or longer. The chelex 100 resin was filtered out by using a filter 
paper and 2,2-Dipyridyl (SIGMA) added to the filtrate to a final concentration of 11 mM or 
any other specific concentration depending on the experimental needs. The iron-depleted 
medium was autoclaved before use. 
 
2.2.3 Iron supplementation disc assay 
 
Vogel Bonner (VB) medium was prepared freshly and 2,2-Dipyridyl was added to obtain a 
final concentration of 1.1 mM. High grade Difco bacto agar was added to 1.5% (w/v) and 
media autoclaved to pour plates. Iron depleted top agar was prepared containing 0.6 % agar. 
The following iron sources’ stock solutions were freshly prepared: 0.2 M ferrous sulphate 
(FeSO4), 0.1 M ferric citrate, 10–4 M haemoglobin, 10–2 M haemin chloride. Bacteria from 
freshly grown plates were washed vigorously with 0.9% NaCl and 100 µl containing 
approximately 2 - 5  X 10–7 bacteria were suspended in 3 ml of iron depleted top agar, mixed 
well and spread as a lawn on the iron depleted VB plates. Sterile filter paper discs were placed 
on dry plates and 8 µl of the iron source was spotted. After a brief period of drying, the plates 
were incubated at 37 °C for 48 hours. All stock solutions were prepared freshly before use. A 
10-4M haemoglobin stock solution was prepared freshly before use by dissolving haemoglobin 
in suitable quantity of sterile iron depleted medium. 0.2 M ferrous sulphate (FeSO4), stock 
solution was prepared freshly before use to prevent precipitation of iron as insoluble ferric 
hydroxide. Ferric chloride (FeCl3) and ferric citrate solutions were also prepared in the same 
way. All iron salt solutions were filter sterilized and not autoclaved. Haemin chloride stock 
solution was prepared by dissolving haemin chloride in the presence of NaOH. 10-2 M stock 
solution was prepared and stored at – 20 ºC. 
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2.2.4 Hydrogen Peroxide (H2O2) sensitivity assay 
Disc Sensitivity assay 
Fresh Luria (L) broth (10.0 g tryptone, 5.0 g yeast extract, 5.0 g NaCl (per liter; pH 7.2)) was 
prepared and used for making L -agar plates and L- soft agar. For L-agar plates, media was 
solidified using 1.5 % Bacto Agar and L-soft agar was prepared with 0.6% bacto agar. All 
morphotypes were grown aerobically at 37 °C in a shaker up to late stationary phase in VB 
medium. After 48 hr (stationary phase) and 72 hr (late stationary phase) 100 µl of bacteria 
was removed and diluted in 3 ml of L-soft agar and spread as a lawn over L-agar plates. 
Sterile filter paper discs were placed on the agar overlay and 8 µl of 30 % H2O2 was spotted 
on the discs. The plates were incubated for 24 hours at 37°C and the diameter of zone of 
growth inhibition around the discs was measured. 
 
Broth Sensitivity Survival percentage assay 
Bacteria were grown aerobically in VB medium until log phase (OD 600 = 0.8) or stationary 
phase (OD600=2.5) at 37 °C in 20 ml volume in 150 ml culture flasks. Organisms were 
diluted 1:10 in 3 ml of prewarmed VB medium and incubated with increasing concentrations 
of H2O2 (Merck) for 15 min. The suspensions were serially diluted in 0.9 % saline containing 
10 mg of bovine liver catalase (Sigma) per ml, and aliquots were plated on LB agar. CFU 
were enumerated after incubation at 37°C for 24 to 48 hr. The percentage viability was 
calculated by comparing the CFU before and after exposure to H2O2. 
 
2.2.5 Paraquat and H2O2 treatment for Proteome analysis  
For proteome analysis of effects of paraquat and H2O2 on the morphotypes, SCV and WT 
20265 were grown aerobically in 200 ml volume of VB medium in 2 liter culture flasks until 
stationary phase (OD600 2.0) and cells were harvested quickly by centrifugation .The 
harvested cells were packed into sterile dialysis bags and suspended in 300 ml fresh VB 
medium containing 0.03 % H2O2. For paraquat treatment, harvested cells were directly 
resuspended in fresh VB medium of 200 ml volume containing 0.5 mM paraquat (methyl 
viologen).The bacteria were incubated for 2 hr along with controls that were paralelly grown 
synchronous cultures  treated the same way except for the fact that they lacked any redox 
agents–H2O2 or paraquat. At the end of the incubation the cells were harvested immediately 
and washed once in 0.9 % NaCl containing bovine liver catalase (Sigma) (10 units /ml) 
followed by a wash once in normal 0.9 % NaCl. The cells were quickly spun down and frozen 
for sample preparation for 2D gel analysis. 
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2.2.6 Anaerobic growth of Pseudomonas aeruginosa  
Vogel Bonner (VB) medium was prepared freshly containing Potassium Nitrate (KNO3) 
supplement at a final concentration of 1 %. Nitrogen gas was bubbled for atleast 1 hr and the 
container closed immediately. The medium was filter sterilized using Millipore filter (0.22 µ) 
and always filled the medium into any container to the maximum level possible so as to expel 
any air in the container 14ml of the medium was quickly aliquoted into 15 ml falcon tubes. 
Approximately 1 X 108  bacteria were inoculated. The tubes were deposited in the anaerocult 
(MERCK) or Anerogen (OXOID) anaerobic growth chamber with appropriate oxygen 
depleting anaerobic pack and indicator strips to monitor anaerobic environment. A negative 
control having VB medium without KNO3 was included. The growth in this tube under 
anaerobic condition is negligible. 
 
2.3 Proteomics 
 
2.3.1 Sample preparation  
2.3.1.1 Extraction of cellular proteins   
The bacterial culture was centrifuged to pellet the bacterial cells by spinning at 4000 rpm for 
5 min in a 50 ml falcon tube. Larger volume cultures were prespun to concentrate the cells to 
a volume less than 50 ml and subsequently transferred to the 50 ml falcon tube. The pelleted 
cells were washed 2 times with cold 0.9 % NaCl by spinning quickly at 4500 rpm for 5 min. 
The pellet was resuspended in an appropriate quantity (usually between 1 - 2 ml) of pre IEF 
buffer (4 % CHAPS, Protease inhibitor tablet Complete (Roche)) depending on the pellet size. 
The samples were placed in an ice beaker. The samples were subjected to ultra-sonication 
with the following sonication parameters: output control 50; duty cycle 5; 3 X for 50 s each. 
The contaminating polysaccharides and nucleic acids, which are undesirable for a clean IEF 
were removed by a phenol extraction and purification as described below. Since sonication of 
the bacterial cells was not satisfactory in the pre IEF buffer having only CHAPS, the heating 
of the cells in the presence of phenol at 72 °C followed by brief chilling on ice was carried out 
to lyse the cells completely to release all nucleic acids.   1 ml of the sonicated cells was taken 
in a 2 ml eppendorf and 1 ml of Tris saturated phenol was added on top and vortexed briefly 
to mix the contents. The tube was heated to 72 °C for 10 min with simultaneous vortexing on 
a thermomixer (Eppendorf). The tube was briefly chilled on ice for 3 min followed by 
centrifugation at 13000 rpm for 10 min at 4 °C. The viscous aqueous phase containing the 
nucleic acids was removed by pipetting without disturbing the white protein layer at the 
aqueous: phenol interface and replaced by 1 ml milliQ water and the heating, cooling, 
                                                                                                             Materials and Methods 
34 
centrifugation steps were repeated again. The nucleic acids were removed by pipetting out the 
aqueous phase and replaced by 1 ml of milliQ water. The above steps were repeated once 
more to completely get rid of the nucleic acids along with the aqueous phase. 
 
 The proteins were finally precipitated by addition of 1 ml of ice-cold acetone at – 20 °C. 
After addition of acetone, the tube was briefly inverted few times to mix the contents and 
incubated in – 20 °C from 1hr to overnight. At the end of the incubation, the tube was 
centrifuged at 13000 rpm, 4 °C for 15 min to pellet out all the protein. The supernatant 
containing phenol and acetone was discarded and the pellet air-dried to expel all the acetone. 
To enhance the purity of the protein powder, it was resuspended in ice-cold acetone and 
washed by brief vortexing and resuspension followed by centrifugation. This was repeated 
twice and finally a dried ready-to-use protein powder was obtained by air-drying. This 
powder was resuspended in about 1 ml of sample solubilization buffer (IEF sample buffer). 
Unsolubilized debris was removed by ultra centrifugation for 45 min at 50000 rpm at 15 °C. 
(Low or High temperatures are not good for the urea component of the solubilization buffer). 
The clear supernatant having the soluble proteins was collected and stored at – 20 °C or – 70 
°C until use or immediately used. The concentration of the protein solution was estimated by 
Bradford Assay. 
 
2.3.1.2  Extraction of Supernatant Proteins  
For the preparation of secreted proteins in the culture supernatant, following centrifugation of 
the cultures (6000 x g, 15 min, 4°C) and passage of the supernatant through a 0.2 µm filter, 
deoxycholic acid (sodium salt) was added to a final concentration of 0.2 mg/ml [stock-
solution: 100 mg/ml, 1:500 dilution]. After 30 min incubation on ice the proteins were 
precipitated by addition of trichloroacetic acid to 6 % [wt/vol] [stock-solution 30 %, 1:5 
dilution] and incubation at 4 °C for 2 hr [or over night]. Following centrifugation at 18,000 g 
for 30 min the precipitated proteins were resuspended in a small amount of water and 8 
volumes acetone (- 20 °C) were added [for example: 5 ml water + 40 ml acetone]. After 
incubation at – 20 °C for 2 hr followed by centrifugation at 3500 g for 20 min at 4 °C, the 
pellet was allowed to dry for 5 min and dissolved in an appropriate amount of solubilization 
buffer. Following centrifugation at 50,000 g for 40 min at 15 °C the protein concentration of 
the supernatant was determined. Protein extracts were either used immediately for 2D gel 
electrophoresis or stored at – 70 °C.  
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2.3.1.3 Sample Solubilization Buffer / IEF sample buffer  
Every 100 ml of the IEF sample buffer contained 15 g Thiourea, 4 g CHAPS, 20 mg Tris     
(170 µl of 1M Tris at preferably alkaline pH), 460 mg DTT, 100 µl Leupeptin (from 1 mg / 
ml stock), 1 ml Pefablock (from 100 mM stock), 500 µl Pharmalyte 3 – 10 pH. All the above 
ingredients were dissolved one after another in 9 M Urea solution to make up the final volume 
to 100 ml. For preparing 100 ml Urea solution 54 g ultrapure Urea was weighed and dissolved 
in 100 ml MilliQ water to obtain 9 M Urea solution. This urea solution was treated with 
serdolit and filtered pure with whatmann filterpaper before using it to dissolve the other 
components of the buffer. This step was essential to deionize Urea in order to free the sample 
buffer of charged ions, which might interfere in the IEF.  Urea and Thiourea took longer time 
to dissolve and were never heated to temperature above 37 °C. IEF sample buffer was 
aliquoted into small vials and frozen. Thawed IEF sample buffer was used only once and 
instantly.   
 
2.3.2 Protein estimation by Bradford Assay 
Spectramax 250 microtiter photometer was used in combination with a SOFTMax PRO 
software to obtain protein concentrations. Bradford assay was performed on 96 well microtiter 
plates using 10 µl/well of the sample (or its dilution) whose protein concentration is to be 
determined. 200 µl of 1:5 diluted commercially available Bradford reagent (BIORAD) was 
dispensed into each well and mixed well with the 10 µl of the unknown sample or the BSA 
standards of known concentrations (1.0 mg, 0.8 mg, 0.6 mg, 0.4 mg, 0.2 mg, 0.1 mg) used for 
generating a standard curve. The software generates a table of results with concentration 
expressed in µg/ml. Using this, the total amount of protein can be estimated.   
 
To measure growth of the bacteria as function of amount of protein, sample pellets were 
collected in 2 ml eppendorf tubes or any tube of convenient volume. Bacterial pellet was 
vacuum dried to remove all traces of liquid. The pellet was resuspended in 100 µl of 
phosphate buffer followed by addition of 50 µl of 2 N NaOH. The tubes were vigorously 
vortexed followed by a brief centrifugation to concentrate all the liquid to the bottom. The 
tubes were boiled for 3-5 minutes to solubilise all the proteins before cooling on ice for 5 min. 
50 µl of 2.2 N HCl was added to neutralize pH and the volume adjusted to a common value in 
all the tubes to be analysed. This preparation was used for protein estimation was by Bradford 
assay on a 96 well microtiter plate format as described above. 
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2.3.3 I dimension - Isoelectric Focussing (IEF)   
The samples to be isoelectric focussed were aliquoted into eppendorf tubes as per the 
following guidelines depending on the type of detection method to be used to view the 
proteins after second dimension SDS PAGE and the pH range of the IPG strips to be used. 
18 cm IPG strip  
pH gradient Amount of protein Staining 
3-10 400 µg in 360 µl Colloidal Coomassie 
 40 – 60 µg in 360 µl Silver Staining 
4-7 600 µg in 360 µl Colloidal Coomassie 
 60-80 µg in 360 µl Silver Staining 
 
24 cm IPG strip 
pH gradient Amount of protein Staining 
4-7 800-1000 µg in 420 µl Colloidal Coomassie 
 80 – 100 µg in 420 µl Silver Staining 
5-8 800-1000 µg in 420 µl Colloidal Coomassie 
 80-100 µg in 420 µl Silver Staining 
. 
The IPG strip holder was thoroughly cleaned in a solution of detergent and later washed 
thoroughly in double distilled water to remove trace dirt and detergent completely. A clean 
tooth brush was used to clean the electrode region. The strip holder was soaked in MilliQ 
water for a brief period and then dried clean. IPG ampholyte buffer corresponding to the pH 
gradient of the IPG strip was added to the samples at 0.5 % of the final concentration.   1 µl of 
Bromophenol blue was added to serve as a tracking dye to monitor the progress of the 
focussing. The electrodes on the IEF tray were moistened with tiny paper strips soaked in 20 
µl SSB. The sample volume was made up to 360 µl or 420 µl with IEF sample buffer. Each 
sample was applied along the entire length of the ceramic IEF tray without any room for air 
bubbles. 
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Figure 2.3.1. IPGphor (Amersham Pharmacia) - I 
Dimension isoelectric focussing instrument used for the 
present study.  
 
 
The IPG strips stored at – 20 °C were labelled and applied on the IEF tray containing the 
protein sample, in such a way that the gel side of the strip is in direct contact with the sample 
liquid. Quickly, silicone oil was applied on top of the strips to prevent dehydration during the 
run. The focussing was carried out for 2 days until 120000 Voltage Hours were achieved with 
a maximum applied voltage being 8000 V. 
 
2.3.4 II Dimension  SDS PAGE 
 
Large format SDS PAGE gels of 12-15% linear acrylamide gradient were prepared in batches 
of 23 gels using the special casting system and glass plates supplied by the manufacturer 
(Hoefer). Typically each gel size was 20.3 x 25.4 x 0.15 cm.To generate a gradient two 
solutions of 1100ml volume each were prepared and dispensed into the casting chamber using 
a gradient mixer supplied along with the casting system. 1100 ml of ‘Light solution’ (38.965 
v/v Rotiphorese Gel 30 Acrylamide solution, 375 mM Tris, pH 8.6, 0.1 % SDS) and a ‘Heavy 
solution’ (48.70 % v/v Rotiphorese Gel 30 Acrylamide solution, 8 % v/v Glycerine, 375 mM 
Tris, pH 8.6, 0.1 % SDS) were prepared and cooled at 4 °C for atleast two hours prior to 
casting. Just before casting, 11ml of 10 % (w/v) APS and 1.57 ml of 10% (v/v) TEMED (for 
Light Solution) and 5.5 ml 10 % w/v APS and 0.42 ml 10 % v/v TEMED (for Heavy 
Solution) were mixed well and dispensed into the respective chambers in the gradient mixer. 
The glass plates were filled with the acrylamide gradient leaving about 2 cm of empty space 
on the top for embedding the IPG strips later on. To produce a flat uniform layer on top, 1-
Butanol was overlaid on the gel surface. The gels were normally solidified overnight. The 
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gels were later removed and stored in a bath of 375 mM Tris, pH 8.6; 0.1 % SDS in airtight 
boxes at 4 °C to prevent drying. Prior to II dimension SDS PAGE, equilibration of the 
isoelectric focussed IPG strips is carried out in order to acquaint the strips to the new buffer 
system containing SDS that will be used during the II dimension separation.  
 
IEF Strips equilibration buffer (Composition for every 500 ml): Urea 180 g (6 M Urea), 
Glycerol 150 g (170 ml of 87 % Glycerol; finally 30 % w/v), 10g SDS (100 ml of 10 % SDS 
stock; finally 2 % w/v), 16.7 ml of 375 mM Tris, pH 8.6. Dissolved in deionised water with 
final volume made up to 500 ml and aliquoted in vials and stored at  – 20 °C.  
 
 
 
 
 
 
 
 
 
 
Figure 2.3.2  IsoDalt (Hoefer) – II 
dimension SDS PAGE apparatus. 
 
Just before 2D SDS PAGE, the IEF strips were equilibrated with 2 solutions A and B 
consecutively with 15 minutes shaking for each procedure. The strips were equilibrated in 
special plastic equilibration trays. Normally a volume of 2.5 ml – 3.0 ml was used for each 
strip. Solution A: 100 mg DTT / 10 ml of IEF equilibration buffer. Solution B:  480 mg 
Iodoacetamide / 10 ml of IEF equilibration buffer.  The iodoacetamide containing solution B 
was handled with care and discarded safely as a toxic substance.  
 
II Dimension SDS PAGE was carried out on 12 – 15 % linear gradient polyacrylamide gel. 
The IE focussed strips were embedded in the polyacrylamide gel by using 1.0 % molten 
agarose (low endosmotic, Biomol) 
 
II dimension running buffer for SDS gel:  Tris base 5.8 g, Glycine 299.6 g, and SDS 19.9 g 
- all above components were dissolved in a final volume of 20 liters of double distilled water. 
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2.3.5 Staining and Visualisation of the Protein spots 
 
Colloidal coomassie stain ( Neuhoff Stain) 
 
Solution A 
20 g of 85 % H3PO4 
800 ml H2O 
100 g ( NH4) SO4 
H2O ad 980 ml  
 
Solution B 
5 % w/v CBB-G250 
 
Solution C  
98 ml solution A and 2 ml Solution B 
shaken overnight  
Staining solution ready for use: 80 ml C and 
20 ml Methanol 
 
Silver staining  
 
 Step Solution Time 
1 Fixation 40 % ethanol 10 % acetic acid  Minimum1.5 hr optimally 3 hr 
Maximum overnight 
2 Washing  30 % ethanol 3 times 40 min each or 2 times 30 
min each 
3 Sensitisation Sodium thiosulphate (0.2 g / l) 1 min 
4 Washing  Deionised water 3 times 2 min each  
5 Staining  0.2 % Silver nitrate 
0.02 % Formaldehyde 
20 minutes 
6 Washing Deionised water 3 times 1 min each 
7 Developing 3 %Sodium carbonate 
0.05 % Formaldehyde 
Sodium thiosulphate 
6- 9 min or even less, needs 
optimisation and judgement 
8 Washing  Deionised water 2 times 2 min each 
9 Stopping  0.37 % EDTA 10 min 
10 Washing Deionised water 3 min 
  
 
Destaining Silver stained gels 
In order to prepare Silver stain destaining solution, two stock solutions were prepared. 
(A) 30 mM Potassium Ferricyanide K3[Fe(CN)6] – 9.87 g/liter and  
(B) 100 mM Sodium Thiosulphate – 24.8 g/liter.  
(C) Ready to use destainer was prepared by mixing the above two stock solutions just 
before use in a 1:1 ratio because the destainer is unstable for long-term storage. So it 
was always prepared and used freshly. 
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Fluorescence Staining with Ruthenium Chelate  
20mM Stock solution of RuBPS stain was prepared and stored in dark at 4°C. Incubation of 
the gels with the staining solution should be carried out in dark, as the Fluorescence stain is 
light sensitive. The gels were fixed overnight in 30 % ethanol and 10 % acetic acid (all v/v). 
The fixation can also be carried out for only 3 - 4 hr. The gels were then rinsed 4 X 30 
minutes in 20 % ethanol to facilitate thorough removal of the acetic acid, as the acids if 
present strongly quench the fluorescence of the chelate. The gels were then stained for 3 - 6 hr 
in 20 % ethanol containing 100-200 nM of Ruthenium Chelate, i.e. 5–10 µl of the stock 
solution per liter of staining solution. The Staining can also be carried out overnight.  To 
reduce background, the gels can be washed overnight in 20 % ethanol. Prior to imaging the 
gels were re-equilibrated in water  (2 X 10 min). A comparison between two fluorescent metal 
chelates for staining proteins separated by electrophoresis has been carried out. One of these 
chelates is ruthenium II tris  (bathophenanthroline disulfonate) and the other is commercial 
Sypro Ruby. Both can be efficiently detected either with UV tables or with commercial laser 
fluorescence scanners. The sensitivity and homogeneity of the stains and the interference with 
mass spectrometry analysis have been investigated. It appears that both stains perform 
similarly for protein detection, while ruthenium II tris(bathophenanthroline disulfonate) 
performs better for mass spectrometry analyses and as cost-effectiveness ratio. However, 
Sypro Ruby is easier to use as a stain. 
 
2.3.6 Mini SDS PAGE gels for Western Blotting 
For western blotting and separation of proteins in only one dimension without Isoelectric 
Focussing on IPG strips, conventional SDS PAGE was employed. The resolving gel and 
stacking gel were prepared by mixing various components in appropriate volumes as 
mentioned in the Table below and poured into the glass plates for solidification. 
Stacking Gel  
Component Volume 
H2O 5.7 ml 
0.5M Tris-Cl pH 6.8 2.5 ml 
Rotiphorese Gel 30 (Acrylamide /Bis-acrylamide solution; Roth) 1.7 ml 
10 %SDS 100 µl 
TEMED 20 µl 
25 % APS 30 µl 
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Resolving Gel 
Component 7.5% 
AA gel 
10% 
AA gel 
12% 
AA gel 
15% 
AA gel 
H2O 7.4 ml 6.1 ml 5.1 ml 3.6 ml 
1.5 M Tris-Cl pH 8.8 3.8 ml 3.8 ml 3.8 ml 3.8 ml 
Rotiphorese Gel 30 (Acrylamide /Bis-acrylamide 
solution; Roth) 
3.8 ml 5.0 ml 6.0 ml 7.5 ml 
10 %SDS 150 µl 150 µl 150 µl 150 µl 
TEMED 20 µl 20 µl 20 µl 20 µl 
25 %APS 10 µl 10 µl 10 µl 10 µl 
 
SDS Running Buffer (10X concentrate) 
3.03 % (w/v) Tris-Base 
14.04 % (w/v) Glycine 
1.00 %(w/v) SDS 
 
Sample buffer (2X concentrate) 
0.5 M Tris/HCl, pH- 6.8 
20 % (v/v) Glycerine 
10 % (w/v) SDS 
5 % (v/v) β-mercaptoethanol 
0.25 % (w/v) bromophenol blue. 
 
 
2.3.7 Western Blotting 
The transfer of proteins from polyacrylamide gels to the membrane (‘Western-Blot’) was 
carried out using a ‘semi-dry’-System, employing a TransBlot SD Transfer system from Bio-
Rad. Four whatmann papers cut into an appropriate size as that of the membrane itself were 
soaked in the transfer buffer (25 mM Tris-Base, 190 mM Glycine, 0.1 % w/v SDS, 20 % v/v 
Methanol, pH 8.5) and applied on the anode plate. A clean PVDF membrane (Roth) of 
identical size was soaked in methanol and briefly drained for a second and subsequently 
soaked in transfer buffer and laid on top of the whatmann papers avoiding any air bubbles in 
between them. The region to be analysed on the SDS-PAGE gels was cut out into an 
appropriate size as the membrane and incubated in the transfer buffer for 2 minutes and laid 
on top of the PVDF membrane carefully avoiding any air bubbles between them. Four 
additional whatmann papers soaked in transfer buffer were quickly placed on top of the gel. A 
long glass pipette was rolled over the arrangement gently, in order to liberate any trapped air 
bubbles. The cathode electrode plate was carefully assembled on top and power applied for 90 
min such that current flow was 0.9 mA /cm2 of the membrane area. A higher voltage limit of 
25 V was adhered to as per the recommendation of the equipment manufacturer. At the end of 
the transfer, the membrane was incubated in blocking solution (5% w/v Skimmed milk 
powder, 1% w/v BSA, 0.02 %v/v Tween 20, 0.02 %v/v gelatin, in TBS solution) for 2 hr on a 
rocking platform. The primary antibody for detection was stored at –20°C in small aliquots by 
diluting in blocking solution. After blocking for 2 hr, for detection, the primary antibody was 
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dispensed at final dilution between 1: 2000 – 1:7500 in the blocking solution. The incubation 
of the membrane with the antibody was carried out for a minimum of 2 hr at 4°C. Incubation 
can also be extended over night. At the end of the incubation, the membrane was rinsed in 
running water once, followed by a sequential wash with a) TBS-T, b) TBS-T + 0.5M NaCl, c) 
TBS-T + 0.5%v/v TritonX-100, 15 minutes each. At the end of the wash, the secondary 
antibody (Anti Rabbit IgA) coupled to a peroxidase (Jackson Immuno Research) was used at 
an effective dilution of 1:8000 in the blocking solution. At the end of 2 hr incubation, the 
membrane was briefly washed in running water. The membrane was sequentially washed with 
a) TBS-T, b) TBS-T + 0.5M NaCl, c) TBS-T + 0.5 % v/v TritonX-100, 15 min each. 
 
The detection of the secondary antibody on the membrane was carried out using a commercial 
kit ‘Lumi Light’ Chemiluminiscence POD-substrates (Roche Molecular Biochemicals). The 
underlying principle behind the generation of the chemiluminesence is the coupled 
disproportionation of the peroxide by peroxidase conjugated to the antibody and simultaneous 
chemiluminescence generation by the luminol proportional to the peroxidase activity.  A 1:1 
mixture of the peroxide substrate and luminol/enhancer solutions supplied in the detection kit 
is poured on to the membrane and the membrane itself sandwiched between two plastic films 
and incubated for 5 min. The documentation of the signals was accomplished by exposing the 
membranes to photosensitive film (BiomaxLight Film, Kodak; exposure time 5 s – 45 s 
depending on the signal intensity) in a dark room or through a video camera (CCD-Camera 
LAS-1000 and Intelligent Dark Box, Fuji film; exposure time: 10 s – 5 min depending on the 
signal intensity). 
     
2.3.8 MALDI-TOF  MS 
2.3.8.1 Excision of protein spots from gels 
The gel was rinsed with water. Spots of interest were excised with the help of a clean pipette 
tip (1ml) cut at the end with a scissors (cutting always close to the bottom edge of the spot to 
suit the size of the protein spot of interest). The excised spots were chopped into cubes 
(approx. 1 mm3) using a sterile scalpel. Gel particles were transferred to an eppendorf tube 
(1.5 ml). Care was taken not to touch the gel with bare hands in order to avoid keratin 
contamination from skin and hair. Prior to first use, the latex gloves were washed with water 
to remove talcum powder and dust entering into the sample tubes. 
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2.3.8.2 Reduction and Alkylation 
Gel pieces were washed with 100-150µl of water for 5 min. The tubes were spun down and 
the liquid discarded. About 15-50 µl acetonitrile (enough to submerge the gels completely), 
was added and incubated for 10 to 15 minutes at 37°C in a votexer, until the gel pieces shrunk 
and became white and stuck together. The gel particles were spun down in a micro centrifuge 
and all the liquid removed. The gel pieces were swollen in about 50 µl of 10 mM 
Dithiothreitol / 0.1 M NH4HCO3 (with liquid enough to cover the gel and incubated for 15 
min at 56 °C to reduce the protein). This in-gel reduction of the proteins is crucial even if 
proteins were reduced prior to an electrophoresis. This enables better cleavage by Trypsin in 
the subsequent steps. The gel particles were spun down and excess liquid removed. The gel 
pieces were dehydrated with acetonitrile as in the previous steps. The acetonitrile was 
discarded and replaced by 50 µl of 55 mM iodoacetamide / 0.1 M NH4HCO3 and incubated 
for 15min at room temperature in the dark. At the end of the incubation, iodoacetamide 
solution was removed and the gel particles were washed with 150–200 µl of 0.1 M NH4HCO3 
for 15 min. The gel particles were spun down and all the liquid discarded. The gel particles 
were dehydrated with acetonitrile and subsequently all liquid removed and the reduced and 
alkylated gel particles were dried in a vacuum centrifuge. 
 
2.3.8.3 In gel digestion with Trypsin 
 The dry, reduced and alkylated gel particles were rehydrated in the Trypsin digestion cocktail 
containing 50 mM NH4HCO3, 5 mM CaCl2 and 12.5 ng/µl of Trypsin at 4 °C (on a ice 
bucket) for 30 – 45 minutes. (After 15 – 20 minutes, the samples were checked and more 
enzyme cocktail added if all the liquid was absorbed by the gel pieces). The remaining 
supernatant was removed and replaced with 5 – 25 µl of the same buffer but without trypsin 
to just submerge the gel pieces and keep them wet during enzymatic cleavage. The samples 
were left at 37 °C overnight to completely digest the proteins. 
  
2.3.8.4 Extraction of peptides  
15 µl of 25 mM NH4HCO3 was added directly to the trypsin digested gel pieces. For Nano ES 
MS/MS analysis, tryptic peptides were extracted from the gel particles. 10 – 15 µl of 25 mM 
NH4HCO3 was added and incubated at 37 °C for 15 min with vortexing. The gel particles 
were spun down and 50 µl acetonitrile (1 - 2 times equal to the volume of gel particles) was 
added and the tubes incubated at 37°C for 15 min with vortexing. The liquid was spun down 
and the supernatant collected and pooled with the earlier supernatant. 40 – 50 µl of 5 % 
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Formic acid was added and vortexed for 15 min at 37 °C. The gel particles were spun down 
and 50 µl of acetonitrile added to the previous mix. The tube was incubated at 37 °C for 15 
minutes with vortexing. The gel particles were spun down and the supernatant pooled with 
previous extracts. The extracted peptide containing pooled supernatant was dried down in a 
vacuum centrifuge. 
 
2.3.8.5 Guanidination of Lysine residues 
Digestion of proteins with Trypsin, generates some peptides with Lysine and some others 
with arginine as terminal residues. An analysis of the over all MALDI-TOF spectra reveals 
the under representation of spectral peaks corresponding to peptides with lysine as the end 
residue and a predominance of the spectral peaks corresponding to arginine containing 
peptides (Krause et al., 1999).  In order to improve the over all spectral quality and 
representation of lysine containing peptides, chemical modification of lysine residues to 
homoarginine (Hale et al., 2000; Brancia et al., 2001) has been widely used. The tryptic 
digests used in this study were also subjected to guanidination of lysine using a modified 
protocol (Beardsley et al., 2002).  The guanidination of lysine with O-methylisourea sulphate 
imparts a mass shift of 42.02 Da on the peptides. Briefly, for guanidination of the lysine 
residues, vacuum dried peptides were dissolved in 20µl 50mM NH4HCO3 and 20µl 2M O-
Methylisourea sulphate (3.2 g / 10ml of 200 mM Na2CO3 (pH 10)). The reaction was 
incubated at 37 °C overnight. The reaction was stopped with 1% TFA in water. The peptide 
solution was used directly for ZipTip purification before spotting onto the MALDI –TOF 
target. 
 
2.3.8.6 Ziptipping for MALDI-TOF 
For obtaining good quality MALDI-TOF MS spectra, the peptides spotted on the target must 
be free of hindering impurities and salts that could generate a strong background noise 
signals. It is therefore imperative to purify and enrich the peptides before placing them on the 
MALDI – target. ZipTip (Millipore), a pipette tip based chromatographic column of very 
small volume (1µl) was used for the purification and concentration of the peptides into a very 
small volume of 1 – 2 µl from a volume of 20-50 µl volume. The column is made of a special 
material that selectively binds the peptides from a hydrophilic solution (5 % Methanol) and 
the peptides can be eluted using a hydrophobic solution (65 % Methanol). The following 
solutions were prepared prior to ZipTipping.   
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Solution A: Wash solution and Elution solution – 65 % Methanol and 0.5 % HCOOH  
Solution B: Equilibration Solution and Peptide Solubilization solution – 5% Methanol and 
0.5% HCOOH 
 
The dried peptides were dissolved in 15 – 25µl of solution B. The wall of the eppendorf tube 
containing the dried peptides was rinsed several times with same solution thoroughly in order 
to scoop and get all the peptides into solution thoroughly. The ZipTip was washed in solution 
A by pippetting for 4 – 6 times with approx. 10 – 15 µl volume so as to wash the packed 
column. The ZipTip was equilibrated in solution B by pipetting a few times with a volume 
enough to wet the column. The empty equilibrated tip was introduced into the peptide 
solution. Avoiding air bubbles, the contents of the tube were carefully pipetted in and out of 
the ZipTip atleast 15 times, simultaneously washing the walls to extract as much peptide as 
possible into the column in the ZipTip.The ZipTip was washed a few times in fresh 
equilibration solution (Solution B) to remove dirt and unbound particles. The ZipTip was 
withdrawn from the tubes with about 15 µl of the equilibration buffer filled in. Gently 
screwing the pipette suction apparatus, all the liquid was expelled out of the ZipTip leaving 
behind only 1 - 1.5 µl. Pressing hard this last trace of fluid from the ZipTip was expelled 
completely and almost instantaneously 1 - 1.5 µl of matrix (α-Cyano-4-Hydroxy Cinnamic 
acid) dissolved in solution A (65 % Methanol and 0.5 % HCOOH) was aspirated. This liquid 
was expelled out onto a MALDI-TOF target in order to spot a mixture of concentrated peptide 
and matrix to crystallize. 
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2.3.8.7 Spot identification by Mass Spectrometry. 
The protein spots were identified by MALDI-TOF (Matrix assisted Laser Desorption / 
Ionization Time Of Flight) mass spectrometry: measurement of peptide masses by MS 
resulting in a list of measured peptide masses which can be matched against theoretically 
predicted peptides of proteins in databases (complete protein sequences required!).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.3   MALDI-TOF (Ultraflex, Bruker) 
used for the present study. 
 
 
The instrument Bruker Ultraflex (figure 2.3.3) was used for the present study. In the standard 
configuration the instrument is equipped with a gridless pulsed ion extraction ion source and a 
grid less reflectron that offer high transmission and optimal focusing. The effective flight path 
in linear mode is 1.2 m and 1.7 m in reflectron mode. The instrument employs a 337 nm laser 
with a computerised attenuation. Both positive and negative ion analysis are also provided in 
its standard configuration. All data were acquired in the reflectron mode utilizing peptide 
standards as internal calibrants. The library searching was fully automated and employed the 
MASCOT search program (Matrix Science). The searches in these applications were carried 
out on a local intranet server. A peaklist generated in the XTOF data analysis software was 
transferred to the BioTools software to be submitted for the library search. 
 
2.3.9 Isolation of Bacterial membranes 
The separation of membranes was performed under conditions that stabilize ribosomes using 
swing bucket ultracentrifuge rotors (Beckman), using 16 ml centrifuge tubes (Beckman). The 
following stock solutions were prepared: 1.5 M Potassium acetate pH 7.5 (made with acetic 
acid), 1M Magnesium acetate, 1M HEPES pH 7.5 (made with KOH and prepared freshly and 
autoclaved), 2.5 M Sucrose. Around 3 g cells were harvested by spinning 3000g for 10 min at 
4 °C. The cells were washed once with PBS at 4 °C. The pellet was stored at – 20 °C until 
further use or used immediately. The cells were lysed in MilliQ water containing 
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commercially available protease inhibitor tablets Complete (Roche) using a french press 
(Aminco). The lysis was monitored by observing a drop of the lysate under the microscope to 
look for any live cells. The lysed cells were stored on ice. A sucrose gradient was set up in the 
centrifuge tubes by overlaying increasing concentrations of sucrose solutions one on top of 
the other. The individual components of the gradient themselves were prepared by mixing the 
various components from the stock solutions above and diluting the 2.5 M sucrose stock as 
per the scheme below. 
 
To obtain 10 ml of individual components of the gradient, water and 2.5 M sucrose were 
mixed as follows. 
 
 
0 M Sucrose  1.5 M Sucrose 2 M Sucrose 
H2O 
(with protease 
inhibitor)  
8.8 ml 2.8 ml 0.8 ml 
2.5 M Sucrose 0 ml 6 ml 8 ml 
 
 
To 10 ml preparation of each concentration the following volume of the other components 
were added from their respective stock solutions in order to obtain a complete gradient onto 
which the sample can be overlayed.  
 
Final concentration                                                Volume from stock solution 
5 mM    Mg acetate     50 µl 
100 mM   K acetate     666 µl 
50 mM   HEPES    500 µl 
1/2000 volume  β-mercaptoethanol  5 µl 
 
The sample itself was prepared as an 8 ml volume sucrose solution with effective 
concentration of sucrose being 0.5 M. 
 
3 ml of 2 M sucrose was laid on the bottom of the centrifuge tube, gently. On top of this 
another 3 ml of 1.5 M sucrose was laid on top carefully avoiding any intermixing. The lysed 
cells (sample) itself  representing the 0.5 M sucrose component of the gradient was gently 
overlaid. 2 ml of 0 M sucrose (containing all components except 2.5 M Sucrose) was laid on 
top to complete the gradient (refer figure 2.3.4). All operations were performed on ice. The 
set up was placed on prechilled rotors and centrifuged in an ultracentrifuge at 27000 rpm (at 
least 50000 g) for 45 min at 4 °C. 
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Figure 2.3.4  Setting up a sucrose gradient and embedding the French pressed cells in the gradient for ultra 
centrifugation to isolate membranes. (Illustration courtesy, Maja Baumgärtner, GBF, Braunschweig). 
 
At the end of the ultra centrifugation, using a long tipped glass pasteur pipette, the membrane 
fraction seen as a white hazy ring at the interface between the 1.5 M sucrose layer and 0.5 M 
sucrose layer was collected. The isolated membrane fraction was mixed well with MilliQ 
water containing protease inhibitors (1:1) and centrifuged in an ultracentrifuge for 1 hr at 
27000 rpm at 4 °C. At the end of the centrifugation, the membrane pellet was washed with 3 
ml volume of ice cold 1M Tris (pH 7.5) for 30 min at 50000 rpm, 4 °C in a table top mini-
ultracentrifuge, in order to get rid of soluble cytoplasmic protein contaminants. The pellet was 
dispersed and treated with ice-cold 0.1M sodium carbonate solution of pH 11 by shaking in a 
rocking platform for 1 hour in order to break up any membrane vesicles. The membrane pellet 
was recovered by ultra centrifugation at 50000 rpm for 30 min at 4 °C. The pellet was 
subsequently washed with ice-cold MilliQ water twice in order to remove any traces of 
sodium carbonate remaining from the previous treatment. All the wash solutions contained 
protease inhibitors and were ice-cold solutions. The final pure membrane pellet was either 
directly dissolved in suitable sample buffers for 16 BAC separation or directly treated with 
Trypsin in case of nano flow LC/MS identification of the various membrane protein species.  
 
 
 
2.0 M
1.5 M
0.5 M
0 M
Membranes
Living /
Unbroken
cells
Membranes Sample (Lysed cells) 
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2.3.10 16 BAC gel analysis 
 
16 BAC - I Dimension  
 
7.5 % separation gel ( 40 ml)  
7.2 g   Urea  
10 ml   30 % AA / 0.8 % Bis AA 
10 ml   300 mM KH2PO4 / 1 % H3PO4  (pH 2.1) 
10 ml   Milli Q water 
1.4 ml   1.7 % Bis AA 
2 ml    80 mM Ascorbic acid  
64 µl    5 mM FeSO4 
1.6 ml   1 : 1200 Hydrogen peroxide H2O2 (made from 30 % stock) 
 
 
16 BAC Overlay   
75 mM  KH2PO4 / 1 % H3PO4  (pH 2.1) 
 
 
Electrode buffers    
 
Anode Buffer 
22.52 g  Glycine  
7.6 ml   85% H3PO4   
and volume made up to 2 liters with double distilled water. 
 
From this 2 liters, 500 ml was taken away and 0.57 g of BAC detergent was added in order to 
be used as cathode buffer. 
 
4% Stacking gel (10 ml) 
1g   Urea 
1.33 ml  30 % AA / 0.8 % BisAA 
2.5 ml   0.5M KH2PO4  (pH 4.1) 
3 ml   H2O 
1.38 ml  1.7 % BisAA 
0.5 ml   80 mM Ascorbic acid 
8.5 µl   5 mM FeSO4 
0.5 ml   1:750 H2O2 (30 % stock solution) 
 
Note: 10 ml of Ascorbic acid and FeSO4 stock were always freshly prepared just before use. 
 
Sample buffer  
4.5 g   Urea 
1 gram  16 BAC (approx 250 mM) 
1 ml   Glycerine 
4 ml   H2O 
1.5 ml   1.5 M DTT 
volume made up to 10 ml with milliQ water. 
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Sample buffer may have to be gently heated up in a microwave oven for a very brief time 1- 
3s to dissolve the 16 BAC detergent. Ideally tiny 20 ml or 10 ml glass beakers were used for 
preparing the buffer. 
 
Note: The gel was poured and stored at 4°C overnight before use. 
 
The gels were run overnight with orange red dye and reversed current lead directions. 
The gels were then stained with Coomassie - R 250 containing fixative in itself. 
The gels were briefly destained in normal fixative for few hours to view the bands. 
The gels were then cut to isolate the strips of independent samples and destained fully. 
 
 
II dimension of the BAC 
 
Sample gel  
3.2 ml   Acrylamide / Bisacrylamide (normal solution used for making gels) 
6.2 ml   Gel buffer 
16.8 ml  H2O  
200 µl   10 % APS 
20 µl   TEMED 
 
Anode buffer 
0.2 M   Tris (36.34 grams) pH 8.9 (with HCl)   
volume was made up to 1.5 liters 
 
Cathode buffer   
0.1 M   Tris  
0.1 M   Tricine 
0.1 %   SDS 
pH 8.25, Volume was made up to 1 liter, the pH is usually 8.25 and need not be tested. 
 
 
Tricine gel  
 
Seperation gel  
48 ml   Acrylamide / Bisacrylamide 
30 ml   Gel buffer 
12 ml   Glycerine  
300 µl   10 % APS  
30 µl   TEMED 
 
Spacer gel  
10.1 ml  Acrylamide / Bisacrlyamide  
10 ml   Gel buffer 
9.9 ml   Distilled water  
100 µl   10 % APS 
10 µl   TEMED 
 
 
 
 
                                                                                                             Materials and Methods 
51 
 
Stock  solutions for Tricine gels 
Gel buffer  
3 M   Tris  
%   SDS 
pH 8.45 ( adjust with HCl ) at 25° C  
 
Overlay solution  
1M   Tris 
%   SDS 
pH 8.45 (with HCl) 
 
3 X sample buffer 
15 %   SDS 
30 %   Glycerine 
150 mM  Tris  
6 %   Mercaptoethanol  
0.006 %  Bromophenol blue 
pH 6.8 (with HCl)   
 
2.3.11 Carbonate extraction of Integral membrane proteins 
Approximately 40 mg (dry weight) of cells were lysed using a sonicator of 10 Watts power 
for 3 X 30 s on ice in 5ml PBS with 150 units of endonuclease and complete mini (Roche). 20 
mg of cellular protein (as determined by Bradford analysis) was diluted to 6ml with 50 mM 
Tris/HCl, pH 7.3 containing 0.7 mg of DNase I (Sigma). The cells were ruptured in an 
Aminco French press with two presses at 9.65 X107 Pascals and the unbroken cells removed 
by centrifugation at 2500 g for 10 min. The supernatant was diluted with ice-cold 0.1 M 
sodium carbonate (pH 11) to a final volume of 60 ml and stirred slowly on ice for 1 hr. The 
carbonate treated membranes were collected by ultra centrifugation in a Beckman 55.2 Ti 
rotor at an average of 115000 g for 1 hr at 4°C. The supernatant was discarded and the 
membrane pellet resuspended and washed in 2 ml of 50 mM Tris/HCl, pH 7.3. The pellet was 
collected by centrifugation at an average of 115 000 g for 20 min (Beckman 55.2 Ti rotor) and 
solubilized for 2D electrophoresis with 1.5 ml of IEF solution [7 M urea, 2 M thiourea, 1% 
(w/v) ASB14, 40 mM Tris, 2 mM tributyl phosphine (TBP) and 0.5% (v/v) Biolytes 3-10 
(Bio-Rad, CA, USA)]. 
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2.3.12 Nano flow LC/MS 
Reverse phase (RP) chromatography is the most common form of chromatography used in 
LC/MS applications of complex peptide mixtures. The basic principle of reverse phase HPLC 
is that the peptides stick to the reverse phase HPLC columns in high aqueous mobile phase 
and are eluted from RP HPLC columns with high organic mobile phase. In RP HPLC peptides 
are separated based on their hydrophobic character by running a linear gradient of the organic 
solvent (acetonitrile). Typically, 60/60 gradient is used to resolve an unknown mixture. 60/60 
gradient means that the gradient starts near 100 % aqueous and ramps to 60 % organic solvent 
in 60 min. The majority of the peptides (10 to 30 amino acids in length) elute by the time the 
gradient reaches 30 % organic. However, for our analysis, 80/120 gradient was used.  
 
Column specifications  
Bonded phase: C18  
Column dimension: 15 cm X 75µm (Pepmap, LC packing, Holland Dionex,USA) 
Particle size: 3 µm 
Pore size: 100 A°  
 
Preferred solvent system for ESI LC/MS 
A: HPLC grade water, 0.1 % formic acid 
B: HPLC grade Acetonitrile, 0.1 % formic acid  
(0.1 % acid is usually included in order to improve the peak shape and sever as a proton 
source in the reverse phase LC/MS). 
 
Flow rate: a flow rate of 200 nanolitres/ min was used. 
 
Sample preparation for LC/MS 
The pellet of protein to be analysed was digested over night with 35 - 50 µl of Trypsin (20 
µg/ml) in 50 mM NH4HCO3 at 37 °C. This solution of Trypsin is approximately 10 times 
more concentrated than the solution of Trypsin used for digestion of the proteins spots picked 
from the gels for subsequent MALDI-TOF MS. At the end of digestion, the tryptic digests 
were centrifuged in a mini-ultracentrifuge at 50000 rpm for 45 min at 4 °C. The debris free 
supernatant having the peptides was collected and dilutions of the peptide mixture were made 
in solvent A (HPLC grade water, 0.1% formic acid). Usually a 1: 20 dilution was found to be 
appropriate to yield an optimal loading. 
 
 
 
                                                                                                             Materials and Methods 
53 
2.4 Real time Polymerase Chain Reaction 
2.4.1 RNA-Preparation from P. aeruginosa  
Care was taken to carryout all the operations as quickly as possible in order to minimise RNA 
degradation and also changes in the gene expression introduced by handling of the cells. 
While working with Phenol and Chloroform the fume hood was used. Only fresh and 
autoclaved (twice) pipette tips and eppendorf cups were used. Different pipettes were used for 
RNA work and DEPC-treated solutions. 
 
• 2,5 ml lysis-buffer (2 % SDS, 30 mM Na-Acetate, 3 mM EDTA; pH 5.5) and 5 ml Phenol 
(pH 5.5; Roth) was pre-incubated in 14 ml Falcon-Tubes at 65 °C in a water-bath.  
• The bacterial cells from 12 ml of fresh culture (OD600 ≈ 0.8 (approx. 9.6 x 109cells; 
inoculated with OD600 ≈ 0.05 using pre-inoculum grown over night; yielding approx. 120 
µg RNA) was recovered from the culture flasks and harvested by centrifugation at 3500 
rpm for 5 min at 4 °C (Hettich-centrifuge in the cold-room) in 14 ml Falcons and 
resuspended quickly in 0.5 ml 0.9 % NaCl or water. 
• The lysis-mixture was quickly added to the harvested cells and the tubes shaken 10 min 
vigorously followed by 5min incubation on ice. The tubes were centrifuged at 20 min at 
3500 rpm, 4°C.   
• The supernatant was collected and mixed with 3 ml Phenol/CHCl3/Isoamylalkohol 
(25:24:1), shaken for 5 min vigorously followed by 5 min incubation on ice. The tubes 
were centrifuged for 10 min at 3500 rpm, 4°C.  
• The supernatant was collected and mixed with 3 ml CHCl3/Isoamylalkohol (24:1), shaken 
for 2 min, followed by 5 min incubation on ice. The tubes were centrifuged for 10 min at 
3500 rpm, 4 °C.  
• The supernatant was collected and mixed with   
0.1 Volume 3 M Na-Acetate (pH 5.5) 
2.5 Volume 99 % EtOH (- 20 °C)  
• The contents of the tubes were let to precipitate for 2 hr to over night at – 20 °C followed 
by centrifugation for 30 min at 3500 rpm, 4 °C. 
• The pellet was washed with 5 ml 70 % EtOH (- 20 °C) and transferred to an eppendorf 
cup containing 70 % EtOH followed by centrifugation for 10 min at 14000 rpm, 4 °C 
(Eppendorf-cooled centrifuge). 
• EtOH was removed as much as possible by pipetting, and pellet was subsequently 
dissolved in 174.2 µl H2O (mixed well, followed by 5 min incubation on ice). To digest 
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the contaminating DNA the following were added followed by 30 min incubation at 37 °C 
on a Thermo mixer ( Eppendorf).  
+ 20 µl DNase-buffer (10X ( 500 mM Na-Acetate (pH 6.5); 100 mM MgCl2, 20 mM 
CaCl2))  
+   4,8 µl DNase (10 U/µl) Roche (5 U DNaseI per 1x109 cells) 
+   1 µl RNasin Promega or SUPERaseIn Ambion 
• The RNA was purified using RNeasy-columns (Qiagen, Hilden, Germany) as described in 
the handbook, eluted with 2 times 30 µl RNAse free water supplied with the kit (and 
incubated briefly for 5 min on ice). 
• The concentration was estimated with UV-absorption on a Spectrophotometer 
(Eppendorf) and quality determined with a MOPS/Formaldehyde Agarose-gel.  The total 
yield was 250 - 100 µg. 
 
2.4.2  cDNA synthesis 
2 µg of total RNA was taken in a 1.5 ml eppendorf. The volume was adjusted to 9 µl using 
RNAse free water. 2 µl of the random primer was added to the tube. The contents were mixed 
well with a pipette and incubated at 65 °C for 10 min followed by  chilling on ice for two 
minutes and brief spin for 15 s to concentrate the contents at the bottom of the reaction tube. 
Following components were added to complete the reaction mixture: 4 µl of 5X concentrated 
first strand buffer of expand RT; 2 µl of 10 mM DTT; 2 µl of 10 mM dNTPs; 1 µl of Expand 
Reverse Transcriptase. 
 
The reaction tube was incubated at 43 °C for 60 min, chilled on ice briefly for 2 minutes and  
spun down to concentrate the contents and stored at – 20 °C until further use. Second strand 
synthesis and PCR amplification were done to check the cDNA synthesis and specificity of 
primers for the target sequence. To 3 µl of the previous reaction mixture, the following 
components were added  
Component Volume 
10 X PCR buffer 2 µl 
2 mM dNTP (dATP, dGTP, dTTP, dCTP) 2 µl 
5pM Forward primer 2 µl 
5pM Reverse primer 2 µl 
Expand Hifi 1 µl 
DdH2O 8 µl 
  
Contents were mixed well and PCR amplified. 
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2.4.3 Lightcycler  
Reactions of 10 µl volume were setup and found to be optimal. The various components of 
the reaction mix are as follows. 
Component Volume 
Primer (Forward) 1 µl 
Primer (Reverse) 1 µl 
SYBR GREEN: ENZYME: dNTPS Mix 1 µl 
DMSO 0.5 µl 
MgCl2 0.4 µl 
H2O 4.1 µl 
cDNA Template 2 µl 
 
The reaction mix was dispensed into the special glass capillary tube that fit in the sample 
carousel of the lightcycler instrument. Further operations were performed as described in the  
the LightCycler manual.    
 
2.5. GeneChip P.aeruginosa Genome Array Analysis 
2.5.1 cDNA Synthesis 
10 µg of total RNA per sample was used. The incubation was performed in a Thermocycler     
(Landgraf). The following mixture was prepared for primer annealing.  
Primer Hybridisation Mix 
Components Volume or Amount Final Concentrations 
Total RNA 10 µg 0.33 µg/µl 
Random Primers (75 ng /µl) or 
Oligo (dT) primer (75 µg/µl) 
10 µl 25 ng/µl 
Spike Transcript (130 pM) (Optional) 2 µl 8.67 pM 
Nuclease-free H2O Up to 30 µl  
Total Volume 30µl  
 
Spike transcripts are sense RNA controls from Bacillus subtilis genes that can serve as control 
transcripts and be spiked into P. aeruginosa total RNA used for target preparation at a 
predetermined concentration in order to monitor labelling, hybridisation and staining 
efficiency.  The contents were mixed and centrifuged and about 50 µl of RNase free paraffin 
was laid on top. RNA primer mix was placed at 70 °C for 10 min followed by 25 °C for 10 
min and then chilled on to 4 °C. The following reaction mix for cDNA synthesis was prepared 
and added to the primer hybridisation mix. 
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cDNA Synthesis Components 
Components Volume or Amount Final Concentrations 
5X 1st Strand Buffer 12 µl 1 X 
100mM DTT 6 µl 10 mM 
10mM dNTPs 3 µl 0.5 mM 
SUPERase•In (20U/µl) 1.5 µl 0.5 U/µl 
SuperScript II (200U/µl) 7.5 µl 25 U/µl 
Total Volume 30 µl  
 
The contents were mixed well by pipetting and centrifuged quickly in order to concentrate all 
the contents of the tube to the bottom. The reaction was carried out by incubating, at 25 °C for 
10 min, 37 °C for 60 min and 42 °C for 60 min. The enzyme was inactivated at 70 °C for 10 
min and held at 4 °C. 20 µl of 1N NaOH was added and incubated at 65 °C for 30 min 
followed by addition of 20 µl of 1N HCl for the neutralization. The reaction mix was 
transferred to a 1.5 ml eppendorf tube. cDNA synthesis products were purified using 
QIAquick Column (Qiagen). Paraffin and contents of the cDNA reaction mix can be run 
through the QIAquick Column together without any problem. Detailed protocols are stated in 
the QIAquick PCR Purification Kit Protocols provided by the supplier. The product was 
eluted with 40 µl of EB Buffer (supplied with QIAquick kit). The purified cDNA product was 
quantified by 260 nm absorbance (1.0 A260 unit = 33 µg/mL of single strand DNA). Typical 
yields of cDNA are 2.5 – 4.0 µg for reactions primed with random primers. However the 
yields of cDNA for reactions primed with Oligo (dT) primers were often low, around 500 – 1 
µg / 10 µg of total RNA used or variable depending on the polyadenylation levels in the 
specific RNA sample.  
 
2.5.2 cDNA  Fragmentation 
The following Fragmentation reaction mix was prepared.  
Fragmentation Reaction 
Components Volume/Amount Concentration 
10X One Phor-All Buffer 5 µl 1 X 
CDNA 40 µl 3-7 µg 
DNase I (0.6U/µl in1X One Phor-All Buffer) X µl 0.6 U/µg of cDNA 
Nuclease –free H2O Upto 50µl.  
 
The reaction was incubated at 37 °C for 10 min. The enzyme was incubated at 98 °C for 10 
min. The fragmented cDNA was added directly to the terminal labelling reaction or stored at 
– 20 °C until further use. To examine the fragmentation result, about ~200ng of the product 
was loaded on 2 % agarose gel and stained with SYBR green for 1 hr. 
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2.5.3 Terminal Labeling  
Enzo BioArrayTM Terminal Labeling Kit with Biotin-ddUTP (Affymetrix) was used to label 
the 3’ termini of the fragmentation products. The following Terminal Label Reaction mix was 
prepared. 
Terminal Label Reaction 
Components Volume/Amount 
5X Reaction Buffer 12 µl 
10X CoCl2 6 µl 
Biotin ddUTP 1 µl 
Terminal Deoxynucleotide Transferase 2 µl 
Fragmentation Product (1.5 – 6 µg) 39 µl 
Total Volume 60 µl 
 
The reaction was incubated at 37 °C for 20 – 60 min. The reaction was stopped by adding 2 µl 
of 0.5 M EDTA. The target was hybridised onto the probe arrays as quickly as possible on the 
same day. 
 
2.5.4 Target Hybridisation; Washing, Staining, Scanning; Data Analysis 
Target Hybridisation, Washing Staining and Scanning of the hybridised chips were performed 
as per the GeneChip Expression Analysis Protocols recommended by the user manual 
accompanying the GeneChip consignment from Affymetrix. These procedures were 
performed by the DNA Microarray facility at the Gesellschaft für Biotechnologische 
Forschung (GBF), Braunschweig. Primary Data Analysis was performed using Microarray 
Suite (MAS) Software 5.0 supplied by Affymetrix. Subsequent analysis was performed using 
Microsoft Access and Microsoft Excel. When primary data was analyzed, a signal for every 
gene was considered to be present only if there was strong presence (P) and/or marginal 
presence (M) of signals (as computed by Affymetrix, MAS 5.0, using default parameters) on 
both replicate chips hybridized with the same cDNA. When there was absence (A) of signal in 
only one of the replicate chips, the gene itself was considered to be undetected. The 
annotations of the genes were based on the most recent annotations available from the 
PseudoCAP website www.pseudomonas.com.  
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3. Results and Discussion 
 
3.1 Differential growth response of morphotypes to iron limitation 
 
3.1.1 Differential growth under iron limitation  
Severe iron limiting conditions are likely to be encountered in vivo in the CF lung habitat 
colonized by Pseudomonas aeruginosa. In order to determine whether there existed any inter-
morphotype differential growth response to iron limiting growth conditions, SCV 20265 and 
WT 20265 were grown in Vogel Bonner medium that was pre treated with a divalent cation 
chelator resin Chelex 100 (BioRad). Ferrous (Fe2+) ions are chelated and removed along with 
the resin. However the efficiency of chelation of iron from the medium is debatable. The 
comparison of growth under chelex 100 treated vogel bonner medium and normal vogel 
bonner (untreated) medium revealed only a slight difference in growth pertaining to the lag 
phase. During log phases of growth no significant inter morphotype growth differences 
between the SCV 20265 and WT 20265 could be recorded (data not shown). So it was 
important to achieve a complete depletion of iron. After a thorough search in the literature 
regarding iron depletion from the medium, use of other iron specific chelators was pursued to 
achieve satisfactory iron depletion. 
 
2,2-dipyridyl is an iron specific chelator widely used for chelating iron from the medium to 
achieve iron depletion or iron limitation. A range of concentrations of the chelator 2,2-
Dipyridyl was tested. At 1.1mM concentration of 2,2-Dipyridyl in the medium, a crucial 
difference in the growth of SCV 20265 and WT 20265 was reproducibly detectable. Bacteria 
were grown in 50 ml falcon tubes with 10 ml volume of Vogel Bonner (VB) medium 
(untreated) or VB medium containing 1.1mM 2,2-Dipyridyl (iron limiting). Typically, the WT 
20265 grows slightly faster in the normal VB medium as compared to the SCV 20265 during 
the early and mid log phases, but eventually both reach the same optical density towards the 
stationary and late stationary phase (refer Figure 3.1.1). This slight difference in the doubling 
time is typical and consistent with the slow growing nature of the SCV in comparison to the 
WT. But there was a completely altered pattern of growth in the presence of 1.1mM 2,2-
Dipyridyl. The SCV 20265 showed an early onset of growth while the WT 20265 was still in 
an extended lag phase (refer Figure 3.1.2). This clear ready adaptation of the SCV 20265 to 
iron limitation stress imposed by the presence of iron chelator 2,2-Dipyridyl was further 
investigated to demonstrate that the observed growth differences were indeed in response to 
iron limitation and not due to 2,2-dipyridyl toxicity. 
                                                                                                                  Results and Discussion 
59 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1 Growth of SCV 20265 and WT 20265 in the normal Vogel Bonner medium (untreated for iron 
depletion). The WT 20265 grows faster than SCV 20265 during log phase but both reach the similar optical 
densities (OD600) towards the stationary phase.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.2 Growth of SCV20265 and WT 20265 under iron limiting conditions in the presence of 
1.1mMDipyridyl in the medium. An early onset of growth of SCV 20265 between 0 and 48 hours is in sharp 
contrast with the extended lag phase of WT 20265.   
 
It was interesting to note that although an early onset of growth of SCV 20265 was detectable, 
WT 20265 eventually grew after an extended lag phase of about 48 hours in the presence of 
1.1mM 2,2-Dipyridyl. Thus the iron chelation in the presence of 1.1mM dipyridyl was not 
potent enough to restrict the growth of even the poorly adapted morphotype. Therefore iron 
limitation by 2,2-Dipyridyl was tested over a range of concentrations starting from 0.1mM to 
11mM, in order to determine the most appropriate concentration for our experiments to study 
the inter-morphotype differential response to iron limitation. Accordingly, at 11mM of the 
chelator concentration in the medium, it was possible to achieve a complete iron depletion 
indicated by a complete inhibition of growth of both the morphotypes. Using this 
concentration of chelator in the medium as an ideal negative control, a range of concentrations 
of Ferrous iron salt, FeSO4 was supplemented in order to revive the growth of the bacteria. 
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2,2-dipyridyl is an iron chelator with selectivity for Fe2+ ions. It chelates Fe2+ ions in a 3:1 
ratio. Therefore, a 11mM concentration of dipyridyl can be expected to chelate approximately 
3.6mM Fe2+. It is likely that between 3.5mM to 3.0mM FeSO4 supplementation there exists a 
near perfect iron depletion condition.  Accordingly, at around 3.3mM of FeSO4 supplement in 
the medium containing 11mM 2,2-dipyridyl would present a situation where the iron 
chelation is in a dynamic equilibrium with scarce amount of ferrous available for the bacteria 
to utilize, which in turn would mimic an iron limited condition. 
 
A range of concentrations of FeSO4 starting from 3.0mM to 10mM was supplemented in the 
presence of fixed amount of 11mM of 2,2-dipyridyl and bacteria inoculated into 1 ml of 
medium in 2ml eppendorf tubes. 2 ml eppendorf tubes were used in order to device a high-
throughput screening system where several conditions with varying concentrations of chelator 
and iron supplement could be tested in parallel for both the morphotypes with greater ease of 
handling as compared to using vessels of higher volume. To provide exchange of gases a tiny 
hole of 0.5mm radius was punched on top of the eppendorfs using a sterile needle. The results 
of the growth pattern of the morphotypes of 20265 are shown in the figure 3.1.3. The cells 
grew in thick non-dispersible clumps in the small volume of 1ml and so growth could not be 
quantified by conventional CFU counting or by measuring the optical density at 600nm, 
because representative sampling was difficult to obtain. Therefore, total protein concentration 
was estimated by Bradford method and the protein concentration was used a measure of 
growth. Most important observation was the ability of SCV 20265 to grow even at the least 
supplemented levels of FeSO4, i.e.3.3mM, while there was no growth of the WT at this iron 
limiting concentration of supplement. There was no growth of any of the morphotypes at 
3.0mM concentrations of FeSO4 supplement because the chelator outnumbers the ferrous 
ions. There was no growth of any of the morphotypes in the unsupplemented tubes, which 
served as a negative control (refer 2 in Fig. 3.1.3). However at higher concentrations of 
supplemented FeSO4 (3.5mM, 4.0mM and 5.0mM FeSO4; refer 4,5,6 in Fig 3.1.3) the WT 
grew, as did the SCV. In a normal medium lacking iron chelator (refer 1 in Fig 3.1.3), the WT 
outgrew the SCV. This clearly demonstrates the ability of SCV to survive and thrive under 
iron limiting conditions as compared to WT 20265. Growth of SCV needed a minimum 
supplementation of 3mM in the presence of 11mM dipyridyl.  
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Figure 3.1.3 Growth of P. aeruginosa 20265 morphotypes - SCV, wildtype and revertant under iron 
limitation and supplementation, measured as a function of protein concentration after 96 hours of growth. 
Shown here are values representing the average mean and calculated standard deviation of protein concentrations 
from three independent experiments carried out with triplets for each experimental condition.  1) Normal Vogel 
Bonner (VB) medium (+Control), 2) Iron depleted VB  (IDVB) Medium (-ve control), 3) IDVB +3.0mM 
FeSO4, 4) IDVB + 3.5 mM FeSO4, 5) IDVB + 4.0 mM FeSO4, 6) IDVB + 5.0mM FeSO4. 
 
Notably, SCV alone were able to grow at 3mM FeSO4 while revertant and wildtype, even 
after incubation for 96 hours did not grow up to any significant level as compared to the SCVs 
(refer 3 in Fig 3.1.3). However, all the three morphotypes grew in the presence of FeSO4 at 
concentrations of 3.5mM onwards. Optimal growth (comparable to growth in iron rich 
condition) occurred upon supplementing the media with 4.0mM to 5.0mM FeSO4.   
 
Morphotypes of two other strains, namely 10 and 29 were tested for their ability to grow 
under the iron limiting conditions described above. The results are presented in the table 3.1.1 
below. The 10 WT and 29 SCV were found to grow with 3.0mM FeSO4 supplement (i.e. iron 
limiting condition) much like the SCV 20265. Other iron sources such as Ferric citrate, 
haemoglobin and haemin chloride were also supplemented instead of FeSO4 in order to check 
if there was any differential preference for certain iron sources. But observable growth was 
detected only with the FeSO4 supplementation. 
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Table 3.1.1. Summary of growth patterns of the different morphotypes tested for growth under iron 
limiting and iron replete conditions with different sources of iron. ‘Yes’ indicates growth  ‘No’ indicates 
absence of growth and  ‘Part Yes’ indicates partial growth or poor growth. (SCV- Small colony variant, REV- 
Revertant, WT – Wildtype) 
 
Strain / morphotype FeSO4 Ferric citrate Porphyrin 
 10mM 
(iron rich) 
3mM 
(iron deplete) 
10-4M Haemoglobin 
(10-4M-10-6M) 
Hemin Chloride 
(10-4M-10-6M) 
20265 SCV 
 
Yes Yes No No No 
20265 REV 
 
Yes No No No No 
20265 WT 
 
Yes No No No No 
10 SCV 
 
Yes No No No No 
10 REV 
 
Yes No No No No 
10 WT 
 
Yes Yes No No No 
29 SCV 
 
Yes Yes No No No 
29 REV 
 
Yes Part Yes No No No 
29 WT 
 
Yes No No No No 
 
 
 
3.1.2 Differential growth response to different iron sources 
Even though the initial approach to study the inter-morphotypic differential responses 
encompassed the investigations of in vitro generated revertant too, it was becoming 
increasingly evident from iron limitation assays and other phenotypic traits and experiments 
of Wehmhöner (2003) and Götz (2003) that the revertant itself was not a genuine reversion of 
the SCV back to its clonal Wildtype phenotype. This was evident from the fact that the 
revertant was different from the wildtype and SCV and so it was reasonable to assume that the 
revertant could be the product of a mutation or genetic switch mechanism that is independent 
of the ones that lead to the occurrence of SCV from the Wildtype. So further analysis of inter-
morphotype studies were restricted to only the clonal SCV and wildtype pairs of any stain 
used. This was done partially to simplify the problem and to enable easier and efficient 
handling of the experiments. Therefore any results of the present study must be 
experimentally verified in the revertant also in order to make the picture complete.  As the 
results of the experiments presented in the previous section 3.1.1, indicated a greater 
preference for iron in the form of Fe2+, differential preference of SCV and WT for different 
iron sources was tested using an agar plate assay. For details about how the assay was 
performed refer to the relevant section in the Materials and Methods section. After testing a 
range of concentrations of the chelator 2,2-Dipyridyl suitable for bringing about complete iron 
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limitation and inhibition of growth in this plate assay, it was found that 1.1mM 2,2-Dipyridyl 
was optimal. This is only one tenth the concentration of chelator used in the liquid assays 
described in section 3.1.1. The results of this assay performed with strain 20265 morphotpes 
is presented in figure 3.1.4.Colonies of SCV 20265 appeared around the discs of all the 
different iron supplements while no WT 20265 grew around any of the discs in spite of 
prolonged incubation. An interesting observation was that when the chelator 2,2-Dipyridyl 
concentration was lowered to about half (i.e. from 1.1mM to 0.5 mM) substantial number of 
colonies of WT 20265 also began to appear around FeSO4 (source of Fe2+) and haemoglobin 
supplemented discs. This is clearly suggestive of the ability of SCV 20265 to mobilize 
different sources of iron efficiently in the presence of iron chelators. A negative control 
included in the experiment had only sterile deionised water spotted on the discs and showed 
no growth of colonies of neither SCV nor WT. This clearly showed that the observed growth 
was dependent only on iron availability and not due to 2,2-Dipyridyl toxicity.  
 
Another interesting observation was that relatively more bacterial colonies appeared around 
the Ferrous (Fe2+) supplemented discs as compared to the number of colonies growing around 
the other sources of iron. The colonies also appeared much earlier than the colonies around 
the other iron sources. This indicates the greater preference for iron in the form of Ferrous 
ions as compared to the other sources like ferric or haem or haemin.  
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Figure. 3.1.4 Iron supplementation assay. Bacteria were spread as a lawn on an iron depleted VB agar plate containing 1.1mM 2,2-dipyridyl by diluting 100µL bacterial
suspension in 3.0ml of 0.6% VB agar containing 1.1mM of 2,2-dipyridyl. Sterile filter paper discs were laid on the lawn of bacteria and 8µl of different iron sources were
spotted. Shown here are the appearance of colonies around the discs for SCV 20265 and complete absence of growth for WT 20265. (Note: the small ring around the Fe(II)
disc of WT 20265 is not because of bacterial growth and is due to the precipitated iron salt.) 
Ferrous 
Fe(II) 
Ferric 
Fe(III) 
Haemoglobin Haemin Deionised water 
(-ve control) 
SCV 20265 
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 1.1mM Dipyridyl 0.5 mM Dipyridyl 
Strain / 
Morphotype 
Ferrous 
Fe (II) 
0.2M 
Ferric 
Fe (III) 
0.1M 
Haemin 
Chloride 
2mM 
Haemo- 
globin 
10-4M 
Ferrous 
Fe (II) 
0.2M 
Ferric 
Fe (III) 
0.1M 
Haemin 
Chloride 
2mM 
Haemo- 
globin 
10-4M 
SCV 20265 + + + + + + + + + + + + + + + + + + + + + + + + 
WT 20265 - - - - - - - - - - - - + + + - - - - - - + + + 
SCV 231 - - -  - - - - - - - - - - - - - - - - - - - - - 
WT 231 - - - - - - - - - - - - + + + + + + + + + + + + 
SCV 52 + + + + + + - - - - - - + + + + + + + + + + + + 
WT 52 - - - - - - - - - - - - + + + + + + + + + + + + 
SCV 8226 - - - - - - - - - - - - + + + + + + + + + + + + 
WT  8226 + + + + +  + + + + + + + + + + + + + + + + + + + 
Table 3.1.2.  Differential response of morphotypes to iron supplementation under two different iron depletion conditions. A plus indicates appearance of growing colonies
around the sterile filter paper discs spotted with the different iron sources mentioned, while a minus indicates the absence of any growth in the 2,2-dipyridyl containing iron
limiting  plates. (+ + + growth in all triplicates; - - - absence of growth in all triplicates )  
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This iron supplementation assay was performed with clonal SCV and WT pairs of three more 
strains that were members of the subgroup having hyperpiliated, cytotoxic, autoaggregative 
SCVs of which the strain 20265 is a representative member. The distribution of the ability to 
adapt and survive iron limitation conditions in the above-described assay, among the members 
of this subgroup, was tested and the results presented in the table 3.1.2. 
 
It can be inferred from the results of the table that the SCV 231 was not as well adapted to 
iron limitation and couldn’t mobilise the iron as well as its clonal wildtype WT 231. This is 
clear from the complete absence of colonies of SCV 231 around the iron supplemented discs 
of both the concentrations of the chelator i.e. 1.1mM and 0.5mM. So the SCV 231 was not 
able to withstand the iron limitation in the first place to be able to subsequently mobilise iron 
from the discs and utilize it for survival and growth, as did the clonal WT 231. 
 
In the case of strains 52 and 8226, SCV 52 and WT 8226 were found to be fitter than their 
respective other clonal morphotype, in surviving the iron limitation and subsequently 
mobilizing the iron for growth. In this respect the WT 8226 and SCV 52 behaved like the 
SCV 20265. Overall picture presented by the results of experiments in section 3.1.1 and 3.1.2 
can be summarised as below. 
 
SCV 20265 represents a clonal variant that is clearly well adapted to iron limitation in its 
vicinity. It is also capable of mobilizing the micronutrient, iron from different iron sources 
and different forms (Fe2+, Fe3+, Haem, Haemin) using its versatile arsenal of iron uptake 
systems. The distribution of adaptive/survival ability to iron limitation among the clonal 
morphotypic variants of different strains isolated from the CF lung habitat is variable i.e. not 
all SCVs are better adapted to iron limitation or mobilization of iron in the presence of a 
chelator. Thus the iron limitation is perhaps one of the many selection forces operating in 
various niches of a CF lung, leading to the occurrence of SCVs. 
 
A detailed proteomic analysis of the proteins relevant to the above observations of the SCV 
20265 and its clonal WT 20265 under iron limitation stress is discussed in the following 
sections 3.1.4 – 3.1.6. 
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3.1.3 Western Blot analysis of Fur protein 
Ferric uptake regulator (fur) is the global regulator of many genes with iron dependent gene 
expression in Pseudomonas aeruginosa (Vasil et al., 2000) and many bacteria including E.coli  
(Escolar et al., 1999). fur acts a positive repressor, i.e. it represses transcription upon 
interaction in the absence of Fe2+.  Binding of Fe2+ to fur increases its affinity for its DNA 
binding site. Hassett et al., (1996) have demonstrated that mutations in the P. aeruginosa fur 
locus affect aerobic growth and SOD and catalase activities in P. aeruginosa. fur mutants 
showed increased manganese superoxide dismutase (Mn-SOD) and decreased catalase 
activities. Sensitivity to both the redox-cycling agent paraquat and hydrogen peroxide was 
greater in each mutant than in the wild type strain. 
 
Since the present study was aimed at studying the differential response of SCV and WT to 
iron limitation and oxidative stress, the expression of fur protein in strain 20265 morphotypes 
was analyzed using western blotting. However, it must be mentioned here that only polyclonal 
sera raised against E. coli fur protein was available and made use of. The E.coli anti-fur 
antibody was received as a gift from Dr.Jose L.Martinez, CNB, Spain.   
 
The blots in figure 3.1.5 reveal that the anti fur antibody locates the fur homologue of P. 
aeruginosa of nearly same size (16Kda), but also seems to show some cross reactivity (in few 
higher molecular weight bands) upon long exposures of 10 min (data not shown). The 
detection of the specific binding was accomplished by using chemiluminescence reaction of 
the enzyme coupled secondary antibody using chemiluminescence substrate. 
 
 
 
 
 
Figure 3.1.5. Western blotting using anti-fur antibody (polyclonal) for probing fur expression levels in 
Pseudomonas aeruginosa 20265 (Chemiluminescence detection with Photographic film) 1) SCV20265 normal 
2) WT20265 normal 3) SCV20265 iron deplete 4) WT iron deplete 5) E.coli log phase  + ve Control  
 
An E.coli log phase (OD600 = 0.6; LB medium) total cellular extract was used as a positive 
control (refer Lane 5 in fig 3.1.5). Strongest signals were detected in this lane because the fur 
expression is maximum in a log phase of growth owing to the abundance of iron in a complex 
medium such as LB. Lanes 1 and 2 show the fur levels in SCV 20265 and WT 20265 log 
phase cellular extracts from VB medium. The intensities of signals are relatively low as 
     1  2    3           4              5 
16 Kda 
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compared to the control. One reason for this is attributable to the lesser iron content in the VB 
medium itself. However in the presence of 1.1mM 2,2-Dipyridyl in the VB medium, the fur 
expression falls down. This is clearly seen in the signal intensities of Lanes 3 and 4. However 
the faint signal in Lane 3 (SCV 20265) in contrast with the complete absence of signal in 
Lane 4 (WT 20265) is somewhat indicative of the lesser need for iron relative to the lower 
levels that can be tolerated by WT 20265. The SCV perhaps shuts down the fur expression 
completely only in response to even lower iron limitation than the level used in the above 
experiment. However the results were only suggestive and not conclusive and warranted the 
use of P. aeruginosa fur specific antibodies to further analyse fur expression. This approach 
needs further investigation.  Although attempts were made to locate fur protein on the 2D 
gels, fur protein still remains elusive. One reason for this could be the possible low levels in 
which fur might be produced considering its nature of being a transcriptional regulator. The 
other abundant proteins could be masking the fur preventing its detection in the normal 
staining methods. Since fur is widely acknowledged to play a decisive role in iron 
metabolism, more focussed approach must be adopted in future studies to determine the 
dynamics of its expression among the various morphotypes in response to iron limitation.  
 
3.1.4  Proteome analysis of iron limitation stress response 
Extensive proteome analysis of strain 20265 was carried out in order to identify the 
differences in their global gene expression at a protein level. This was important in order to 
identify candidate gene products that might provide insight into the molecular basis of the 
differential adaptation observed in the growth experiments discussed in section 3.1.1 and 
3.1.2 and to understand the overall behavior and possible causes for the occurrence of SCV 
phenotype. Cells were grown in VB medium in 1liter culture flasks and harvested at log phase 
(OD600=0.6) and stationary phase (OD600 =1.5). Supernatants were prepared as described in 
the materials and methods section before.  Vogel Bonner medium was an ideal choice because 
of the minimal salts defining it and the compatibility of its components to sample preparation 
for proteome analysis.  
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Figure 3.1.6. Supernatant proteins of log phase cultures (OD600=0.6) of morphotypes of strain 20265 
grown in normal Vogel Bonner medium. Secreted proteins (Secretome) were resolved on an IPG strip of pH 
range 3-10 and 12-15% linear gradient gel. Abundant secretion of HasAp (hemophore) can be seen in SCV 
20265(a), which is hardly detectable in WT 20265 (b) during early log phase of growth.     
 
The log phase supernatants analyzed (refer figure 3.1.6) showed the higher expression of 
hasAp (a haemophore) PA3407 in SCV 20265 as compared to the WT 20265.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.7. Supernatant proteins of stationary phase cultures (OD600=1.5) of morphotypes of strain 
20265 grown in normal Vogel Bonner medium. Secreted proteins (Secretome) were resolved on an IPG strip 
of pH range 3-10 and 12-15% linear gradient gel. HasAp (hemophore) is detectable as an abundant protein 
species in both supernatants. SCV 20265 (a) secretes Alkaline metalloproteinase precursor AprA and AprX also 
in much higher levels compared to WT 20265 (b).   
 
2D gel analysis of late supernatants obtained from stationary phase cultures shown in figure 
3.1.7 revealed that the alkaline metalloproteinase precursor (AprA) was also differentially 
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expressed. Notably, its is widely known that low iron levels induce AprA expression. The 
hasAp is also expressed in WT 20265 in significant amounts during stationary phase of 
growth.  
 
In order to investigate the effect of the iron chelator 2,2-Dipyridyl on the proteome of the 
morphotypes of strain 20265, SCV and WT were grown aerobically up to a log phase (OD600 
0.6) in the normal Vogel Bonner medium. 2,2-Dipyridyl was introduced into the cultures at a 
final effective concentration of 1.1mM and incubated again for 4 hours along with 
synchronous cultures lacking 2,2-Dipyridyl. At the end of 4 hours incubation, the cells were 
harvested from both the 2,2-Dipyridyl treated and untreated cultures, washed and total cellular 
protein extracted and analysed on a 2D gel. Comparison of the treated and untreated cultures 
of SCV and WT revealed the effect of 2,2-Dipyridyl on several iron acquisition and oxidative 
stress related proteins. The figure 3.1.8 shows the 2D gels prepared from cultures of the 
morphotypes of strain 20265 with and without iron chelation by 2,2-Dipyridyl. It was 
interesting to note that although the resolution of a large number of proteins on the 2D gels 
was achieved, the specific iron-depletion responsive proteome was far from complete. Several 
proteins that were previously known to be iron regulated were also identified by MALDI 
TOF/ MS.  Table 3.1.3 and 3.1.4 show a selected list of proteins that were differentially 
expressed under iron limitation imposed by the presence of 1.1mM of 2,2 Dipyridyl.  
 
Table 3.1.3. Selected list of iron regulated proteins expressed higher in SCV 20265 during growth in the 
presence of 2,2-Dipyridyl.  
 
PA 
Number 
Protein Name Gene 
Name 
Function Class 
PA4236 Catalase katA Adaptation, protection Class 1 
PA4366 superoxide dismutase sodB Adaptation, protection Class 1 
PA3901 Fe(III) dicitrate transport protein FecA fecA Transport of small molecules Class 2 
PA4221 Fe(III)-pyochelin outer membrane 
receptor precursor 
fptA Transport of small molecules Class 1 
PA2398 ferripyoverdine receptor fpvA Transport of small molecules Class 1 
PA4470 fumarate hydratase fumC1 Energy metabolism Class 1 
PA4468 superoxide dismutase sodM Adaptation, protection Class 1 
PA4880 probable bacterioferritin  Central intermediary metabolism Class 3 
PA3529 probable peroxidase  Putative enzymes Class 3 
PA2399 pyoverdine synthetase D pvdD Adaptation, protection Class 1 
 
Table 3.1.4. Selected list of proteins expressed higher in WT 20265 during growth in the presence of 2,2-
Dipyridyl. 
 
PA4067 Outer membrane protein  G precursor oprG Membrane proteins Class 1 
PA2476 thiol:disulfide interchange protein  dsbG Chaperones & heat shock proteins Class 2 
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Figure 3.1.8. Cellular protein extracts of SCV 20265 and WT 20265 from 2,2-Dipyridyl treated cultures.  
Total Cellular protein extracts were resolved on IPG strips of pH range 4-7; 12-15% linear gradient gel. SCV 
20265 cellular extract without 2,2-Dipyridyl treatment (a), WT 20265 cellular extract without 2,2-Dipyridyl 
treatment (b), SCV 20265 cellular extract from 2,2-Dipyridyl treated culture (c), WT 20265 cellular extract from 
2,2-Dipyridyl treated culture (d). 
 
 
The total supernatant proteins from the above cultures were also resolved on the 2D gels and 
the results are shown in figure 3.1.8. The effect of iron chelation on the supernatants was 
readily detectable as some readily observable protein patterns on the 2D gel.  
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Figure 3.1.9. Supernatant protein extracts of SCV 20265 and WT 20265 from 2,2-Dipyridyl treated 
cultures. Secretome was resolved on IPG strips of pH range 3-10; 12-15% linear gradient gel. SCV 20265 
supernatant from normal VB cultures (a), SCV 20265 supernatant from 1.1mM 2,2-Dipyridyl treated cultures 
(b), WT 20265 supernatant from normal VB cultures (c), WT 20265 supernatant from 1.1mM 2,2-Dipyridyl 
treated cultures (d). 
 
However upon identification by peptide mass fingerprinting with MALDI TOF, many of the 
proteins identified were typical ribosomal proteins and house keeping cellular proteins that 
were released upon cell lysis. Some typically iron regulated proteins like the Hemophore 
HasAp and alkaline protease were also detected readily owing to their high abundance. 
 
As most part of the protein profile of soluble cellular proteome, remained the same for both 
the morphotypes, it became important to adopt subproteome analysis. The membrane 
subproteome and the secreted supernatant subproteome (secretome) were the most obvious 
candidates for such analysis. The membrane proteins owing to their relative low abundance 
and high hydrophobicity mediated poor solubility in conventional IEF buffers, were grossly 
underrepresented in the 2D gels made from total cellular extract. The supernatants were too 
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not detected in the cellular extracts. A close look at the secretome was important as many of 
the virulence determinants such as hemophores, Type III secreted effectors, exotoxins etc. are 
often a part of the secretome. 
 
 
3.1.5 Membrane subproteome analysis by 16 BAC system 
As with any other subproteomic approach, obtaining the membrane subproteome and 
secretome involved prefractionation and enrichment of these protein subsets from the whole 
cell extracts. Details of the seperation and enrichments are available in the materials and 
methods section. Briefly, the membrane proteins were obtained by subjecting the lysed cells 
on a sucrose gradient stabilized ultra centrifugation in the presence of protease inhibitors. The 
harvested cells were lysed by French pressing and subsequently overlayed on to the sucrose 
gradient as indicated in the materials and methods. Under these conditions of centrifugation, 
the ribosomal proteins which are the most predominant species of proteins were stabilized and 
their undesirable dispersal was avoided as much as possible. Membrane proteins obtained this 
way are not devoid of membrane associated proteins and the structural components of the 
membrane like the lipid bilayer. Resolution of membrane proteins by 2D gel electrophoresis 
is a challenging task owing to their hydrophobic nature and precipitation at their pI during 
isoelectric focusing step. Integral membrane proteins, particularly those with more than one 
transmembrane domain, have traditionally been difficult to separate by two dimensional 
electrophoresis methods. In a 16 BAC based separation, the first dimension involves 
discontinuous gel electrophoresis in an acid buffer system using the cationic detergent 16 
BAC (Benzyldimethyl-n-hexadecylammonium chloride). The second dimension consists of 
discontinuous SDS-PAGE.  
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Figure 3.1.10 shows the resolution of the membrane enriched protein fractions visualized at 
the end of first and second dimensional linear separation on gels using 16 BAC detergent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.10. 16 BAC isolation of membrane protein fraction. Stained and Visualized at the end of I 
dimension and II dimension. SCV 20265 grown in the presence of 1.1mM Dipyridyl (a), WT 20265 grown in 
normal VB medium (b), SCV 20265 grown in normal VB medium (c). It can be noted that only few membrane 
proteins could be resolved on the gels representing a fraction of the total membrane subproteome.  
 
The number of proteins that could be resolved, was arguably less making it difficult to 
analyze expression levels among different morphotypes. Additionally, the 16 BAC system of 
resolving membrane proteins was cumbersome and tedious. This made it unfit for handling 
many samples at a time. It was interesting to know that among the many proteins identified by 
subsequent MALDI-TOF, haemophore receptor HasR was one among them. HasR is a typical 
membrane protein with membrane spanning domains and involved in the haemophore 
(HasAp) mediated haem uptake. A list of membrane proteins identified by MALDI-TOF after 
resolving on a 16 BAC gel is given in Table 3.1.5.  Figure 3.1.11 shows the positions of 
some of the membrane proteins identified on the 16 BAC gel 
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Figure 3.1.11. Membrane proteins identified by MALDI-TOF after a resolution on a gel using a 16 BAC 
system. The gels were stained with colloidal coomassie. 
 
Table 3.1.5. Selected list of membrane proteins resolved using 16 BAC and identified by MALDI-TOF/MS  
 
PA Number Protein Name Gene 
Name 
Function Class 
PA3408 Haem uptake outer membrane receptor HasR 
precursor 
hasR Transport of small molecules Class 2 
PA3790 Putative copper transport outer membrane 
porin OprC precursor 
oprC Transport of small molecules Class 1 
PA4837 probable outer membrane protein precursor  Membrane proteins Class 3 
PA2391 probable outer membrane protein precursor opmQ Membrane proteins;Transport of small 
molecules 
Class 3 
PA4582 conserved hypothetical protein  Hypothetical, unclassified, unknown Class 4 
PA1777 Major porin and structural outer membrane 
porin OprF precursor 
oprF Membrane proteins;Transport of small 
molecules 
Class 1 
PA1053 conserved hypothetical protein  Hypothetical, unclassified, 
unknown;Membrane proteins 
Class 4 
PA2398 ferripyoverdine receptor fpvA Transport of small molecules Class 1 
PA0595 organic solvent tolerance protein OstA 
precursor 
ostA Adaptation, protection Class 2 
PA1178 PhoP/Q and low Mg2+ inducible outer 
membrane protein H1 precursor 
oprH Transport of small molecules/Outer 
membrane protein 
Class 1 
PA4624 hypothetical protein  Hypothetical, unclassified, unknown  Class 4 
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Enrichment and prefractionation of membrane proteins and subsequent resolution of the 
membrane proteins on a 2D gel, was attempted, applying the method described in Nouwens et 
al., (2000), as an alternative to the cumbersome 16 BAC system and sucrose gradient 
centrifugation. Briefly, the membrane proteins were obtained by ultra centrifugation of 
sodium carbonate treated membranes and membrane proteins solubilized in a conventional 
IPG buffer that has CHAPS replaced by ASB-14 and DTT replaced by Tributyl phosphine. 
More detailed protocol is available in the materials and methods section. ASB-14 is a 
zwitterionic detergent like CHAPS (used for solubilising cytosolic proteins during IEF) with a 
better ability to solubilize many of the hydrophobic integral membrane that are often not 
solublized by CHAPS proteins. Results (data not shown) revealed that the carbonate 
extraction of integral membrane proteins seemed to be not as efficient as the sucrose gradient 
strategy and henceforth the method had to be abandoned. Further analysis of the membrane 
subproteome was all restricted to sucrose gradient prefractionated membranes. 
 
3.1.6 Nano flow LC/MS analysis of membrane and supernatant subproteomes 
 Special gel based seperation of membrane proteins using the 16 BAC system or using special 
detergents like ASB14 were highly challenging and cumbersome. The number of proteins 
resolved was a far cry from the number of proteins that would represent a subproteome at any 
give time. Therefore, the outputs from these conventional strategies were less informative. So, 
a sophisticated gel less nano flow LC/MS based identification of proteins in membrane 
enriched fractions and later supernatants, was adopted owing to its ease and power of 
identifying many more proteins than one would identify with the gel based approaches. 
However, in order to be able to weigh the pros and cons of the gel based resolution and gel 
less nano flow LC/MS based approach to analyze complex subproteomes like membrane 
proteins and supernatant proteins (secretome), an attempt was made to first resolve the 
membrane fractions with a 16 BAC system using BAC detergent for solubilising the 
membrane proteins of the morphotypes of strain 20265. 
 
Nano flow LC/MS was used to investigate the membrane and supernatant protein patterns 
which are likely to be affected most by the presence of 2,2-Dipyridyl in the medium than the 
cyosolic proteins. Majority of the membrane proteins are not amenable for 2D gel analysis 
using conventional buffers owing to their hydrophobicity and hence poor solubility. Nanoflow 
LC/MS based gel free analysis proved to be a much more efficient strategy. It was ideal for 
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handling many samples at any one time. Figure 3.1.12 shows the schematic representation of 
the nanoflow LC/MS to analyze subproteomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.12. Schematic representation of a subproteome analysis by nanoflow LC/MS approach. 
 
 
During a nano flow LC/MS analysis the HPLC generates UV spectra of the various peptides 
eluted from the complex tryptic digest based on their hydophobicity into the steady flowing 
stream of a solvent gradient over the entire period of flow through the separation column. 
These spectra are particularly useful for assessing the concentration of peptides eluted. Even 
though these spectra are by themselves not informative about protein patterns in the samples, 
they are useful in normalization of the peptide loads for different samples being compared. 
Figure 3.1.13 reveals the nearly equal amounts of protein digests from different samples of 
SCV and WT 20265 used. Figure 3.1.14 gives an overview of the number of proteins 
identified by LC/MS approach from membrane and supernatant proteins-enriched fraction of 
SCV 20265 and WT 20265 grown under normal and iron limited conditions. In response to 
iron limitation, the number of detected secreted proteins increased while the number of 
detected membrane proteins detected. Overall, more iron responsive proteins could be 
detected in SCV 20265 fractions as compared to WT 20265 fractions.   
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Figure 3.1.13. UV spectra of the various protein digests of membrane proteins of SCV 20265 and WT 20265 
used for analysis with nano flow LC/MS. SCV 20265 iron limited membrane subproteome (A), SCV 20265 
normal membrane subproteome (B), WT 20265 iron limited membrane subproteome (C), WT 20265 normal 
membrane subproteome (D). Peaks correspond to the eluted peptides.  
 
Figure 3.1.14 Overview of the LC/MS analysis of supernatant proteins and membrane proteins of SCV 20265 
and WT 20265 under normal and iron limiting growth conditions. Membrane proteins (1-3): Membrane 
proteins detected after growth in normal VB medium (1); Membrane proteins detected after growth iron limited 
VB medium (2); morphotype specific iron limited membrane proteins (3). Supernatant proteins (4-6): 
supernatant proteins detected after growth in normal VB medium (4); supernatant proteins detected after growth 
in iron limited VB medium (5); morphotype specific iron limited supernatant proteins (6).    
 
The results of the significant hits of proteins, identified from the membrane fractions and 
supernatants of SCV 20265 and WT 20265 grown under normal and iron limiting conditions 
are listed in the tables 3.1.6–3.1.17.
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Table 3.1.6.    List of proteins detected in the membrane enriched fraction of iron starved SCV20265 grown in the presence of 1.1mM 2,2-Dipyridyl in the Vogel Bonner 
medium. These proteins were not detected in the SCV 20265 in the absence of 2,2-Dipyridyl in the medium.  
  
PA 
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides 
matched 
PA0595 OstA organic solvent tolerance protein OstA precursor Adaptation, protection Class 2 104207 31 3 
PA0962  probable dna-binding stress protein Adaptation, protection Class 3 17482 57 1 
PA2386 PvdA L-ornithine N5-oxygenase Adaptation, protection Class 1 49447 311 6 
PA2424  probable non-ribosomal peptide synthetase Adaptation, protection Class 3 479998 29 9 
PA4290  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 58368 53 1 
PA2399 PvdD pyoverdine synthetase D Adaptation, protection;Secreted Factors (toxins, enzymes, alginate) Class 1 273510 83 1 
PA4671  probable ribosomal protein L25 Adaptation, protection;Translation, post-translational modification, degradation Class 3 21949 96 4 
PA1927 MetE 5-methyltetrahydropteroyltriglutamate-homocysteine S-
methyltransferase 
Amino acid biosynthesis and metabolism Class 2 86157 40 3 
PA3068 GdhB NAD-dependent glutamate dehydrogenase Amino acid biosynthesis and metabolism Class 2 182525 70 3 
PA5323 ArgB acetylglutamate kinase Amino acid biosynthesis and metabolism Class 2 31829 62 1 
PA3108 PurF Amidophosphoribosyltransferase Amino acid biosynthesis and metabolism;Nucleotide biosynthesis and metabolism Class 2 55335 59 2 
PA2261  probable 2-ketogluconate kinase Carbon compound catabolism Class 3 34020 31 2 
PA4412 MurG 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine 
transferase Carbon compound catabolism;Cell wall / LPS / capsule 
Class 2 37775 54 1 
PA1528 ZipA cell division protein ZipA Cell division Class 2 32217 143 2 
PA4407 FtsZ cell division protein FtsZ Cell division Class 2 41192 49 1 
PA4408 FtsA cell division protein FtsA Cell division Class 2 44618 63 2 
PA2393  probable dipeptidase precursor Central intermediary metabolism Class 3 49330 347 9 
PA3126 IbpA heat-shock protein IbpA Chaperones & heat shock proteins Class 2 16573 194 6 
PA3617 RecA RecA protein DNA replication, recombination, modification and repair Class 1 36856 82 2 
PA1552  probable cytochrome c Energy metabolism Class 3 34622 96 2 
PA1553  probable cytochrome c oxidase subunit Energy metabolism Class 3 22744 51 3 
PA1787 AcnB aconitate hydratase 2 Energy metabolism Class 2 93569 27 2 
PA2994 NqrF Na+-translocating NADH:quinone oxidoreductase, subunit 
Nqr6 
Energy metabolism Class 2 45441 55 1 
PA5490 Cc4 cytochrome c4 precursor Energy metabolism Class 2 20721 170 3 
PA5554 AtpD ATP synthase beta chain Energy metabolism Class 2 49469 54 1 
PA5556 AtpA ATP synthase alpha chain Energy metabolism Class 2 55359 154 4 
PA5558 AtpF ATP synthase B chain Energy metabolism Class 2 16946 233 6 
PA0946  hypothetical protein Hypothetical, unclassified, unknown Class 4 36754 56 1 
PA1323  hypothetical protein Hypothetical, unclassified, unknown Class 4 11579 38 1 
PA2361  hypothetical protein Hypothetical, unclassified, unknown Class 4 141260 40 3 
PA2392  hypothetical protein Hypothetical, unclassified, unknown Class 4 62255 102 3 
PA2548  hypothetical protein Hypothetical, unclassified, unknown Class 4 51000 28 1 
PA2754  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11867 30 1 
PA3481  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 38864 104 1 
PA3797  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29977 25 2 
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PA3804  hypothetical protein Hypothetical, unclassified, unknown Class 4 36081 121 2 
PA3848  hypothetical protein Hypothetical, unclassified, unknown Class 4 50516 42 2 
PA3988  hypothetical protein Hypothetical, unclassified, unknown Class 4 22870 40 1 
PA4372  hypothetical protein Hypothetical, unclassified, unknown Class 4 38300 118 2 
PA4452  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 10771 29 1 
PA4656  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 33831 57 1 
PA5037  hypothetical protein Hypothetical, unclassified, unknown Class 4 57412 52 1 
PA1245  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 41392 439 6 
PA5473  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 63222 76 1 
PA5568  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 64034 73 2 
PA2853 OprI Outer membrane lipoprotein OprI precursor Membrane proteins Class 1 8829 56 1 
PA4370 IcmP Insulin-cleaving metalloproteinase outer membrane protein 
precursor 
Membrane proteins Class 1 47202 301 7 
PA0969 TolQ TolQ protein Membrane proteins;Transport of small molecules Class 1 25266 117 2 
PA0973 OprL Peptidoglycan associated lipoprotein OprL precursor Membrane proteins;Transport of small molecules Class 1 17914 78 3 
PA2520 CzcA RND divalent metal cation efflux transporter CzcA Membrane proteins;Transport of small molecules Class 2 113805 34 6 
PA3901 FecA Fe(III) dicitrate transport protein FecA Membrane proteins;Transport of small molecules Class 2 85415 69 3 
PA4224 PchG pyochelin biosynthetic protein PchG Membrane proteins;Transport of small molecules Class 1 37673 197 4 
PA3050 PyrD Dihydroorotate dehydrogenase Nucleotide biosynthesis and metabolism Class 2 36106 48 1 
PA4756 CarB Carbamoylphosphate synthetase large subunit Nucleotide biosynthesis and metabolism;Amino acid biosynthesis and metabolism Class 1 117257 40 2 
PA3820 SecF secretion protein SecF Protein secretion/export apparatus Class 2 33021 27 2 
PA0953  probable thioredoxin Putative enzymes Class 3 16885 89 2 
PA2815  probable acyl-CoA dehydrogenase Putative enzymes Class 3 88707 72 1 
PA0641  probable bacteriophage protein Related to phage, transposon, or plasmid Class 3 130710 33 7 
PA1249 AprA alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) Class 1 50402 248 5 
PA1246 AprD alkaline protease secretion protein AprD Secreted Factors (toxins, enzymes, alginate);Protein secretion/export apparatus Class 1 63631 41 1 
PA0963 Asps aspartyl-tRNA synthetase Transcription, RNA processing and degradation Class 2 66166 68 4 
PA2976 Rne ribonuclease E Transcription, RNA processing and degradation Class 2 117395 158 4 
PA4269 RpoC DNA-directed RNA polymerase beta* chain Transcription, RNA processing and degradation Class 2 154287 86 3 
PA3656 RpsB 30S ribosomal protein S2 Translation, post-translational modification, degradation Class 2 27319 126 2 
PA4272 RplJ 50S ribosomal protein L10 Translation, post-translational modification, degradation Class 2 17623 55 1 
PA4273 RplA 50S ribosomal protein L1 Translation, post-translational modification, degradation Class 2 24219 26 1 
PA4432 RpsI 30S ribosomal protein S9 Translation, post-translational modification, degradation Class 2 14606 27 1 
PA4808 SelA L-seryl-tRNA(ser) selenium transferase Translation, post-translational modification, degradation Class 2 50261 56 1 
PA3745 RpsP 30S ribosomal protein S16 Translation, post-translational modification, degradation;DNA replication, 
recombination, modification and repair 
Class 2 9199 29 1 
PA2408  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 27048 44 2 
PA4222  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 61355 92 2 
PA0425 mexA RND multidrug efflux membrane fusion protein MexA 
precursor 
Transport of small molecules;Antibiotic resistance and susceptibility Class 1 40945 337 9 
PA0971 TolA TolA protein Transport of small molecules;Membrane proteins Class 2 37912 89 1 
PA4225 PchF pyochelin synthetase Transport of small molecules;Secreted Factors (toxins, enzymes, alginate) Class 1 196962 79 4 
PA4226 PchE dihydroaeruginoic acid synthetase Transport of small molecules;Secreted Factors (toxins, enzymes, alginate) Class 1 156325 67 3 
PA3271  probable two-component sensor Two-component regulatory systems Class 3 127373 107 3 
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Table 3.1.7 List of proteins detected in the membrane enriched fraction of SCV20265 grown in normal Vogel Bonner medium without any iron chelator 2,2-Dipyridyl.   
 
PA 
Number 
Gene 
name 
Protein name Function Class Mass Score Peptides 
matched 
PA0139 AhpC alkyl hydroperoxide reductase subunit C Adaptation, protection Class 2 20529 153 3 
PA4761      DnaK DnaK protein Adaptation, protection;Chaperones & heat shock proteins;DNA replication, 
recombination, modification and repair 
Class 2 68361 380 11 
PA1561 Aer aerotaxis receptor Aer Adaptation, protection;Chemotaxis Class 2 57144 40 3 
PA3529 PA3529 probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 196 5 
PA4235    BfrA Bacterioferritin Adaptation, protection;Transport of small molecules Class 1 17929 33 1 
PA0316 Sera D-3-phosphoglycerate dehydrogenase Amino acid biosynthesis and metabolism Class 2 44189 195 6 
PA0895     AruC N-succinylglutamate 5-semialdehyde dehydrogenase Amino acid biosynthesis and metabolism Class 1 43720 55 1 
PA1685 MasA enolase-phosphatase E-1 Amino acid biosynthesis and metabolism Class 2 26455 54 1 
PA1750 PA1750 phospho-2-dehydro-3-deoxyheptonate aldolase Amino acid biosynthesis and metabolism Class 2 39108 55 1 
PA3164   PA3164 still frameshift 3-PHOSPHOSHIKIMATE 1-
CARBOXYVINYLTRANSFERASE prephenate dehydr 
Amino acid biosynthesis and metabolism Class 2 79271 85 1 
PA4402   Arg Glutamate N-acetyltransferase Amino acid biosynthesis and metabolism Class 2 41736 42 1 
PA5171 ArcA arginine deiminase Amino acid biosynthesis and metabolism Class 1 46407 48 2 
PA5429 AspA Aspartate ammonia-lyase Amino acid biosynthesis and metabolism Class 2 51038 33 1 
PA4696 Ilv acetolactate synthase large subunit Amino acid biosynthesis and metabolism;Biosynthesis of cofactors, prosthetic groups 
and carriers 
Class 2 62978 45 3 
PA2623 Icd isocitrate dehydrogenase Amino acid biosynthesis and metabolism;Carbon compound catabolism;Energy 
metabolism 
Class 2 45548 155 3 
PA5015 AceE pyruvate dehydrogenase Amino acid biosynthesis and metabolism;Energy metabolism Class 1 99501 312 9 
PA2744   ThrS threonyl-tRNA synthetase Amino acid biosynthesis and metabolism;Translation, post-translational modification, 
degradation 
Class 2 73034 46 3 
PA2019 PA2019 RND multidrug efflux membrane fusion protein precursor Antibiotic resistance and susceptibility;Transport of small molecules; inner membrane  Class 2 42061 69 2 
PA4054 Rib GTP cyclohydrolase II / 3,4-dihydroxy-2-butanone 4-
phosphate synthase 
Biosynthesis of cofactors, prosthetic groups and carriers Class 2 39413 52 2 
PA2323 PA2323 probable glyceraldehyde-3-phosphate dehydrogenase Carbon compound catabolism Class 3 59923 92 3 
PA3636 KdsA 2-dehydro-3-deoxyphosphooctonate aldolase Carbon compound catabolism;Cell wall / LPS / capsule Class 1 31123 41 1 
PA0482 GlcB malate synthase G Carbon compound catabolism;Central intermediary metabolism Class 2 78611 139 5 
PA0552 Pgk phosphoglycerate kinase Carbon compound catabolism;Energy metabolism Class 2 40379 47 2 
PA5427   AdhA alcohol dehydrogenase Carbon compound catabolism;Energy metabolism;cytoplasmic Class 2 35889 112 2 
PA4481 MreB rod shape-determining protein MreB Cell division;Cell wall / LPS / capsule Class 2 36953 85 4 
PA1800 Tig trigger factor Cell division;Chaperones & heat shock proteins Class 2 48552 66 2 
PA4751   FtsH cell division protein FtsH Cell division;inner membrane Class 2 69911 103 2 
PA3244    Mind cell division inhibitor MinD Cell division;'Inner membrane-associated Class 2 29617 74 1 
PA4941     HflC protease subunit HflC Cell division;Translation, post-translational modification, degradation Class 2 33095 42 3 
PA4942 HflK protease subunit HflK Cell division;Translation, post-translational modification, degradation Class 2 44018 130 3 
PA3643      LpxB lipid A-disaccharide synthase Cell wall / LPS / capsule Class 2 41268 63 4 
PA4406    LpxC UDP-3-O-acyl-N-acetylglucosamine deacetylase Cell wall / LPS / capsule Class 1 33414 75 2 
PA4450   MurA UDP-N-acetylglucosamine 1-carboxyvinyltransferase Cell wall / LPS / capsule Class 2 44617 47 2 
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PA4545    Coml. competence protein ComL Cell wall / LPS / capsule Class 2 38591 73 2 
PA3999    DacC D-ala-D-ala-carboxypeptidase;'penicillin-binding protein 6 
precursor 
Cell wall / LPS / capsule;Periplasm Class 2 42431 113 3 
PA2023    GalU UTP--glucose-1-phosphate uridylyltransferase Central intermediary metabolism Class 2 31216 58 2 
PA3182      Pgl 6-phosphogluconolactonase Central intermediary metabolism Class 1 25556 101 1 
PA3471 PA3471 probable malic enzyme Central intermediary metabolism Class 3 62381 61 1 
PA3452 MqoA malate:quinone oxidoreductase Central intermediary metabolism;Energy metabolism Class 2 57174 31 3 
PA1596 HtpG heat shock protein HtpG Chaperones & heat shock proteins Class 2 71624 146 4 
PA4572 FklB peptidyl-prolyl cis-trans isomerase FklB Chaperones & heat shock proteins;Translation, post-translational modification, 
degradation;Outer membrane 
Class 2 21782 51 2 
PA3002 Mfd transcription-repair coupling protein Mfd DNA replication, recombination, modification and repair Class 2 128716 34 1 
PA0669   PA0669 probable DNA polymerase alpha chain DNA replication, recombination, modification and repair;Putative enzymes Class 3 115697 38 2 
PA1555     PA1555 probable cytochrome c Energy metabolism Class 3 33791 111 2 
PA1562 AcnA aconitate hydratase 1 Energy metabolism Class 2 99086 80 2 
PA1583    SdhA Succinate dehydrogenase (A subunit)] Energy metabolism Class 2 63492 245 5 
PA1588 SucC succinyl-CoA synthetase beta chain Energy metabolism Class 2 41517 222 5 
PA1589 SucD succinyl-CoA synthetase alpha chain Energy metabolism Class 2 30247 228 5 
PA2951    EtfA electron transfer flavoprotein alpha-subunit Energy metabolism Class 2 31404 183 5 
PA2952 EtfB electron transfer flavoprotein beta-subunit Energy metabolism Class 2 26360 139 4 
PA4429 PA4429 probable cytochrome c1 precursor Energy metabolism Class 3 28975 53 2 
PA5490 Cc4 cytochrome c4 precursor Energy metabolism Class 2 20721 38 2 
PA5555 AtpG ATP synthase gamma chain Energy metabolism Class 2 31533 32 1 
PA5558   AtpF ATP synthase B chain Energy metabolism Class 2 16946 115 2 
PA4329   PykA pyruvate kinase II Energy metabolism;Carbon compound catabolism Class 2 52220 168 5 
PA4587 CcpR cytochrome c551 peroxidase precursor Energy metabolism;Periplasmic Class 1 37380 90 3 
PA2968 FabD malonyl-CoA-[acyl-carrier-protein] transacylase Fatty acid and phospholipid metabolism Class 1 32424 42 1 
PA3112 AccD acetyl-CoA carboxylase beta subunit Fatty acid and phospholipid metabolism Class 2 31822 37 1 
PA3639    AccA acetyl-coenzyme A carboxylase carboxyl transferase (alpha 
subunit) 
Fatty acid and phospholipid metabolism Class 2 34925 56 2 
PA0141 PA0141 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 34441 114 3 
PA0588 PA0588 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 73676 170 3 
PA0833    PA0833 hypothetical protein Hypothetical, unclassified, unknown Class 4 24698 262 6 
PA1011      PA1011 hypothetical protein Hypothetical, unclassified, unknown Class 4 43030 359 8 
PA1767   PA1767 hypothetical protein Hypothetical, unclassified, unknown Class 4 56777 82 1 
PA1789 PA1789 hypothetical protein Hypothetical, unclassified, unknown Class 4 31254 112 3 
PA2078 PA2078 hypothetical protein Hypothetical, unclassified, unknown Class 4 67255 25 4 
PA2831    PA2831 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 42906 47 1 
PA3031 PA3031 hypothetical protein Hypothetical, unclassified, unknown Class 4 8007 25 1 
PA3214 PA3214 hypothetical protein Hypothetical, unclassified, unknown Class 4 23200 54 1 
PA3309   PA3309 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 16486 131 3 
PA3613   PA3613 hypothetical protein Hypothetical, unclassified, unknown Class 4 88324 60 4 
PA3691 PA3691 hypothetical protein Hypothetical, unclassified, unknown Class 4 14459 114 2 
PA3800    PA3800 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 40372 164 4 
PA4308 PA4308 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 53214 87 2 
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PA4328      PA4328 hypothetical protein Hypothetical, unclassified, unknown Class 4 34398 53 1 
PA4352   PA4352 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 30953 196 8 
PA4372 PA4372 hypothetical protein Hypothetical, unclassified, unknown Class 4 38300 38 1 
PA4423     PA4423 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 65589 112 3 
PA4426 PA4426 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20607 160 5 
PA4441   PA4441 hypothetical protein Hypothetical, unclassified, unknown Class 4 16408 60 2 
PA4465 PA4465 conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 32199 50 1 
PA4639 PA4639 hypothetical protein Hypothetical, unclassified, unknown Class 4 20723 205 5 
PA4699    PA4699 hypothetical protein Hypothetical, unclassified, unknown Class 4 25986 46 1 
PA5506 PA5506 hypothetical protein Hypothetical, unclassified, unknown Class 4 32124 36 1 
PA4016 PA4016 hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 62565 36 2 
PA2462 PA2462 hypothetical protein Hypothetical, unclassified, unknown;outermembrane Class 4 572832 45 12 
PA3372   PA3372 conserved hypothetical protein Hypothetical, unclassified, unknown;Transport of small molecules Class 4 27882 26 2 
PA1041 PA1041 Probable outer membrane protein precursor Membrane proteins Class 3 21734 87 1 
PA1119 PA1119 Probable outer membrane protein precursor Membrane proteins Class 3 18399 57 4 
PA2900   PA2900 Probable outer membrane protein precursor Membrane proteins Class 3 29835 118 1 
PA3648 PA3648 Probable outer membrane protein precursor Membrane proteins Class 3 88233 161 3 
PA3692   PA3692 Probable outer membrane protein precursor Membrane proteins Class 3 28497 464 9 
PA4876 OsmE osmotically inducible lipoprotein OsmE Membrane proteins;Adaptation, protection Class 2 12515 73 2 
PA2853   OprI outer membrane lipoprotein OprI precursor Membrane proteins;Outer membrane Class 1 8829 53 1 
PA4370      PA4370 Insulin-cleaving metalloproteinase outer membrane protein 
precursor 
Membrane proteins;Outer membrane Class 1 47202 55 3 
PA3821 SecD Secretion protein SecD Membrane proteins;Protein secretion/export apparatus;'Inner membrane protein Class 2 67632 126 1 
PA1777 OprF outer membrane protein OprF precursor Membrane proteins;Transport of small molecules Class 1 37616 350 12 
PA0427 OprM outer membrane protein OprM precursor Membrane proteins;Transport of small molecules;Antibiotic resistance and susceptibility Class 1 52566 25 1 
PA4358 PA4358 Probable ferrous iron transport protein Membrane proteins;Transport of small molecules;Inner membrane protein Class 3 82459 52 2 
PA0413 PA0413 still frameshift probable component of chemotactic signal 
transduction system 
Motility & Attachment;Chemotaxis;Two-component regulatory systems Class 3 268412 82 5 
PA3115      FimV motility protein FimV Motility & Attachment;Membrane proteins Class 1 96871 52 3 
PA3637 PyrG CTP synthase Nucleotide biosynthesis and metabolism Class 2 59581 129 2 
PA3686   Adk Adenylate kinase Nucleotide biosynthesis and metabolism Class 2 23093 43 1 
PA0299 SpuC putrescine aminotransferase Putative enzymes Class 1 50421 52 1 
PA0744 PA0744 Probable enoyl-CoA hydratase/isomerase Putative enzymes Class 3 40564 36 1 
PA2491 PA2491 Probable oxidoreductase Putative enzymes Class 3 36809 58 2 
PA3972 PA3972 Probable acyl-CoA dehydrogenase Putative enzymes Class 3 60300 47 2 
PA4128 PA4128 conserved hypothetical protein Putative enzymes Class 4 28186 33 2 
PA4434   PA4434 Probable oxidoreductase Putative enzymes Class 3 38620 75 3 
PA3841   ExoS exoenzyme S – ADP-ribosyltransferase Secreted Factors (toxins, enzymes, alginate);'Type III Secretion Class 1 48273 115 2 
PA4238 RpoA DNA-directed RNA polymerase alpha chain Transcription, RNA processing and degradation Class 2 36627 32 1 
PA4745 NusA N utilization substance protein A Transcription, RNA processing and degradation Class 2 54625 128 3 
PA5239 Rho transcription termination factor Rho Transcription, RNA processing and degradation Class 2 47040 85 5 
PA0576  RpoD sigma factor RpoD Transcriptional regulators Class 1 69600 41 3 
PA2834   PA2834 Probable transcriptional regulator Transcriptional regulators;'Cytoplasmic Class 3 36098 30 2 
PA0459      PA0459 Probable ClpA/B protease ATP binding subunit Translation, post-translational modification, degradation Class 3 94118 96 3 
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PA2071   fusA2 elongation factor G Translation, post-translational modification, degradation Class 2 77525 106 3 
PA3162 RpsA 30S ribosomal protein S1 Translation, post-translational modification, degradation Class 2 61832 241 5 
PA4240 RpsK 30S ribosomal protein S11 Translation, post-translational modification, degradation Class 2 13621 30 1 
PA4257      RpsC 30S ribosomal protein S3 Translation, post-translational modification, degradation Class 2 25822 26 2 
PA4271 RplL 50S ribosomal protein L7 / L12 Translation, post-translational modification, degradation Class 2 12472 27 5 
PA4542 ClpB ClpB protein Translation, post-translational modification, degradation Class 2 94947 289 6 
PA4744   InfB translation initiation factor IF-2 Translation, post-translational modification, degradation Class 2 90857 69 3 
PA5051      ArgS arginyl-tRNA synthetase Translation, post-translational modification, degradation Class 2 65158 355 8 
PA4265 TufA elongation factor Tu  Translation, post-translational modification, degradation;'Cytoplasmic Class 2 43342 516 12 
PA4266      FusA1 elongation factor G Translation, post-translational modification, degradation;'Cytoplasmic Class 2 77735 336 8 
PA4264 RpsJ 30S ribosomal protein S10 Translation, post-translational modification, degradation;Transcription, RNA processing 
and degradation 
Class 2 11759 55 1 
PA2987   PA2987 probable ATP-binding component of ABC transporter Transport of small molecules Class 3 24635 52 2 
PA4595 PA4595 probable ATP-binding component of ABC transporter Transport of small molecules Class 3 61283 32 2 
PA3891 PA3891 probable ATP-binding component of ABC transporter Transport of small molecules;Inner membrane associated Class 3 43276 36 2 
PA0972 TolB TolB protein Transport of small molecules;Periplasmic Class 2 47722 28 1 
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Table 3.1.8.   List of proteins detected in the membrane enriched fraction of iron starved WT 20265 grown in the presence of 1.1mM 2,2-Dipyridyl in the Vogel Bonner medium. 
These proteins were not detected in the absence of  2,2-Dipyridyl in the growth medium of  WT 20265.    
 
PA 
 Number 
Gene 
Name  
Protein Name Function Class Mass Score Peptides 
matched 
PA0962  probable dna-binding stress protein Adaptation, protection Class 3 17482 72 1 
PA4307 pctC chemotactic transducer PctC Adaptation, protection;Chemotaxis Class 1 68266 54 1 
PA3529  probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 89 3 
PA2623 icd isocitrate dehydrogenase Amino acid biosynthesis and metabolism;Carbon compound 
catabolism;Energy metabolism 
Class 2 45548 36 3 
PA2494 mexF RND multidrug efflux transporter MexF Antibiotic resistance and susceptibility;Membrane proteins;Transport of 
small molecules 
Class 1 115437 803 19 
PA2019  RND multidrug efflux membrane fusion protein 
precursor 
Antibiotic resistance and susceptibility;Transport of small molecules Class 2 42061 54 2 
PA2493 mexE RND multidrug efflux membrane fusion protein MexE 
precursor 
Antibiotic resistance and susceptibility;Transport of small molecules Class 1 45004 268 8 
PA2009 hmgA homogentisate 1,2-dioxygenase Carbon compound catabolism Class 2 47811 31 2 
PA3244 minD cell division inhibitor MinD Cell division Class 2 29617 29 2 
PA2813  probable glutathione S-transferase Central intermediary metabolism Class 3 23390 46 1 
PA1805 ppiD peptidyl-prolyl cis-trans isomerase D Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 68699 92 3 
PA1552  probable cytochrome c Energy metabolism Class 3 34622 32 3 
PA1584 sdhB succinate dehydrogenase (B subunit) Energy metabolism Class 2 26138 58 1 
PA1586 sucB dihydrolipoamide succinyltransferase (E2 subunit) Energy metabolism Class 2 42861 104 2 
PA2999 nqrA Na+-translocating NADH:ubiquinone oxidoreductase 
subunit Nrq1 
Energy metabolism Class 2 48051 32 1 
PA3639 accA acetyl-coenzyme A carboxylase carboxyl transferase 
(alpha subunit) 
Fatty acid and phospholipid metabolism Class 2 34925 72 1 
PA0588  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 73676 211 4 
PA0759  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 33647 32 1 
PA0807  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 28703 29 3 
PA0946  hypothetical protein Hypothetical, unclassified, unknown Class 4 36754 48 1 
PA3804  hypothetical protein Hypothetical, unclassified, unknown Class 4 36081 109 1 
PA3909  hypothetical protein Hypothetical, unclassified, unknown Class 4 83029 27 5 
PA4372  hypothetical protein Hypothetical, unclassified, unknown Class 4 38300 91 2 
PA4394  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29799 81 1 
PA4423  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 65589 250 6 
PA4459  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 21340 35 2 
PA4016  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 62565 29 1 
PA0973 oprL Peptidoglycan associated lipoprotein OprL precursor Membrane proteins;Transport of small molecules Class 1 17914 163 2 
PA3920  probable metal transporting P-type ATPase Membrane proteins;Transport of small molecules Class 3 83386 71 2 
PA1860  hypothetical protein Putative enzymes Class 4 32016 29 2 
PA2491  probable oxidoreductase Putative enzymes Class 3 36809 142 3 
PA3593  probable acyl-CoA dehydrogenase Putative enzymes Class 3 64115 56 5 
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PA2478  probable thiol:disulfide interchange protein Putative enzymes;Membrane proteins Class 3 62054 104 2 
PA4270 rpoB DNA-directed RNA polymerase beta chain Transcription, RNA processing and degradation Class 2 150744 27 5 
PA1490  probable transcriptional regulator Transcriptional regulators Class 3 28365 30 2 
PA3656 rpsB 30S ribosomal protein S2 Translation, post-translational modification, degradation Class 2 27319 61 1 
PA4265 tufA elongation factor Tu Translation, post-translational modification, degradation Class 2 43342 183 6 
PA4267 rpsG 30S ribosomal protein S7 Translation, post-translational modification, degradation Class 2 17493 36 1 
PA3745 rpsP 30S ribosomal protein S16 Translation, post-translational modification, degradation;DNA replication, 
recombination, modification and repair 
Class 2 9199 71 1 
PA1922  probable TonB-dependent receptor Transport of small molecules Class 3 72218 50 5 
PA2812  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 34519 171 5 
PA4461  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 26434 66 2 
PA4595  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 61283 96 3 
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Table 3.1.9 List of proteins detected in the membrane enriched fraction of WT 20265 grown in normal Vogel Bonner medium without any iron chelator 2,2-Dipyridyl.  
  
PA 
Number 
Gene 
Name 
Product Name Function Class Mass Score Peptides 
matched 
PA3327  probable non-ribosomal peptide synthetase Adaptation, protection Class 3 259246 38 8 
PA1561 aer aerotaxis receptor Aer Adaptation, protection;Chemotaxis Class 2 57144 105 2 
PA1608  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 58202 61 2 
PA1646  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 69781 115 3 
PA1930  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 47772 68 2 
PA2573  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 57669 64 2 
PA2652  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 60307 158 5 
PA2654  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 77078 122 4 
PA2788  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 56354 92 2 
PA2867  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 51425 59 2 
PA3708  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 59023 132 4 
PA4309 pctA chemotactic transducer PctA Adaptation, protection;Chemotaxis Class 1 67975 257 7 
PA4633  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 76576 59 2 
PA4844  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 70740 102 2 
PA5072  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 69659 125 3 
PA2018  RND multidrug efflux transporter Antibiotic resistance and susceptibility;Membrane proteins;Transport of 
small molecules 
Class 2 112626 127 4 
PA4598 mexD RND multidrug efflux transporter MexD Antibiotic resistance and susceptibility;Membrane proteins;Transport of 
small molecules 
Class 1 111525 39 2 
PA2019  RND multidrug efflux membrane fusion protein 
precursor 
Antibiotic resistance and susceptibility;Transport of small molecules Class 2 42061 140 5 
PA5427 adhA alcohol dehydrogenase Carbon compound catabolism;Energy metabolism Class 2 35889 63 3 
PA1528 zipA cell division protein ZipA Cell division Class 2 32217 118 2 
PA4407 ftsZ cell division protein FtsZ Cell division Class 2 41192 72 4 
PA4408 ftsA cell division protein FtsA Cell division Class 2 44618 118 4 
PA4751 ftsH cell division protein FtsH Cell division Class 2 69911 239 8 
PA4481 mreB rod shape-determining protein MreB Cell division;Cell wall / LPS / capsule Class 2 36953 86 5 
PA4941 hflC protease subunit HflC Cell division;Translation, post-translational modification, degradation Class 2 33095 72 2 
PA4942 hflK protease subunit HflK Cell division;Translation, post-translational modification, degradation Class 2 44018 323 8 
PA3999 dacC D-ala-D-ala-carboxypeptidase Cell wall / LPS / capsule Class 2 42431 251 8 
PA4545 comL competence protein ComL Cell wall / LPS / capsule Class 2 38591 61 1 
PA4700 mrcB penicillin-binding protein 1B Cell wall / LPS / capsule Class 2 85434 27 1 
PA4997 msbA transport protein MsbA Cell wall / LPS / capsule;Fatty acid and phospholipid metabolism;Transport 
of small molecules 
Class 2 66390 98 2 
PA4385 groEL GroEL protein Chaperones & heat shock proteins Class 1 57050 64 4 
PA1805 ppiD peptidyl-prolyl cis-trans isomerase D Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 68699 107 3 
PA2476 dsbG thiol:disulfide interchange protein DsbG Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 28035 31 1 
PA0004 gyrB DNA gyrase subunit B DNA replication, recombination, modification and repair Class 2 90133 31 3 
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PA3617 recA RecA protein DNA replication, recombination, modification and repair Class 1 36856 28 1 
PA3640 dnaE DNA polymerase III, alpha chain DNA replication, recombination, modification and repair Class 2 130822 69 4 
PA1555  probable cytochrome c Energy metabolism Class 3 33791 132 2 
PA1583 sdhA succinate dehydrogenase (A subunit) Energy metabolism Class 2 63492 28 2 
PA4429  probable cytochrome c1 precursor Energy metabolism Class 3 28975 90 2 
PA5490 cc4 cytochrome c4 precursor Energy metabolism Class 2 20721 26 1 
PA5554 atpD ATP synthase beta chain Energy metabolism Class 2 49469 56 1 
PA5555 atpG ATP synthase gamma chain Energy metabolism Class 2 31533 74 3 
PA5556 atpA ATP synthase alpha chain Energy metabolism Class 2 55359 141 5 
PA5558 atpF ATP synthase B chain Energy metabolism Class 2 16946 152 5 
PA0541  hypothetical protein Hypothetical, unclassified, unknown Class 4 17112 35 1 
PA0788  hypothetical protein Hypothetical, unclassified, unknown Class 4 116374 39 4 
PA0946  hypothetical protein Hypothetical, unclassified, unknown Class 4 36754 68 3 
PA1011  hypothetical protein Hypothetical, unclassified, unknown Class 4 43030 348 11 
PA1064  hypothetical protein Hypothetical, unclassified, unknown Class 4 24157 81 1 
PA1198  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 22273 65 2 
PA1293  hypothetical protein Hypothetical, unclassified, unknown Class 4 38770 35 1 
PA1324  hypothetical protein Hypothetical, unclassified, unknown Class 4 18292 90 2 
PA2163  hypothetical protein Hypothetical, unclassified, unknown Class 4 74710 32 4 
PA2462  hypothetical protein Hypothetical, unclassified, unknown Class 4 572832 34 9 
PA2548  hypothetical protein Hypothetical, unclassified, unknown Class 4 51000 26 2 
PA2883  hypothetical protein Hypothetical, unclassified, unknown Class 4 6265 42 1 
PA2901  hypothetical protein Hypothetical, unclassified, unknown Class 4 12928 73 1 
PA3674  hypothetical protein Hypothetical, unclassified, unknown Class 4 14385 100 2 
PA3691  hypothetical protein Hypothetical, unclassified, unknown Class 4 14459 155 6 
PA3800  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 40372 228 4 
PA3848  hypothetical protein Hypothetical, unclassified, unknown Class 4 50516 40 2 
PA3988  hypothetical protein Hypothetical, unclassified, unknown Class 4 22870 44 2 
PA4352  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 30953 51 4 
PA4372  hypothetical protein Hypothetical, unclassified, unknown Class 4 38300 82 3 
PA4426  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20607 77 2 
PA4441  hypothetical protein Hypothetical, unclassified, unknown Class 4 16408 122 5 
PA4639  hypothetical protein Hypothetical, unclassified, unknown Class 4 20723 90 2 
PA4699  hypothetical protein Hypothetical, unclassified, unknown Class 4 25986 41 2 
PA4735  hypothetical protein Hypothetical, unclassified, unknown Class 4 118518 58 2 
PA4842  hypothetical protein Hypothetical, unclassified, unknown Class 4 39964 176 5 
PA5006  hypothetical protein Hypothetical, unclassified, unknown Class 4 54811 47 1 
PA5037  hypothetical protein Hypothetical, unclassified, unknown Class 4 57412 174 3 
PA5258  hypothetical protein Hypothetical, unclassified, unknown Class 4 40767 237 5 
PA5506  hypothetical protein Hypothetical, unclassified, unknown Class 4 32124 37 1 
PA0070  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 31697 32 2 
PA0833  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 24698 57 1 
PA1767  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 56777 56 1 
PA4961  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 56732 33 2 
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PA5568  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 64034 70 3 
PA1041  probable outer membrane protein precursor Membrane proteins Class 3 21734 75 3 
PA1119  probable outer membrane protein precursor Membrane proteins Class 3 18399 31 1 
PA2853 oprI Outer membrane lipoprotein OprI precursor Membrane proteins Class 1 8829 85 1 
PA2900  probable outer membrane protein precursor Membrane proteins Class 3 29835 104 1 
PA3648  probable outer membrane protein precursor Membrane proteins Class 3 88233 101 2 
PA3692  probable outer membrane protein precursor Membrane proteins Class 3 28497 694 14 
PA4370 icmP Insulin-cleaving metalloproteinase outer membrane 
protein precursor 
Membrane proteins Class 1 47202 186 11 
PA4765 omlA Outer membrane lipoprotein OmlA precursor Membrane proteins Class 1 19383 35 2 
PA4876 osmE osmotically inducible lipoprotein OsmE Membrane proteins;Adaptation, protection Class 2 12515 121 3 
PA0260  hypothetical protein Membrane proteins;Hypothetical, unclassified, unknown Class 4 78154 33 4 
PA3821 secD secretion protein SecD Membrane proteins;Protein secretion/export apparatus Class 2 67632 116 2 
PA0969 tolQ TolQ protein Membrane proteins;Transport of small molecules Class 1 25266 94 1 
PA1777 oprF Major porin and structural outer membrane porin OprF 
precursor 
Membrane proteins;Transport of small molecules Class 1 37616 477 31 
PA5291  probable choline transporter Membrane proteins;Transport of small molecules Class 3 73408 65 1 
PA1092 fliC flagellin type B Motility & Attachment Class 1 49213 48 2 
PA0411 pilJ twitching motility protein PilJ Motility & Attachment;Chemotaxis Class 1 72484 87 3 
PA3115 fimV Motility protein FimV Motility & Attachment;Membrane proteins Class 1 96871 37 1 
PA3805 pilF type 4 fimbrial biogenesis protein PilF Motility & Attachment;Protein secretion/export apparatus Class 1 28520 105 3 
PA1013 purC phosphoribosylaminoimidazole-succinocarboxamide 
synthase 
Nucleotide biosynthesis and metabolism Class 2 26814 31 1 
PA2815  probable acyl-CoA dehydrogenase Putative enzymes Class 3 88707 131 6 
PA3324  probable short-chain dehydrogenase Putative enzymes Class 3 65729 32 3 
PA3896  probable 2-hydroxyacid dehydrogenase Putative enzymes Class 3 35610 29 2 
PA4431  probable iron-sulfur protein Putative enzymes Class 3 20815 57 1 
PA4819  probable glycosyl transferase Putative enzymes Class 3 35670 26 3 
PA5008  hypothetical protein Putative enzymes;Hypothetical, unclassified, unknown Class 4 29041 29 18 
PA2477  probable thiol:disulfide interchange protein Putative enzymes;Membrane proteins Class 3 30144 81 3 
PA2976 rne ribonuclease E Transcription, RNA processing and degradation Class 2 117395 164 4 
PA4271 rplL 50S ribosomal protein L7 / L12 Translation, post-translational modification, degradation Class 2 12472 34 1 
PA3262  probable peptidyl-prolyl cis-trans isomerase, FkbP-type Translation, post-translational modification, degradation;Chaperones & 
heat shock proteins 
Class 3 26829 135 5 
PA0972 tolB TolB protein Transport of small molecules Class 2 47722 36 2 
PA1435  probable RND efflux membrane fusion protein 
precursor 
Transport of small molecules Class 3 41171 45 2 
PA2857  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 24570 50 2 
PA2987  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 24635 30 2 
PA0425 mexA RND multidrug efflux membrane fusion protein MexA 
precursor 
Transport of small molecules;Antibiotic resistance and susceptibility Class 1 40945 38 1 
PA1180 phoQ two-component sensor PhoQ Two-component regulatory systems Class 1 50249 122 2 
PA2480  probable two-component sensor Two-component regulatory systems Class 3 47663 51 3 
PA4982  probable two-component sensor Two-component regulatory systems Class 3 109071 27 2 
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Table 3.1.10.  List of iron limitation specific proteins detected in the membrane enriched fraction of only SCV 20265 under iron-limited growth. These proteins were not detected 
in the WT 20265 samples from either normal or iron limited cultures. These proteins were also not detected in the SCV 20265 grown in normal Vogel bonner medium in the 
absence of 2,2-Dipyridyl. 
 
PA  
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides  
matched 
PA0595 ostA organic solvent tolerance protein OstA precursor Adaptation, protection Class 2 104207 31 3 
PA2386 pvdA L-ornithine N5-oxygenase Adaptation, protection Class 1 49447 311 6 
PA2424  probable non-ribosomal peptide synthetase Adaptation, protection Class 3 479998 29 9 
PA4290  probable chemotaxis transducer Adaptation, protection;Chemotaxis Class 3 58368 53 1 
PA2399 pvdD pyoverdine synthetase D Adaptation, protection;Secreted Factors (toxins, enzymes, 
alginate) 
Class 1 273510 83 1 
PA4671  probable ribosomal protein L25 Adaptation, protection;Translation, post-translational 
modification, degradation 
Class 3 21949 96 4 
PA1927 metE 5-methyltetrahydropteroyltriglutamate-homocysteine S-
methyltransferase 
Amino acid biosynthesis and metabolism Class 2 86157 40 3 
PA3068 gdhB NAD-dependent glutamate dehydrogenase Amino acid biosynthesis and metabolism Class 2 182525 70 3 
PA5323 argB Acetylglutamate kinase Amino acid biosynthesis and metabolism Class 2 31829 62 1 
PA3108 purF amidophosphoribosyltransferase Amino acid biosynthesis and metabolism;Nucleotide 
biosynthesis and metabolism 
Class 2 55335 59 2 
PA2261  probable 2-ketogluconate kinase Carbon compound catabolism Class 3 34020 31 2 
PA4412 murG UDP-N-acetylglucosamine--N-acetylmuramyl-
(pentapeptide) pyrophosphoryl-undecaprenol N-
acetylglucosamine transferase 
Carbon compound catabolism;Cell wall / LPS / capsule Class 2 37775 54 1 
PA2393  probable dipeptidase precursor Central intermediary metabolism Class 3 49330 347 9 
PA3126 ibpA heat-shock protein IbpA Chaperones & heat shock proteins Class 2 16573 194 6 
PA3617 recA RecA protein DNA replication, recombination, modification and repair Class 1 36856 82 2 
PA1552  probable cytochrome c Energy metabolism Class 3 34622 96 2 
PA1553  probable cytochrome c oxidase subunit Energy metabolism Class 3 22744 51 3 
PA1787 acnB aconitate hydratase 2 Energy metabolism Class 2 93569 27 2 
PA2994 nqrF Na+-translocating NADH:quinone oxidoreductase, 
subunit Nqr6 
Energy metabolism Class 2 45441 55 1 
PA1323  hypothetical protein Hypothetical, unclassified, unknown Class 4 11579 38 1 
PA2361  hypothetical protein Hypothetical, unclassified, unknown Class 4 141260 40 3 
PA2392  hypothetical protein Hypothetical, unclassified, unknown Class 4 62255 102 3 
PA2754  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11867 30 1 
PA3481  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 38864 104 1 
PA3797  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29977 25 2 
PA4452  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 10771 29 1 
PA4656  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 33831 57 1 
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PA1245  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 41392 439 6 
PA5473  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 63222 76 1 
PA2520 czcA RND divalent metal cation efflux transporter CzcA Membrane proteins;Transport of small molecules Class 2 113805 34 6 
PA3901 fecA Fe(III) dicitrate transport protein FecA Membrane proteins;Transport of small molecules Class 2 85415 69 3 
PA4224 pchG pyochelin biosynthetic protein PchG Membrane proteins;Transport of small molecules Class 1 37673 197 4 
PA3050 pyrD Dihydroorotate dehydrogenase Nucleotide biosynthesis and metabolism Class 2 36106 48 1 
PA4756 carB carbamoylphosphate synthetase large subunit Nucleotide biosynthesis and metabolism;Amino acid 
biosynthesis and metabolism 
Class 1 117257 40 2 
PA3820 secF secretion protein SecF Protein secretion/export apparatus Class 2 33021 27 2 
PA0953  probable thioredoxin Putative enzymes Class 3 16885 89 2 
PA0641  probable bacteriophage protein Related to phage, transposon, or plasmid Class 3 130710 33 7 
PA1249 aprA alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) Class 1 50402 248 5 
PA1246 aprD alkaline protease secretion protein AprD Secreted Factors (toxins, enzymes, alginate);Protein 
secretion/export apparatus 
Class 1 63631 41 1 
PA0963 aspS aspartyl-tRNA synthetase Transcription, RNA processing and degradation Class 2 66166 68 4 
PA4269 rpoC DNA-directed RNA polymerase beta* chain Transcription, RNA processing and degradation Class 2 154287 86 3 
PA4272 rplJ 50S ribosomal protein L10 Translation, post-translational modification, degradation Class 2 17623 55 1 
PA4273 rplA 50S ribosomal protein L1 Translation, post-translational modification, degradation Class 2 24219 26 1 
PA4432 rpsI 30S ribosomal protein S9 Translation, post-translational modification, degradation Class 2 14606 27 1 
PA4808 selA L-seryl-tRNA(ser) selenium transferase Translation, post-translational modification, degradation Class 2 50261 56 1 
PA2408  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 27048 44 2 
PA4222  probable ATP-binding component of ABC transporter Transport of small molecules Class 3 61355 92 2 
PA0971 tolA TolA protein Transport of small molecules;Membrane proteins Class 2 37912 89 1 
PA4225 pchF pyochelin synthetase Transport of small molecules;Secreted Factors (toxins, 
enzymes, alginate) 
Class 1 196962 79 4 
PA4226 pchE dihydroaeruginoic acid synthetase Transport of small molecules;Secreted Factors (toxins, 
enzymes, alginate) 
Class 1 156325 67 3 
PA3271  probable two-component sensor Two-component regulatory systems Class 3 127373 107 3 
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Table 3.1.11.   List of iron limitation specific proteins detected in the membrane enriched fraction of only WT 20265 under iron-limited growth. These proteins were not detected 
in the SCV 20265 samples from both normal and iron limited cultures. These proteins were also not detected in the WT 20265 cultures grown in the absence of  2,2-Dipyridyl. 
 
PA 
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides 
matched 
PA4307 pctC chemotactic transducer PctC Adaptation, protection;Chemotaxis Class 1 68266 54 1 
PA2494 mexF RND multidrug efflux transporter MexF Antibiotic resistance and susceptibility;Membrane proteins;Transport of 
small molecules 
Class 1 115437 803 19 
PA2493 mexE RND multidrug efflux membrane fusion protein MexE 
precursor 
Antibiotic resistance and susceptibility;Transport of small molecules Class 1 45004 268 8 
PA2009 hmgA Homogentisate 1,2-dioxygenase Carbon compound catabolism Class 2 47811 31 2 
PA3244 minD cell division inhibitor MinD Cell division Class 2 29617 29 2 
PA2813  probable glutathione S-transferase Central intermediary metabolism Class 3 23390 46 1 
PA1805 ppiD peptidyl-prolyl cis-trans isomerase D Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 68699 92 3 
PA1584 sdhB succinate dehydrogenase (B subunit) Energy metabolism Class 2 26138 58 1 
PA1586 sucB dihydrolipoamide succinyltransferase (E2 subunit) Energy metabolism Class 2 42861 104 2 
PA2999 nqrA Na+-translocating NADH:ubiquinone oxidoreductase 
subunit Nrq1 
Energy metabolism Class 2 48051 32 1 
PA0759  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 33647 32 1 
PA0807  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 28703 29 3 
PA3909  hypothetical protein Hypothetical, unclassified, unknown Class 4 83029 27 5 
PA4394  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29799 81 1 
PA4459  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 21340 35 2 
PA3920  probable metal transporting P-type ATPase Membrane proteins;Transport of small molecules Class 3 83386 71 2 
PA1860  hypothetical protein Putative enzymes Class 4 32016 29 2 
PA3593  probable acyl-CoA dehydrogenase Putative enzymes Class 3 64115 56 5 
PA2478  probable thiol:disulfide interchange protein Putative enzymes;Membrane proteins Class 3 62054 104 2 
PA4270 rpoB DNA-directed RNA polymerase beta chain Transcription, RNA processing and degradation Class 2 150744 27 5 
PA1490  probable transcriptional regulator Transcriptional regulators Class 3 28365 30 2 
PA4267 rpsG 30S ribosomal protein S7 Translation, post-translational modification, degradation Class 2 17493 36 1 
PA3745 rpsP 30S ribosomal protein S16 Translation, post-translational modification, degradation;DNA replication, 
recombination, modification and repair 
Class 2 9199 71 1 
PA1922  probable TonB-dependent receptor Transport of small molecules Class 3 72218 50 5 
PA2812  probable ATP-binding component of ABC 
transporter 
Transport of small molecules Class 3 34519 171 5 
PA4461  probable ATP-binding component of ABC 
transporter 
Transport of small molecules Class 3 26434 66 2 
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Table 3.1.12.   List of proteins detected in the secreted proteins(secretome) enriched fraction of SCV 20265 grown in normal Vogel Bonner medium.  
 
PA 
Number 
Gene 
Name 
Protein 
Name 
Function Class Mass Score Peptides 
matched 
PA0139 ahpC alkyl hydroperoxide reductase subunit C Adaptation, protection Class 2 20529 37 1 
PA4366 sodB superoxide dismutase Adaptation, protection Class 1 21337 43 1 
PA4761 dnaK DnaK protein Adaptation, protection;Chaperones & heat shock proteins;DNA 
replication, recombination, modification and repair 
Class 2 68361 491 13 
PA1178 oprH PhoP/Q and low Mg2+ inducible outer 
membrane protein H1 precursor 
Adaptation, protection;Membrane proteins Class 1 21561 242 8 
PA3529  Probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 201 6 
PA0456  Probable cold-shock protein Adaptation, protection;Transcriptional regulators Class 3 7702 28 1 
PA5015 aceE Pyruvate dehydrogenase Amino acid biosynthesis and metabolism;Energy metabolism Class 1 99501 41 3 
PA0854 fumC2 Fumarate hydratase Carbon compound catabolism;Energy metabolism Class 2 49091 27 2 
PA4385 groEL GroEL protein Chaperones & heat shock proteins Class 1 57050 557 19 
PA4386 groES GroES protein Chaperones & heat shock proteins Class 1 10260 83 2 
PA1804 hupB DNA-binding protein HU DNA replication, recombination, modification and repair Class 1 9081 120 2 
PA1588 sucC succinyl-CoA synthetase beta chain Energy metabolism Class 2 41517 83 3 
PA2951 etfA electron transfer flavoprotein alpha-subunit Energy metabolism Class 2 31404 54 3 
PA2952 etfB electron transfer flavoprotein beta-subunit Energy metabolism Class 2 26360 30 1 
PA4922 azu azurin precursor Energy metabolism Class 1 15998 122 7 
PA5300 cycB cytochrome c5 Energy metabolism Class 2 13450 51 1 
PA0423  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20764 78 3 
PA0460  hypothetical protein Hypothetical, unclassified, unknown Class 4 18716 64 1 
PA0542  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 14758 81 1 
PA1711  hypothetical protein Hypothetical, unclassified, unknown Class 4 8691 64 1 
PA1830  hypothetical protein Hypothetical, unclassified, unknown Class 4 11102 26 1 
PA2453  hypothetical protein Hypothetical, unclassified, unknown Class 4 8112 83 3 
PA2462  hypothetical protein Hypothetical, unclassified, unknown Class 4 572832 34 6 
PA3031  hypothetical protein Hypothetical, unclassified, unknown Class 4 8007 57 2 
PA3611  hypothetical protein Hypothetical, unclassified, unknown Class 4 14977 55 2 
PA3836  hypothetical protein Hypothetical, unclassified, unknown Class 4 34199 27 1 
PA4063  hypothetical protein Hypothetical, unclassified, unknown Class 4 21222 37 3 
PA4453  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 23745 50 4 
PA4625  hypothetical protein Hypothetical, unclassified, unknown Class 4 219625 91 3 
PA4739  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11753 177 5 
PA3647  Probable outer membrane protein precursor Membrane proteins Class 3 19078 30 1 
PA3692  Probable outer membrane protein precursor Membrane proteins Class 3 28497 46 1 
PA1777 oprF Major porin and structural outer membrane 
porin OprF precursor 
Membrane proteins;Transport of small molecules Class 1 37616 58 1 
PA5505  Probable TonB-dependent receptor Membrane proteins;Transport of small molecules Class 3 28048 90 4 
PA1092 fliC flagellin type B Motility & Attachment Class 1 49213 165 3 
PA1706 pcrV type III secretion protein PcrV Protein secretion/export apparatus Class 1 32264 61 2 
PA1708 popB translocator protein PopB Protein secretion/export apparatus Class 1 40036 177 5 
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PA1709 popD Translocator outer membrane protein PopD 
precursor 
Protein secretion/export apparatus Class 1 31290 256 7 
PA4128  conserved hypothetical protein Putative enzymes Class 4 28186 24 2 
PA0044 exoT exoenzyme T Secreted Factors (toxins, enzymes, alginate) Class 1 48485 783 21 
PA3841 exoS exoenzyme S Secreted Factors (toxins, enzymes, alginate) Class 1 48273 1391 33 
PA5483 algB two-component response regulator AlgB Transcriptional regulators;Two-component regulatory systems Class 1 49292 31 2 
PA2851 efp translation elongation factor P Translation, post-translational modification, degradation Class 2 20972 43 1 
PA4265 tufA elongation factor Tu Translation, post-translational modification, degradation Class 2 43342 239 6 
PA4266 fusA1 elongation factor G Translation, post-translational modification, degradation Class 2 77735 239 9 
PA4273 rplA 50S ribosomal protein L1 Translation, post-translational modification, degradation Class 2 24219 50 1 
PA4542 clpB ClpB protein Translation, post-translational modification, degradation Class 2 94947 92 4 
PA0300 spuD polyamine transport protein Transport of small molecules Class 1 40604 30 3 
PA0888 aotJ arginine/ornithine binding protein AotJ Transport of small molecules Class 1 27992 35 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                                        Results and Discussion 
95 
Table 3.1.13.   List of proteins detected in the secreted proteins (secretome) enriched fraction of SCV 20265 grown in vogel bonner medium containing 1.1mM of 2,2-Dipyridyl. 
  
PA 
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides 
matched 
PA4366 sodB superoxide dismutase Adaptation, protection Class 1 21337 43 1 
PA4761 dnaK DnaK protein Adaptation, protection;Chaperones & heat shock proteins;DNA 
replication, recombination, modification and repair Class 2 68361 494 12 
PA1178 oprH PhoP/Q and low Mg2+ inducible outer 
membrane protein H1 precursor 
Adaptation, protection;Membrane proteins 
Class 1 21561 426 13 
PA3529  probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 226 6 
PA0456  probable cold-shock protein Adaptation, protection;Transcriptional regulators Class 3 7702 85 2 
PA4694 ilvC ketol-acid reductoisomerase Amino acid biosynthesis and metabolism;Biosynthesis of 
cofactors, prosthetic groups and carriers Class 2 36401 39 2 
PA2623 icd isocitrate dehydrogenase Amino acid biosynthesis and metabolism;Carbon compound 
catabolism;Energy metabolism Class 2 45548 127 6 
PA1587 lpdG lipoamide dehydrogenase-glc Amino acid biosynthesis and metabolism;Energy metabolism Class 2 50134 52 2 
PA3181  2-keto-3-deoxy-6-phosphogluconate aldolase Carbon compound catabolism;Central intermediary metabolism Class 2 23939 34 1 
PA4385 groEL GroEL protein Chaperones & heat shock proteins Class 1 57050 696 17 
PA4386 groES GroES protein Chaperones & heat shock proteins Class 1 10260 84 2 
PA3227 ppiA peptidyl-prolyl cis-trans isomerase A Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation Class 2 20092 135 3 
PA5489 dsbA thiol:disulfide interchange protein DsbA Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation Class 2 23360 177 6 
PA1804 hupB DNA-binding protein HU DNA replication, recombination, modification and repair Class 1 9081 121 3 
PA4762 grpE heat shock protein GrpE DNA replication, recombination, modification and 
repair;Chaperones & heat shock proteins Class 2 20689 40 1 
PA1588 sucC succinyl-CoA synthetase beta chain Energy metabolism Class 2 41517 362 10 
PA1589 sucD succinyl-CoA synthetase alpha chain Energy metabolism Class 2 30247 136 4 
PA2951 etfA electron transfer flavoprotein alpha-subunit Energy metabolism Class 2 31404 99 3 
PA2952 etfB electron transfer flavoprotein beta-subunit Energy metabolism Class 2 26360 131 3 
PA4470 fumC1 fumarate hydratase Energy metabolism Class 1 48665 31 1 
PA4922 azu azurin precursor Energy metabolism Class 1 15998 204 7 
PA0315  hypothetical protein Hypothetical, unclassified, unknown Class 4 15453 72 2 
PA0388  hypothetical protein Hypothetical, unclassified, unknown Class 4 15293 60 3 
PA0423  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20764 481 10 
PA0460  hypothetical protein Hypothetical, unclassified, unknown Class 4 18716 32 2 
PA0542  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 14758 83 1 
PA0549  hypothetical protein Hypothetical, unclassified, unknown Class 4 41061 25 2 
PA0754  hypothetical protein Hypothetical, unclassified, unknown Class 4 34896 44 1 
PA0856  hypothetical protein Hypothetical, unclassified, unknown Class 4 19986 80 1 
PA0943  hypothetical protein Hypothetical, unclassified, unknown Class 4 27166 114 4 
PA1221  hypothetical protein Hypothetical, unclassified, unknown Class 4 67540 34 1 
PA1830  hypothetical protein Hypothetical, unclassified, unknown Class 4 11102 55 1 
PA2451  hypothetical protein Hypothetical, unclassified, unknown Class 4 21957 29 1 
PA2453  hypothetical protein Hypothetical, unclassified, unknown Class 4 8112 45 2 
                                                                                                                                                                                                        Results and Discussion 
96 
PA2474  hypothetical protein Hypothetical, unclassified, unknown Class 4 34191 30 1 
PA3031  hypothetical protein Hypothetical, unclassified, unknown Class 4 8007 90 2 
PA3435  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 15861 35 1 
PA3598  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29572 27 1 
PA3931  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 28084 114 4 
PA4063  hypothetical protein Hypothetical, unclassified, unknown Class 4 21222 94 4 
PA4395  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 18033 25 1 
PA4453  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 23745 117 3 
PA4625  hypothetical protein Hypothetical, unclassified, unknown Class 4 219625 65 2 
PA4708  hypothetical protein Hypothetical, unclassified, unknown Class 4 31019 159 5 
PA4738  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 7607 89 3 
PA4739  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11753 283 9 
PA5305  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11520 45 1 
PA5359  hypothetical protein Hypothetical, unclassified, unknown Class 4 16461 27 1 
PA5481  hypothetical protein Hypothetical, unclassified, unknown Class 4 17355 56 3 
PA1245  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 41392 54 2 
PA3647  probable outer membrane protein precursor Membrane proteins Class 3 19078 76 1 
PA1777 oprF Major porin and structural outer membrane 
porin OprF precursor 
Membrane proteins;Transport of small molecules 
Class 1 37616 131 3 
PA5505  probable TonB-dependent receptor Membrane proteins;Transport of small molecules Class 3 28048 78 3 
PA3807 ndk nucleoside diphosphate kinase Nucleotide biosynthesis and metabolism Class 1 15582 50 2 
PA5240 trxA thioredoxin Nucleotide biosynthesis and metabolism;Translation, post-
translational modification, degradation;Energy metabolism Class 2 11862 74 3 
PA1249 aprA alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) Class 1 50402 209 6 
PA3743 trmD tRNA (guanine-N1)-methyltransferase Transcription, RNA processing and degradation Class 2 28341 25 1 
PA4755 greA transcription elongation factor GreA Transcription, RNA processing and degradation Class 2 17148 206 5 
PA5483 algB two-component response regulator AlgB Transcriptional regulators;Two-component regulatory systems Class 1 49292 27 1 
PA3162 rpsA 30S ribosomal protein S1 Translation, post-translational modification, degradation Class 2 61832 40 3 
PA3653 frr ribosome recycling factor Translation, post-translational modification, degradation Class 1 20473 52 4 
PA4265 tufA elongation factor Tu Translation, post-translational modification, degradation Class 2 43342 180 4 
PA4266 fusA1 elongation factor G Translation, post-translational modification, degradation Class 2 77735 432 14 
PA5051 argS arginyl-tRNA synthetase Translation, post-translational modification, degradation Class 2 65158 25 1 
PA0283 sbp sulfate-binding protein precursor Transport of small molecules Class 2 36411 127 3 
PA0300 spuD polyamine transport protein Transport of small molecules Class 1 40604 110 3 
PA0888 aotJ arginine/ornithine binding protein AotJ Transport of small molecules Class 1 27992 188 5 
PA0958 oprD Basic amino acid, basic peptide and imipenem 
outer membrane porin OprD precursor 
Transport of small molecules 
Class 1 48331 78 1 
PA1074 braC branched-chain amino acid transport protein 
BraC 
Transport of small molecules 
Class 1 39744 107 4 
PA1342  probable binding protein component of ABC 
transporter 
Transport of small molecules 
Class 3 33033 173 6 
PA3190  probable binding protein component of ABC 
sugar transporter 
Transport of small molecules 
Class 3 45103 68 3 
PA3313  hypothetical protein Transport of small molecules Class 4 36516 93 4 
PA3407 hasAp heme acquisition protein HasAp Transport of small molecules Class 1 20890 62 4 
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Table 3.1.14.   List of proteins detected in the secreted proteins (secretome) enriched fraction of WT 20265 grown in normal Vogel Bonner medium.  
 
PA 
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides 
Matched 
PA0139 ahpC alkyl hydroperoxide reductase subunit C Adaptation, protection Class 2 20529 122 3 
PA4366 sodB superoxide dismutase Adaptation, protection Class 1 21337 71 2 
PA4761 dnaK DnaK protein Adaptation, protection;Chaperones & heat shock proteins;DNA 
replication, recombination, modification and repair Class 2 68361 329 10 
PA1178 oprH PhoP/Q and low Mg2+ inducible outer 
membrane protein H1 precursor Adaptation, protection;Membrane proteins Class 1 21561 392 10 
PA3529  probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 156 3 
PA0456  probable cold-shock protein Adaptation, protection;Transcriptional regulators Class 3 7702 74 2 
PA1159  probable cold-shock protein Adaptation, protection;Transcriptional regulators Class 3 7720 69 1 
PA2623 icd isocitrate dehydrogenase Amino acid biosynthesis and metabolism;Carbon compound 
catabolism;Energy metabolism Class 2 45548 92 4 
PA4385 groEL GroEL protein Chaperones & heat shock proteins Class 1 57050 845 21 
PA4386 groES GroES protein Chaperones & heat shock proteins Class 1 10260 149 4 
PA2476 dsbG thiol:disulfide interchange protein DsbG Chaperones & heat shock proteins;Translation, post-translational  Class 2 28035 34 1 
PA1804 hupB DNA-binding protein HU DNA replication, recombination, modification and repair Class 1 9081 133 2 
PA1588 sucC succinyl-CoA synthetase beta chain Energy metabolism Class 2 41517 52 2 
PA1589 sucD succinyl-CoA synthetase alpha chain Energy metabolism Class 2 30247 101 4 
PA4922 azu azurin precursor Energy metabolism Class 1 15998 64 2 
PA2966 acpP acyl carrier protein Fatty acid and phospholipid metabolism Class 1 8735 36 1 
PA0312  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 17403 32 2 
PA0315  hypothetical protein Hypothetical, unclassified, unknown Class 4 15453 27 1 
PA0423  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20764 179 6 
PA0505  hypothetical protein Hypothetical, unclassified, unknown Class 4 7866 174 3 
PA0587  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 48712 37 2 
PA0807  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 28703 62 2 
PA1093  hypothetical protein Hypothetical, unclassified, unknown Class 4 13026 37 1 
PA1198  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 22273 42 1 
PA2506  hypothetical protein Hypothetical, unclassified, unknown Class 4 8042 28 1 
PA2567  hypothetical protein Hypothetical, unclassified, unknown Class 4 65577 26 2 
PA3351  hypothetical protein Hypothetical, unclassified, unknown Class 4 11244 252 5 
PA4739  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11753 159 3 
PA3819  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 18961 29 1 
PA1092 fliC flagellin type B Motility & Attachment Class 1 49213 174 4 
PA1086 flgK flagellar hook-associated protein 1 FlgK Motility & Attachment;Cell wall / LPS / capsule Class 2 71690 172 4 
PA2071 fusA2 elongation factor G Translation, post-translational modification, degradation Class 2 77525 45 4 
PA4254 rpsQ 30S ribosomal protein S17 Translation, post-translational modification, degradation Class 2 10080 26 1 
PA4265 tufA elongation factor Tu Translation, post-translational modification, degradation Class 2 43342 375 10 
PA4266 fusA1 elongation factor G Translation, post-translational modification, degradation Class 2 77735 248 11 
PA4273 rplA 50S ribosomal protein L1 Translation, post-translational modification, degradation Class 2 24219 85 2 
PA4274 rplK 50S ribosomal protein L11 Translation, post-translational modification, degradation Class 2 14898 34 1 
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Table 3.1.15.   List of proteins detected in the secreted proteins (secretome) enriched fraction of WT 20265 grown in Vogel Bonner medium containing 1.1mM of 2,2-Dipyridyl. 
  
PA 
Number 
Gene 
Name 
Protein Name Function Class Mass Score Peptides 
matched 
PA0139 ahpC alkyl hydroperoxide reductase subunit C Adaptation, protection Class 2 20529 36 1 
PA0300 spuD polyamine transport protein Transport of small molecules Class 1 40604 37 2 
PA0329  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11766 41 1 
PA0423  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 20764 73 3 
PA0542  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 14758 64 2 
PA0856  hypothetical protein Hypothetical, unclassified, unknown Class 4 19986 70 1 
PA0938  hypothetical protein Hypothetical, unclassified, unknown Class 4 49236 30 1 
PA1092 fliC flagellin type B Motility & Attachment Class 1 49213 48 1 
PA1178 oprH PhoP/Q and low Mg2+ inducible outer 
membrane protein H1 precursor 
Adaptation, protection;Membrane proteins Class 1 21561 146 5 
PA1221  hypothetical protein Hypothetical, unclassified, unknown Class 4 67540 24 3 
PA1342  probable binding protein component of ABC 
transporter 
Transport of small molecules Class 3 33033 46 1 
PA1588 sucC succinyl-CoA synthetase beta chain Energy metabolism Class 2 41517 47 2 
PA1777 oprF Major porin and structural outer membrane 
porin OprF precursor 
Membrane proteins;Transport of small molecules Class 1 37616 164 4 
PA1804 hupB DNA-binding protein HU DNA replication, recombination, modification and repair Class 1 9081 67 2 
PA1830  hypothetical protein Hypothetical, unclassified, unknown Class 4 11102 25 1 
PA2302  probable non-ribosomal peptide synthetase Putative enzymes Class 3 228903 31 2 
PA2453  hypothetical protein Hypothetical, unclassified, unknown Class 4 8112 36 1 
PA2476 dsbG thiol:disulfide interchange protein DsbG Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 28035 100 5 
PA2851 efp translation elongation factor P Translation, post-translational modification, degradation Class 2 20972 40 1 
PA2853 oprI Outer membrane lipoprotein OprI precursor Membrane proteins Class 1 8829 46 1 
PA2951 etfA electron transfer flavoprotein alpha-subunit Energy metabolism Class 2 31404 45 2 
PA2952 etfB electron transfer flavoprotein beta-subunit Energy metabolism Class 2 26360 25 1 
PA2970 rpmF 50S ribosomal protein L32 Translation, post-translational modification, degradation Class 2 6787 51 2 
PA3229  hypothetical protein Hypothetical, unclassified, unknown Class 4 9621 72 2 
PA3529  probable peroxidase Adaptation, protection;Putative enzymes Class 3 21808 171 5 
PA3647  probable outer membrane protein precursor Membrane proteins Class 3 19078 30 3 
PA3692  probable outer membrane protein precursor Membrane proteins Class 3 28497 182 5 
PA3745 rpsP 30S ribosomal protein S16 Translation, post-translational modification, degradation;DNA 
replication, recombination, modification and repair 
Class 2 9199 30 2 
PA3819  conserved hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 18961 28 1 
PA3836  hypothetical protein Hypothetical, unclassified, unknown Class 4 34199 31 1 
PA3848  hypothetical protein Hypothetical, unclassified, unknown Class 4 50516 29 1 
PA4240 rpsK 30S ribosomal protein S11 Translation, post-translational modification, degradation Class 2 13621 58 1 
PA4244 rplO 50S ribosomal protein L15 Translation, post-translational modification, degradation Class 2 15165 39 1 
PA4247 rplR 50S ribosomal protein L18 Translation, post-translational modification, degradation Class 2 12654 66 1 
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PA4249 rpsH 30S ribosomal protein S8 Translation, post-translational modification, degradation Class 2 14162 33 2 
PA4264 rpsJ 30S ribosomal protein S10 Translation, post-translational modification, 
degradation;Transcription, RNA processing and degradation 
Class 2 11759 50 1 
PA4265 tufA elongation factor Tu Translation, post-translational modification, degradation Class 2 43342 151 4 
PA4266 fusA1 elongation factor G Translation, post-translational modification, degradation Class 2 77735 224 10 
PA4273 rplA 50S ribosomal protein L1 Translation, post-translational modification, degradation Class 2 24219 53 2 
PA4274 rplK 50S ribosomal protein L11 Translation, post-translational modification, degradation Class 2 14898 55 1 
PA4385 groEL GroEL protein Chaperones & heat shock proteins Class 1 57050 275 9 
PA4386 groES GroES protein Chaperones & heat shock proteins Class 1 10260 60 2 
PA4563 rpsT 30S ribosomal protein S20 Translation, post-translational modification, degradation;Central 
intermediary metabolism 
Class 2 9911 64 1 
PA4611  hypothetical protein Hypothetical, unclassified, unknown Class 4 9710 71 2 
PA4694 ilvC ketol-acid reductoisomerase Amino acid biosynthesis and metabolism;Biosynthesis of 
cofactors, prosthetic groups and carriers 
Class 2 36401 32 1 
PA4739  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11753 65 3 
PA4755 greA transcription elongation factor GreA Transcription, RNA processing and degradation Class 2 17148 27 1 
PA4761 dnaK DnaK protein Adaptation, protection;Chaperones & heat shock proteins;DNA 
replication, recombination, modification and repair 
Class 2 68361 97 6 
PA4814 fadH2 2,4-dienoyl-CoA reductase FadH2 Fatty acid and phospholipid metabolism Class 2 74586 25 1 
PA4932 rplI 50S ribosomal protein L9 Translation, post-translational modification, degradation Class 2 15522 47 1 
PA5167  probable c4-dicarboxylate-binding protein Membrane proteins;Transport of small molecules Class 3 37027 60 1 
PA5505  probable TonB-dependent receptor Membrane proteins;Transport of small molecules Class 3 28048 29 1 
PA5506  hypothetical protein Hypothetical, unclassified, unknown Class 4 32124 34 2 
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Table 3.1.16.   List of iron limitation specific proteins detected in the secreted proteins (secretome) enriched fraction of only SCV 20265 under iron-limited growth. These 
proteins were not detected in the WT 20265 supernatant samples from both normal and iron limited cultures. 
 
PA 
Number 
Gene 
Name 
Product Name Function Class Mass Score Peptides 
matched 
PA4694 ilvC ketol-acid reductoisomerase Amino acid biosynthesis and metabolism;Biosynthesis of 
cofactors, prosthetic groups and carriers 
Class 2 36401 39 2 
PA1587 lpdG lipoamide dehydrogenase-glc Amino acid biosynthesis and metabolism;Energy metabolism Class 2 50134 52 2 
PA3181  2-keto-3-deoxy-6-phosphogluconate aldolase Carbon compound catabolism;Central intermediary metabolism Class 2 23939 34 1 
PA3227 ppiA peptidyl-prolyl cis-trans isomerase A Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 20092 135 3 
PA5489 dsbA thiol:disulfide interchange protein DsbA Chaperones & heat shock proteins;Translation, post-translational 
modification, degradation 
Class 2 23360 177 6 
PA4762 grpE heat shock protein GrpE DNA replication, recombination, modification and 
repair;Chaperones & heat shock proteins 
Class 2 20689 40 1 
PA4470 fumC1 Fumarate hydratase Energy metabolism Class 1 48665 31 1 
PA0388  hypothetical protein Hypothetical, unclassified, unknown Class 4 15293 60 3 
PA0549  hypothetical protein Hypothetical, unclassified, unknown Class 4 41061 25 2 
PA0754  hypothetical protein Hypothetical, unclassified, unknown Class 4 34896 44 1 
PA0943  hypothetical protein Hypothetical, unclassified, unknown Class 4 27166 114 4 
PA2451  hypothetical protein Hypothetical, unclassified, unknown Class 4 21957 29 1 
PA2474  hypothetical protein Hypothetical, unclassified, unknown Class 4 34191 30 1 
PA3435  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 15861 35 1 
PA3598  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 29572 27 1 
PA3691  hypothetical protein Hypothetical, unclassified, unknown Class 4 14459 86 2 
PA3931  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 28084 114 4 
PA4395  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 18033 25 1 
PA4708  hypothetical protein Hypothetical, unclassified, unknown Class 4 31019 159 5 
PA4738  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 7607 89 3 
PA5305  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11520 45 1 
PA5359  hypothetical protein Hypothetical, unclassified, unknown Class 4 16461 27 1 
PA5481  hypothetical protein Hypothetical, unclassified, unknown Class 4 17355 56 3 
PA1245  hypothetical protein Hypothetical, unclassified, unknown;Membrane proteins Class 4 41392 54 2 
PA3807 ndk nucleoside diphosphate kinase Nucleotide biosynthesis and metabolism Class 1 15582 50 2 
PA5240 trxA Thioredoxin Nucleotide biosynthesis and metabolism;Translation, post-
translational modification, degradation;Energy metabolism 
Class 2 11862 74 3 
PA1249 aprA alkaline metalloproteinase precursor Secreted Factors (toxins, enzymes, alginate) Class 1 50402 209 6 
PA3743 trmD tRNA (guanine-N1)-methyltransferase Transcription, RNA processing and degradation Class 2 28341 25 1 
PA3162 rpsA 30S ribosomal protein S1 Translation, post-translational modification, degradation Class 2 61832 40 3 
PA3653 frr ribosome recycling factor Translation, post-translational modification, degradation Class 1 20473 52 4 
PA5051 argS arginyl-tRNA synthetase Translation, post-translational modification, degradation Class 2 65158 25 1 
PA0283 sbp sulfate-binding protein precursor Transport of small molecules Class 2 36411 127 3 
PA0958 oprD Basic amino acid, basic peptide and imipenem 
outer membrane porin OprD precursor 
Transport of small molecules Class 1 48331 78 1 
PA1074 braC branched-chain amino acid transport protein Transport of small molecules Class 1 39744 107 4 
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BraC 
PA3190  Probable binding protein component of ABC 
sugar transporter 
Transport of small molecules Class 3 45103 68 3 
PA3313  hypothetical protein Transport of small molecules Class 4 36516 93 4 
PA3407 hasAp heme acquisition protein HasAp Transport of small molecules Class 1 20890 62 4 
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Table 3.1.17.   List of iron limitation specific proteins detected in the secreted proteins (secretome) enriched fraction of only WT 20265 under iron-limited growth. These proteins 
were not detected in the SCV 20265 supernatant samples from both normal and iron limited cultures. 
 
PA 
Number 
Gene 
Name 
Product Name Function Class Mass Score Peptides 
matched 
PA0329  conserved hypothetical protein Hypothetical, unclassified, unknown Class 4 11766 41 1 
PA0938  hypothetical protein Hypothetical, unclassified, unknown Class 4 49236 30 1 
PA2302  probable non-ribosomal peptide synthetase Putative enzymes Class 3 228903 31 2 
PA2853 oprI Outer membrane lipoprotein OprI precursor Membrane proteins Class 1 8829 46 1 
PA2970 rpmF 50S ribosomal protein L32 Translation, post-translational modification, degradation Class 2 6787 51 2 
PA3229  hypothetical protein Hypothetical, unclassified, unknown Class 4 9621 72 2 
PA3745 rpsP 30S ribosomal protein S16 Translation, post-translational modification, degradation;DNA 
replication, recombination, modification and repair 
Class 2 9199 30 2 
PA3848  hypothetical protein Hypothetical, unclassified, unknown Class 4 50516 29 1 
PA4240 rpsK 30S ribosomal protein S11 Translation, post-translational modification, degradation Class 2 13621 58 1 
PA4244 rplO 50S ribosomal protein L15 Translation, post-translational modification, degradation Class 2 15165 39 1 
PA4247 rplR 50S ribosomal protein L18 Translation, post-translational modification, degradation Class 2 12654 66 1 
PA4249 rpsH 30S ribosomal protein S8 Translation, post-translational modification, degradation Class 2 14162 33 2 
PA4264 rpsJ 30S ribosomal protein S10 Translation, post-translational modification, 
degradation;Transcription, RNA processing and degradation 
Class 2 11759 50 1 
PA4563 rpsT 30S ribosomal protein S20 Translation, post-translational modification, degradation;Central 
intermediary metabolism 
Class 2 9911 64 1 
PA4611  hypothetical protein Hypothetical, unclassified, unknown Class 4 9710 71 2 
PA4814 fadH2 2,4-dienoyl-CoA reductase FadH2 Fatty acid and phospholipid metabolism Class 2 74586 25 1 
PA4932 rplI 50S ribosomal protein L9 Translation, post-translational modification, degradation Class 2 15522 47 1 
PA5167  probable c4-dicarboxylate-binding protein Membrane proteins;Transport of small molecules Class 3 37027 60 1 
PA5506   hypothetical protein Hypothetical, unclassified, unknown Class 4 32124 34 2 
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A brief summary of the data presented in the above tables (3.1.6-3.1.17) is as follows. From 
the membrane enriched fractions of SCV 20265 grown under iron limitation in the presence 
of 1.1mM of 2,2-Dipyridyl, 76 proteins were identified (refer table 3.1.6). These proteins 
were not detected in the normally grown SCV 20265. From the membrane enriched fractions 
of SCV 20265 grown under normal VB medium, about 131 proteins were identified (refer 
table 3.1.7). In case of the WT 20265, 43 proteins were identified from the membrane 
enriched fraction of WT 20265 grown in the presence of iron chelator (refer Table 3.1.8) and 
116 proteins (refer Table 3.1.9), from the membrane enriched fraction of WT 20265 grown in 
normal VB medium in the absence of any iron chelator.  
 
About 51 proteins (refer Table 3.1.10), were found to be exclusively detected in the SCV 
20265 membrane fraction of iron starved cells while 26 proteins (refer Table 3.1.11) were 
detected in the membrane enriched fractions of only iron starved WT 20265. It is reasonable 
to expect that many, if not all of these short listed proteins are truly iron responsive and have 
the potential to explain some of the observed differential responses to iron limitation and 
preferences for certain iron supplementation, that were seen in the assays described in the 
previous sections. Significance of the possible differential expression of some of these 
proteins is discussed in the Discussions section 3.1.8. 
 
The supernatant enriched fractions of normal and iron limited SCV 20265 and WT 20265 
were also analysed by LC/MS. The results of protein identifications from these fractions are 
enlisted in the tables 3.1.12-3.1.17. In summary, a total of 49 proteins were detected in the 
normal supernatant of SCV 20265 (refer Table 3.1.12) while a total of 74 proteins were 
detected in the iron limited culture supernatants in the presence of 2,2-Dipyridyl (refer Table 
3.1.13). In case of WT 20265, 37 proteins (refer Table 3.1.4) were detected in the culture 
supernatant of bacteria grown in normal VB medium while 53 proteins (refer Table 3.1.5) 
were detected in the iron limited culture supernatants. About 37 proteins (refer Table 3.1.16) 
were detected exclusively in the SCV 20265 supernatants in response to iron limitation caused 
by the presence of 1.1mM of 2,2-Dipyridyl in the medium while 19 proteins (refer Table 
3.1.17) were detected exclusively in the WT 20265 supernatant in response to iron limitation.  
 
One interesting observation was that, in response to the presence of 2,2-Dipyridyl (and 
therefore iron limitation in the medium) the number of proteins detectable in the membrane 
enriched fractions of both the morphotypes (SCV 20265 and WT 20265) was less than the 
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number of proteins detected in membrane fractions of normal (2,2-Dipyridyl absent) cultures. 
On the other hand the number of proteins detectable in the supernatants of iron-limited 
cultures of both the morphotypes was more than the number of proteins detectable in the 
normal supernatants of both the morphotypes. 
        
3.1.7 Real Time PCR analysis of PA 4358 (feoB) 
The polytopic membrane protein feoB, which is essential for Fe (II) uptake in bacteria, 
contains a guanine-nucleotide-specific nucleotide binding site (Marlovits et al., 2002). G 
proteins are critical for the regulation of membrane protein function and signal transduction. 
Nevertheless, coupling between G proteins and membrane proteins with multiple membrane-
spanning domains has so far been observed only in higher organisms. Using real time PCR, 
the levels of mRNA transcripts of probable ferrous iron transporter PA4358 with 78 % 
similarity to feoB (ferrous iron transport protein B) of E. coli, was quantified in cultures of 
SCV 20265 and WT 20265 during the log phase of growth (OD600 0.80). The differential 
expression of the feoB protein detected in the membrane sub proteome during nano flow 
LC/MS analysis (refer LC/MS results tables 3.1.5 and 3.1.6), was indicative of possible 
differences at the level of transcription of this gene. feoB homologue in Pseudomonas 
aeruginosa, PA4358 was repeatedly detected in SCV 20265 membrane fractions but never 
detected in the WT 20265. Apart from this, it was also important to monitor the expression 
levels of feoB transcripts using a sensitive and accurate gene expression method like real time 
PCR in order to quantitatively document the expression differences which was not readily 
possible at a protein level with the LC/MS technique.  
 
The house keeping gene rpoD (PA0576) (sigma 70 factor) whose expression levels are 
constant during the log phase was chosen as the external standard and internal reference. rpoD 
is the choice of similar real time and reverse transcriptase PCR analysis of gene expression in 
Pseudomonas aeruginosa. The levels of feoB transcripts were therefore quantified relative to 
the levels of rpoD transcripts. 
 
The higher preference for Ferrous (Fe2+) as a source of iron for growth as revealed by the 
appearance of more colonies around ferrous sulphate spotted discs on the plate assays 
described in Fig 3.1.4. in section 3.1.2 and liquid assays under microaerobic conditions in 2ml 
eppendorf assays in Figure 3.1.3 in section 3.1.2, were indicative of the involvement of a 
specialized ferrous iron transporter which might very well be the hitherto not so well studied 
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or described PA4358 annotated as a probable ferrous iron transporter on account of its very 
high similarity to its well studied counterpart in E.coli. 
 
Briefly, six independent cultures (volume 15 ml) of SCV 20265 and WT 20265 were grown 
up to log phase (OD600 0.8) in 150 ml flasks with continuous shaking at 37 °C. Total RNA 
was prepared from the cultures independently and after DNAse treatment, quality control on 
formaldehyde agarose gels followed by quantification, the RNAs were pooled in 2 pools each 
comprising RNA samples from 3 independent cultures in a 1:1:1 ratio. Each of these pools 
representing an average of three independent cultures was used for real time PCR analysis 
independently. The rationale behind such a strategy was to exclude the variations that may 
occur between independent cultures. The real time PCR was performed with LightCycler 
(Roche) with SYBR Green-I fluorescence based detection of amplified products. The results 
are summarized in the figures and tables below. 
 
Table 3.1.18    Lightcycler Quantification report. The quantification of transcript units and the calculated ratio 
of feoB/rpoD transcripts expressed as fold difference in gene expression is presented below for two different 
pools of samples of SCV 20265 and WT 20265 each comprising total RNA preparation from three independent 
cultures in total. 
 
Pool A 
S 
No. 
WT 20265 A SCV 20265 A 
 RpoD 
Transcript 
units 
FeoB 
Transcript 
Units 
Calculated 
ratio (Fold 
Difference)
RpoD 
Transcript 
units 
FeoB 
Transcript 
Units 
Calculated 
ratio (Fold 
Difference) 
1 0.0000810 0.00000270 3.3 0.0000138 0.00000329 23.8 
2 0.0000835 0.00000244 2.9 0.0000130 0.00000454 34.9 
(1) 0.0000810 0.00000244 3.1 0.0000138 0.00000454 32.89 
(2) 0.0000835 0.00000270 3.2 0.0000130 0.00000329 25.30 
 
Pool B 
S 
No. 
WT 20265 B SCV 20265 B 
 RpoD 
Transcript 
units 
FeoB 
Transcript 
Units 
Calculated 
ratio (Fold 
Difference)
RpoD 
Transcript 
units 
FeoB 
Transcript 
Units 
Calculated 
ratio (Fold 
Difference) 
1 0.0000376 0.00000156 4.1 0.0000195 0.00000466 23.89 
2 0.0000313 0.00000180 5.7 0.0000184 0.00000466 25.32 
(1) 0.0000376 0.00000180 4.7 0.0000195 0.00000466 23.89 
(2) 0.0000313 0.00000156 4.9 0.0000184 0.00000466 25.32 
 
The table 3.1.18 is a summary of the relative abundance of mRNA transcripts of FeoB with 
respect to the house keeping gene sigma factor rpoD in SCV20265 and WT20625.  
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Figure 3.1.15.  Expression of PA 4358 (probable ferrous iron transporter) in SCV 20265 and WT 20265. 
The fold change in gene expression of PA4358 in the morphotypes of 20265 revealed a significant differential 
regulation. The SCV 20265 shows about 20 folds higher expression as compared to WT 20265 under log phase. 
The error bars represent the standard deviation of the values obtained from two independent experiments and a 
total of four independent cross comparisons.   
 
The whole procedure of using lightcycler SYBR green I system as above was to obtain a semi 
quantification of the relative abundance of the PA4358 transcripts in SCV and WT 20265 
relative to the rpoD transcripts which is considering it to be expressed to its fullest capacity, 
being an important house keeping gene. Thus absolute quantification of the specific 
transcripts was not the goal of the above analysis.    
 
The pattern of higher expression of the feoB homologue in SCV 20265 (about 20 folds higher 
than WT 20265) as compared to its WT 20265 at a mRNA level as revealed by the real time 
PCR analysis (figure 3.1.15) was found to correlate well with the observations at the protein 
level determined using nano flow LC/MS of membrane protein. feoB homolog in P. 
aeruginosa, PA4358 might have a greater role in the iron uptake in P. aeruginosa than 
previously thought. Further investigations are needed to decipher the role of feoB in virulence 
and adaptation of P. aeruginosa diverse morphotypic variants in the CF lung.     
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3.1.8 Discussion 
In the human body iron is present in growth-limiting amounts for any invading bacteria 
(Braun, 2001). P. aeruginosa is found in a remarkable variety of environments, which furnish 
a variety of exigencies, both in terms of how to obtain iron from its surroundings and how to 
deal with potentially toxic levels once it starts to increase its uptake. Consequently, in 
comparison with many other frank pathogens that need to acquire iron only from the limited 
ecological niches to which they are restricted, i.e. a human host (Vasil and Ochsner, 1999), P. 
aeruginosa has to use an assortment of strategies for accessing iron and for regulating its 
intake (Table 1.4.1). On the other hand, iron deficiency has been shown to be directly, related 
to the increased severity of suppurative lung disease in CF patients.  It has been speculated 
that iron loss into the airway may, contribute to iron deficiency and may facilitate PA 
infection (Reid et al., 2002). Chelation of iron to iron-binding proteins is a strategy of host 
defense. Some pathogens counter this via the secretion of low-molecular-weight iron-
chelating agents (siderophores), human phagocytes possess a high-capacity mechanism for 
iron acquisition from low-molecular-weight iron chelates, in vivo, this process could serve as 
an additional mechanism of host defense to limit iron availability to invading siderophore-
producing microbes (Britigan et al., 2000).  
 
Because of the high insolubility of iron (III) in aerobic conditions, many gram-negative 
bacteria produce, under iron limitation, small iron-chelating compounds called siderophores, 
together with new outer-membrane proteins, which function as receptors for the 
ferrisiderophores (Dao et al., 1999; Folschweiller et al., 2000). It has been shown that by 
chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing 
the bacteria to wander across the surface instead of forming cell clusters and biofilms. These 
findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in 
biofilm development, the time bacteria stop roaming as individuals and aggregate into durable 
communities (Singh et al., 2002). However, it is well known that Pseudomonas aeruginosa 
like many other bacteria prefers to grow as a biofilm and does form robust biofilms in the CF 
lung. Thus it has several efficient iron uptake systems to obtain this precious micronutrient. 
 
Proteome analysis of the SCV 20265 supernatants in an earlier work form our laboratory 
(Wehmhöner, 2003) also revealed a higher expression of hemophore HasAp in SCV 20265 as 
compared to the WT 20265 as observed in this study (figure 3.1.6). This led us to speculate 
that iron limitation, could be an important selection pressure among other stress conditions, 
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for the occurrence of Small Colony Variant phenotype in the CF lung. Diverse morphotypes 
of Pseudomonas aeruginosa are a common occurrence in the CF lung habitat, which offers a 
plethora of niches each with a unique of combination of stress conditions ranging from iron 
limitation to anaerobic stress. This study began to test the hypothesis that SCV 20265 was one 
such morphotype or clonal variant that was specialized for surviving under iron limitation 
stress. 
 
Accordingly, the iron limitation was studied using various assays on liquid broth and agar 
plates using 2,2-Dipyridyl as an iron chelator to mimic an iron-limiting environment of the 
lung. Several chelators are used to achieve chelation of iron. The selectivity and affinity of 
chelators is a crucial criterion to be considered. 2,2-Dipyridyl is not metabolized and is 
considered a selective chelator of Ferrous (Fe2+) iron, which is the biologically useful and 
soluble form of iron. 2,2-Dipyridyl has been extensively used for iron limitation studies in 
many bacteria including Pseudomonas aeruginosa (Ochsner et al., 2002; Ochsner, Johnson, 
and Vasil, 2000).  
 
 
Observations on the ability of SCV 20265 to mobilize and utilize iron from haemoglobin 
supplemented on discs, discussed in the section 3.1.2 can be correlated well with the higher 
expression of hemophore HasAp.  Although an alternative haem uptake system (phu) exists in 
Pseudomonas aeruginosa, its affinity and role in haem uptake is much lesser compared to the 
Has system encoding the haemophore HasAp (Ochsner, Johnson, and Vasil, 2000). The 
secretion of haemophore is certainly inducible by iron limitation such as the presence of 2,2-
dipyridyl in the medium. When HasAp secretion in SCV 20265 could be induced even in the 
absence of an iron limiting stress under log phase of growth, it is reasonable to expect that the 
expression of HasAp in SCV 20265 under conditions of iron limitation would be even more 
prolific. The likely existence of a survival advantage for SCVs as compared to the wildtype in  
an iron limiting environment of the cystic fibrosis lung with haemoglobin (released by 
spontaneous or bacterial haemolysin induced lysis of RBCs), as a prominent source of iron, 
can also be expected. 
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Figure 3.1.16.   Schematic representation of 
HasAp export by an ABC transporter system and 
its ability to chelate haem as a source of iron. 
Also shown is the genetic organization of the 
genes of the Has operon.  
 
 
HasAp is required for P. aeruginosa utilization of haemoglobin iron. It can replace HasA for 
HasR-dependent haemoblobin acquisition in a system reconstituted in Escherichia coli. 
HasAp, like HasA, lacks a signal peptide and is secreted by an ABC transporter (Letoffe, 
Redeker, and Wandersman, 1998). Functional iron deficiency (defined by transferrin 
saturation <16%) was found in 44 (62%) of 71 adult cystic fibrosis (CF) patients and 
haemoglobin concentration and mean cell volume were lower in iron-deficient patients, in 
whom there was a non-significant trend for lower serum ferritin (Palma, Worgall, and Quadri, 
2003; Pond, Morton, and Conway, 1996). This study indicates that haemoglobin might be 
available in abundance as an iron source in the airway. 
 
The results of the iron limitation assays and iron sources supplementation assays clearly 
indicated that the adaptation to iron limitation was not common to all the small colony 
variants. This was evident from the fact that the strain 10 wildtype was found to be better 
adapted to iron limitation as compared to its clonal SCV.  Similarly the 8226 Wildtype was 
able to mobilize iron from the different sources better than its clonal SCV (refer table 3.1.2). 
In this respect it was better adapted to iron stress much like the SCV 20265.  Thus, it is not 
fitting to say that SCV phenotype is purely an outcome of iron limitation stress. But SCV 
20265 did indeed have a clear adaptation to iron limitation as revealed by the protein 
expression pattern in the proteome analysis.  
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Fur repressor regulates the expression of a range of genes in an intracellular Fe2+ 
concentration dependant fashion in many gram negative bacteria including P. aeruginosa 
(Ochsner and Vasil, 1996). Thus it was of interest to analyse its expression levels in the SCV 
20265 that was well adapted to iron limitation. Accordingly, a western blot analysis with anti-
fur raised against E.coli fur was performed. Since the E.coli fur and Pseudomonas fur are 
closely related, we expected to see some signals. The Pseudomonas fur protein was detected 
with negligible noise signals caused by cross reactivity. But the analysis revealed not so 
significant differences in the fur levels as seen in figure 3.1.5. Even though fur is the chief 
gobal regulator of iron-regulated genes in P. aeruginosa, there are several other extra 
cytoplasmic factors and sigma factors like the pvdS, which are also crucial in the context of 
iron regulation. Venturi et al., (1995) have suggested that gene regulation of siderophore 
mediated iron uptake in P. aeruginosa involves several regulatory elements apart from Fur 
repressor, owing to possibility of P. aeruginosa being able to utilise heterologous 
siderophores.  
 
A recent global analysis of iron–dependent gene expression in P. aeruginosa (Ochsner et al., 
2002) has revealed 205 iron regulated genes (118 were induced by iron starvation, and 87 
were repressed), many of which fur dependent. This number represents a high proportion 
(4%) of P. aeruginosa genes and confirms that iron availability can have a major influence on 
gene expression in bacteria. Genes induced by low iron included those encoding: iron 
acquisition systems (~30), proteases, exotoxin A, fumarase C, SodA, ferridoxin, ferridoxin 
reductase, and several oxidoreductases and dehydrogenases. The activities of fumarase- and 
manganese-cofactored superoxide dismutase (SOD), encoded by the fumC and sodA genes in 
P. aeruginosa, are known to be elevated in mucoid, alginate-producing bacteria and in 
response to iron deprivation (Hassett et al., 1997). Bacteria exposed to the iron chelator 2,2-
Dipyridyl, but not ferric chloride, have demonstrated an increase in fumarase activity. Mucoid 
bacteria either are in an iron-starved state relative to nonmucoid bacteria or simply require 
more iron for the process of alginate biosynthesis. In addition, the iron-regulated, 
tricarboxylic acid cycle enzyme fumarase C is essential for optimal alginate production by P. 
aeruginosa (Hassett et al., 1997). In our 2D gel analysis of the SCV 20265 and WT 20265 
under iron limitation, we could identify differential expression of many of these proteins. 
However it must be admitted that unlike the DNA microarray approach where almost all the 
expressed transcripts can be analysed, the Proteomics approach is hindered with the its 
inherent inability to resolve only a thousand protein spots on a single gel. The relative 
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abundances of different protein species is also a crucial factor to be considered because 
abundant protein spots can mask the low abundant protein spots. 
 
Proteome analysis of the isogenic mophotypes of P. aeruginosa 20265 by Wehmhoner et al., 
(2003) has revealed that cellular extracts gave very similar protein patterns in two-
dimensional gels, suggesting that the conserved species-specific core genome encodes 
proteins that are expressed under standard culture conditions in vitro. In contrast, the protein 
profiles of extracts of culture supernatants were dependent on the growth phase, and there 
were significant differences between clones. In this study the secretome expression was 
concluded to be a sensitive measure of P. aeruginosa strain variation. This was more or less 
the case with the present study too. Not so many differences were seen in the cellular extracts. 
So a subproteome approach was adopted exploiting gel less proteomics a strategy of nanoflow 
LC/MS. The supernatant proteome (secretome) and membrane subproteome were the focus of 
this study.  
 
Hanna et. al, (2000) have compared proteins expressed by isogenic mucoid and non mucoid 
CF strains using 2D gel electrophoresis and mass spectrometry similar to the approach used in 
this study. Their results included proteins such as the OprH, OprF, Fe-SOD, DNAK, AhpC, 
catalase, Ornithine carbamolyase that were also detected in our study. This suggests that these 
proteins are common to many CF isolates. Their work has also emphasizes the need to focus 
attention on the membrane proteins. 
 
The extensive subproteome analysis of the secretome and membrane subproteome was carried 
out using gel-less LC/MS approach with some focus on the dynamics of expression of these 
subproteomes in response to the presence of 2,2-Dipyridyl in the medium. The results of the 
protein identifications presented in the tables 3.1.6-3.1.17, included several iron uptake 
related proteins such as the HasAp, genes of Pyoverdine gene cluster pvd. On the other hand 
in the normal supernatants of SCV 20265, several Type III secretion components like popB 
and type III toxins exoS and exoT were detected (refer table 3.1.12). These were exclusively 
detected in the SCV 20265 supernatants. dsbA was yet another protein detected exclusively in 
SCV 20265 supernatants. dsbA is induced during mucoid conversion and is important for 
protease production and twitching motility (Malhotra et al., 2000). Also dsbA has been known 
to be important for virulence. The differential expression of these proteins correlates well with 
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enhanced cytotoxicity of SCV 20265 compared to the WT 20265 that has been observed in 
other works from our laboratory. 
 
Pyoverdin is capable of iron acquisition from lactoferrin and transferrin (Xiao and Kisaalita, 
1997). Pyoverdines have also been demonstrated to bind and oxidize ferrous ions and it has 
been suggested that iron exchange and reduction mechanisms in fluorescent pseudomonads is 
interrelated (Xiao and Kisaalita, 1998). Pyoverdin has been demonstrated to be involved in 
signalling its own production and also some virulence factors like exotoxin A and 
endoprotease (Lamont et al., 2002). An enhanced expression of ferripyoverdine receptors and 
pvd genes in SCV 20265 can thus have enormous consequences for the SCV 20265 
adaptation to iron limitation or mobilization of iron from a variety of iron sources.     
 
The PhoP-PhoQ has been implicated in the resistance of P. aeruginosa to aminoglycosides 
and the polycationic antibiotic polymyxin B and the expression of outer membrane protein 
OprH  (Macfarlane et al., 2000). OprG has been shown to be involved in low affinity iron 
uptake (Yates, Morris, and Brown, 1989). These were also some candidates that have been 
identified as being possibly differentially expressed. 
 
Outer membrane proteins (OMPs) of Gram-negative bacteria have diverse functions and are 
directly involved in the interaction with various environments encountered by pathogenic 
organisms. Thus, OMPs represent important virulence factors and play essential roles in 
bacterial adaptation to host niches, which are usually hostile to invading pathogens. OMPs 
contribute to bacterial adaptive responses including iron uptake, antimicrobial peptide 
resistance, serum resistance, and drug/bile resistance (Lin, Huang, and Zhang, 2002).  
 
The LC/MS approach presented in the present study must be viewed as a crude screening 
strategy to shortlist the proteins of interest for subsequent study with conventional, more 
informative but cumbersome, gel based proteomics. However, the data from the LC/MS 
analysis of membrane subproteomes and supernatants were in good correlation with the 
observations on the plate and growth assays under iron limitation described in the sections 
3.1.1 and 3.1.2. Thus, we could say that these differentially expressed proteins to some extent, 
contributed for the relative fitness of the SCV 20265 under iron limitation. It was also 
possible to use the LC/MS approach to pick up a candidate protein from a broad analysis of 
the membrane subproteome study its expression level further at the transcription level using 
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real time PCR. PA 4358 was consistently detected only in the SCV 20265 membrane fraction 
but not in that of the WT 20265 (table 3.1.7). So gene specific primers were designed for this 
gene and its expression was studied using real time PCR. Interestingly, the higher expression 
of this probable ferrous iron transporter in the SCV 20265 at a protein level was found to be 
the case even at the level of transcription. This finding has an important implication in being 
able to explain the higher preference for ferrous iron as a source of iron.  
 
The involvement of selective ferrous iron transporter like the feoB may explain this 
observation. It is important to recall here that FeSO4 was found to be the most potent iron 
source capable of permitting growth of bacteria in the presence of 11mM Dipyridyl in the 
experiments discussed in section 3.1.1. The role of feoB homologue in P. aeruginosa has not 
been studied well so far. The annotation of this gene and assignment of function have been 
purely based on sequence similarities to the somewhat well studied counterpart in E. coli. 
However a vital role for feoB in pathogenicity has been demonstrated in Helicobacter pylori 
(Velayudhan et al., 2000) and Legionella pneumophila (Robey and Cianciotto, 2002) using  
feoB mutants. Thus it is possible that a similar role might exist for the P. aeruginosa feoB. 
This remains to be demonstrated using knockouts in the future. 
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3.2  Differential response of morphotypes to oxidative stress 
 
3.2.1 Sensitivity of the morphotypes to hydrogen peroxide induced oxidative stress 
Sensitivity to hydrogen peroxide, a major source of oxidative stress was measured using a 
plate assay adopted from a similar assay described by Brown. et. al., (1995). Briefly, bacteria 
were grown in liquid medium up to log phase or stationary phase and spread on solidified LB 
agar plates uniformly as a lawn. Sterile discs saturated with hydrogen peroxide (3 % or 30 %) 
were placed on each plate and allowed to dry followed by incubation at 37 °C overnight. The 
following day, diameter of zone of inhibition of growth around the discs was measured for 
both morphotypes. A large ZOI indicated the high sensitivity to the hydrogen peroxide. 
Figure 3.2.1 shows the differential sensitivity SCV 20265 and WT 20265 to hydrogen 
peroxide. SCV 20265 had a relatively small zone of inhibition as compared to the WT 20265 
during stationary phase of growth and iron depleted growth. The differences were not so 
pronounced during log phases of growth (data not shown).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.1. Sensitivity of morphotypes of strain 20265 to hydrogen peroxide induced oxidative stress. 
Note the larger diameter of the zone of inhibition around the hydrogen peroxide (30%) impregnated discs in 
Wild type 20265 (a) as compared to that of SCV 20265 (b). 
 
The disc assays were also performed using the morphotypes of three other strains namely 
8226, 231 and 52 to see if this differential sensitivity was prevalent among the morphotypes 
of these strains which are too members of the hyperpiliated, cytotoxic subgroup of SCVs of 
which 20265 is the representative strain.  It was observed that the resistance of SCV to 
hydrogen peroxide compared to its clonal wildtype counterpart was not a widespread 
occurrence among all members of the subgroup of hyperpiliated and cytotoxic SCVs tested. 
Instead, WT 52, WT 8226, WT 231 were more resistant (having less diameter of ZOI) as 
compared to their respective SCVs (refer figure 3.2.2). This is indicative of the fact that 
a b
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oxidative stress is only one of the many stress conditions that might select for the occurrence 
SCVs in the lung. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.2. Sensitivity of SCV and wildtype bacteria of the four strains of P.aeruginosa to hydrogen 
peroxide. Sensitivity was recorded as the mean SE (n=9) of the diameter of growth inhibition in millimeters. 9 
plates from three independent experiments were tested. Strain 231(1), Strain 52 (2), Strain 8226 (3), Strain 
20265 (4). (Blue bars represent SCV and Red bars represent Wildtype) 
 
In order to further demonstrate differential sensitivity of the morphotypes of strain 20265 to 
hydrogen peroxide more precisely, survival percentage of the bacteria was estimated 
following a brief exposure of known number of bacteria to a known concentration of 
hydrogen peroxide. The procedure described by Ma et al., (1999) was modified and adopted. 
Briefly, about 6 – 8 X 107 bacteria of each morphotype was diluted in a final volume of 3 ml 
of fresh Vogel Bonner medium (pre incubated at 37°C) containing 0.03 % or 0.003 % 
hydrogen peroxide, followed by an incubation of the tubes for 15 min at 37 °C in a shaker. 
After the exposure to hydrogen peroxide, 100 µl of the bacteria was withdrawn and 
immediately serial diluted in 0.9 % NaCl solution containing bovine catalase and plated. The 
plates were counted the following day to assess the percentage of bacteria that survived the 
exposure to hydrogen peroxide. The results are presented in the table 3.2.1 below.  
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Table 3.2.1 Hydrogen peroxide survival percentage assay. Survival percentages of SCV and WT of strain 
20265 from two independent experiments are shown in the table. Note the high survival % of SCV 20265 
following an H2O2 insult. 
 
The results of the survival percentage assay summarized in the table above clearly established 
that the SCV 20265 did indeed survive better an H2O2 insult as compared to the WT 20265. 
The average survival of 76% for SCV 20265 as compared to the 59% for the WT 20265 
during exposure to 0.03% hydrogen peroxide is in accordance with the observations in the 
disc assays discussed earlier. More impressive was the ability of SCV 20265 to begin dividing 
(125 % survival) upon exposure to 0.003% H2O2 while only 80 % of the WT 20265 could 
survive.  
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3.2.2 Proteome analysis of oxidative stress response 
3.2.2.1 Response to Hydrogen peroxide 
Bacteria were grown up to stationary phase(OD600 2.0 - 2.5) as with the above experiments. 
As P. aeruginosa has endogenous catalase activity, most of the hydrogen peroxide is removed 
by action of these catalases readily. KatA, KatB are the major catalases of P. aeruginosa. The 
cells were filled in a dialysis bag and and suspended in fresh medium containing 0.03 % 
hydrogen peroxide for 2 hr with shaking. During the period of incubation, the dialysis bag 
regulates diffusion of hydrogen peroxide and prevents rapid depletion of the same, thus 
ensuring a steady flow of hydrogen peroxide throughout the incubation period providing the 
stress to the bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.3 Proteome analysis of hydrogen peroxide induced stress (IPG strips of pH range 5-8 and gels 
of 12-15% linear gradient) WT 20265 untreated (a), SCV 20265 untreated (b), WT 20265 after 2 hours 
exposure to H2O2 (c), SCV 20265 after 2 hours exposure to H2O2 (d). Inset boxes show regions of differential 
expression. 
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In the previous section 3.2.1, the resistance of SCV 20265 to hydrogen peroxide has been 
demonstrated on two modes. The important objective of the proteome analysis was to look for 
some key differences at a proteome level that might explain the differential sensitivity of the 
SCV 20265 to hydrogen peroxide on the plate assays and survival percentage assays. 
Following separation of the total cellular extract made from hydrogen peroxide treated and 
untreated bacteria on 2D gels, Proteome Weaver, an image analysis program was used to 
locate differentially expressed proteins.  
 
 
 
 
 
 
 
 
 
 
Figure 3.2.4. Expression of PA3529 (probable peroxidase) and Mn-SOD following hydrogen peroxide 
treatment. Image analysis using proteome weaver. False colouring for better visualisation of expression 
differences (A),  Normal View of the corresponding region of the gels (B). 
 
 
PA3529, a probable peroxidase was a notable protein that had a differential expression in 
response to hydrogen peroxide treatment (refer Figure 3.2.4). Interestingly this probable 
peroxidase also was found to be differentially expressed in response to iron limitation (refer 
figure 3.1.7). The MnSOD was also found to be slightly more in the SCV 20265 cellular 
extracts treated with hydrogen peroxide compared to similar extract of the WT 20265. 
Although it has been described in the literature that KatB is a key protein that is highly 
expressed in response to a hydrogen peroxide insult, KatB was not identified among the spots 
selected for MS identification. This only hints at the need to optimise the assay and IPG strips 
used for resolving the protein extracts. The widely used 4-7 pH range IPG strips were not 
optimal to detect these key genes. Henceforth, the analysis and discussions are restricted to 
those proteins with relevance to oxidative stress, identified from the present analysis.      
 
 
 
 
SCV20265 WT 20265 SCV20265  untreated SCV20265 treated
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3.2.2.2 Response to Paraquat treatment  
Response to paraquat was measured. Unlike hydrogen peroxide used for oxidative stress in 
the previous approach, paraquat generates a constant supply of hydrogen peroxide, which 
ensures an induction of a sustained oxidative stress response during the whole period of 
incubation. Accordingly, the two morphotypes from strain 20265 were exposed to paraquat    
(methyl viologen) at a final concentration of 0.25 mM for 2 hr after growing them both to an 
OD600 of   2.0 (Stationary phase). As a control, parallely grown bacteria were incubated for 2 
hours without any paraquat treatment. Total cellular extracts were made from both treated and 
untreated cells and resolved on a 12-15 % linear gradient 2D gel with pH range of 5-8.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.5 Proteome analysis of paraquat induced oxidative stress. (IPG strips of pH range 5-8 and gels 
of 12-15% linear gradient) SCV 20265 untreated (A), SCV 20265 treated (B), WT 20265 untreated(C), WT 
20265 treated (D). Inset boxes show proteins of differential expression  
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Table 3.2.2 List of proteins identified by MALDI TOF that are related to oxidative stress resistance.  
 
PA 
Number 
Protein Name Gene 
name 
Function Class 
PA4922 azurin precursor Azu Energy metabolism Class 1 
PA4236 catalase KatA Adaptation, protection Class 1 
PA3529 probable peroxidase  Putative enzymes Class 3 
PA4366 superoxide dismutase SodB Adaptation, protection Class 1 
PA4468 superoxide dismutase SodM Adaptation, protection Class 1 
PA0139 
alkyl hydroperoxide 
reductase subunit C AhpC Adaptation, protection Class 2 
 
Figure 3.2.5 and Table 3.2.2 summarize the results of the proteome analysis of paraquat 
induced oxidative stress. It was interesting to note that several key oxidative stress related 
proteins were detected. The expression of the probable peroxidase PA3529 was markedly 
high as in was the case in the hydrogen peroxide treatments. ahpC was yet another candidate 
that showed an up regulation in response to paraquat treatment. It can be clearly seen from the 
figure 3.2.4 that, in SCV 20265, both these proteins were expressed in levels higher than the 
WT 20265  
 
3.2.3 Discussion 
Neutrophils form superoxide anion (*O2) and hydrogen peroxide (H2O2) and release 
myeloperoxidase (MPO) during ingestion of microbial pathogens (Britigan et al., 1996). 
Biofilm bacteria show marked resistance to oxidizing agents (e.g., H2O2, HOCl) relative to 
planktonic cells (Hassett et al., 1999). Superoxide promotes hydroxyl-radical formation and 
consequent DNA damage in cells of all types. Superoxide may accelerate oxidative DNA 
damage by leaching iron from storage proteins or enzymic [4Fe-4S] clusters. The released 
iron might then deposit on the surface of the DNA, where it could catalyze the formation of 
DNA oxidants using other electron donors (Keyer and Imlay, 1996). The leading cause of 
mortality in patients with cystic fibrosis (CF) is respiratory failure due in large part to chronic 
lung infection with P. aeruginosa strains that undergo mucoid conversion, display a biofilm 
mode of growth in vivo and resist the infiltration of polymorphonuclear leukocytes (PMNs), 
which release free oxygen radicals such as H2O2.The mucoid phenotype among the strains 
infecting CF patients indicates overproduction of a linear polysaccharide called alginate. 
Mucoid conversion is a response to oxygen radical exposure and that this response is a 
mechanism of defense by the bacteria. PMNs and their oxygen radicals can cause this 
phenotypic and genotypic change which is so typical of the intractable form of P. aeruginosa 
in the CF lung (Mathee et al., 1999).  
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It has been shown that PAO1 can create microaerobic/anaerobic growth conditions by at least 
two mechanisms: (i) blockage of the transfer of oxygen and (ii) formation of a polysaccharide 
capsule on the cell surface. It has been also postulated that the blockage of oxygen transfer 
may play an important role in the defense of this pathogen against reactive oxygen 
intermediates (Sabra, Kim, and Zeng, 2002). This might be very well the case with SCV 
20265’s better resistance to hydrogen peroxide induced oxidative stress as revealed by 
oxidative stress assays described in figure 3.2.1 and Table 3.2.1. In the subsequent section 
the better growth of SCV 20265 under microaerobic/anaerobic conditions has been 
demonstrated to support this view.  
 
Improved oxidative-stress-sustaining properties have been observed when the 
flavohemoglobins from E. coli, Klebsiella pneumoniae, Deinococcus radiodurans, and P. 
aeruginosa were expressed in E. coli (Frey et al., 2002). If we recall figure 3.1.6, SCV 20265 
shows a higher expression of haemoglobin scavenging Haemophore HasAp. This could be 
correlated with its ability to acquire external haemoglobin for incorporation into its 
falvihaemoglobin or use it directly by some unknown mechanism to resist oxidative stress 
apart from its direct use as a source of iron. Additionally the haem from haemoglobin 
scavenged by the haemophore hasAp might be used in the synthesis of catalases. Thus it is 
intriguing to think that the iron related phenotypes of SCV 20265 might also have some 
implications to the oxidative stress related phenotypes. However the direct links to these two 
phenotypic traits need further experimental proof. 
 
P. aeruginosa bfrA may be required as one source of iron for the haem prosthetic group of 
katA and thus for protection against H2O2 (Ma et al., 1999). Iron availability, but not oxygen 
availability, has been shown to be a major factor affecting catalase expression in biofilms 
(Frederick et al., 2001). Thus there occurs a strong relationship between iron metabolism and 
the management of oxidative stress. 
 
Proteome analysis of the cellular extracts of the 20265 SCV and WT treated with hydrogen 
peroxide and paraquat showed no gross changes in the protein pattern. The expression 
differences of some of the key oxidative stress proteins were not as prolific as was the case 
with the iron acquisition related proteins discussed in the previous section on response of the 
morphotypes to iron. However, the plate assays and broth H2O2 sensitivity assays (figure 
3.2.1 and table 3.2.1) have revealed a significantly higher resistance of SCV 20265 to H2O2. 
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KatB is not produced during the normal P. aeruginosa growth cycle, and catalase activity is 
considered to be greater in nonmucoid than in mucoid, alginate-producing organisms. When 
exposed to hydrogen peroxide and, to a greater extent, paraquat, total catalase activity is also 
elevated. In addition, an increase in katB activity causes a marked increase in resistance to 
hydrogen peroxide. katB was localized to the cytoplasm, while katA, the "housekeeping" 
enzyme, can be detected in both cytoplasmic and periplasmic extracts. A P. aeruginosa katB 
mutant has been shown to demonstrate 50 % greater sensitivity to hydrogen peroxide than 
wildtype bacteria, suggesting that katB is essential for optimal resistance of P. aeruginosa to 
exogenous hydrogen peroxide (Brown et al., 1995). However, no katB was detected using 2D 
gel analysis of paraquat treated and H2O2 treated samples. Perhaps the pH range of the IPG 
strips used was not optimal for resolving the katB spots. A more focussed proteome analysis 
might help in the detection of  katB and analysis of its expression. 
 
Sensitivity to both the redox-cycling agent paraquat and hydrogen peroxide has been shown to 
be greater in fur mutants.  Mutations in the P. aeruginosa fur locus affect aerobic growth and 
SOD and catalase activities in P. aeruginosa and reduced siderophore-mediated iron uptake, 
especially that by pyoverdin, may be one possible mechanism contributing to such effect 
(Hassett et al., 1996). Accordingly, the differences in pyoverdin synthesis genes and its 
cognate receptors expression, and the expression of several oxidative stress resistance related 
thioredoxins, elaborated in the tables 3.1.6 – 3.1.17, can be correlated with the sensitivity of 
WT 20265 to exogenous hydrogen peroxide.  
 
In general, fur protein is autoregulated by fur and by Fe2+ and linked to the metabolism of the 
cell via cAMP signaling. Additionally, in E.coli, regulation of  fur by oxidative stress 
response via soxRS and oxyR has also been reported (Zeng et al., 1999). It is possible such a 
mechanism could also operate in P. aeruginosa given the high similarities in their metabolic 
pathways. Though  fur is traditionally known as a global repressor, fur also has been 
suspected to positively regulate some genes. Recently, the positive regulation of sodB by fur 
by a posttranscriptional mechanism has been reported in E. coli (Dubrac and Touati, 2000).   
 
Iron SOD is more important than manganese SOD for aerobic growth, resistance to paraquat, 
and optimal pyocyanin biosynthesis in P. aeruginosa (Hassett, Schweizer, and Ohman, 1995).  
However, in biofilm studies, Hassett et al., (1999) have shown that catalase activity in wild-
type bacteria was significantly reduced relative to planktonic bacteria; catalase activity in the 
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PAI (Pseudomonas Autoinducer) mutants was reduced even further and consistent with 
relative differences observed between each strain grown planktonically. While wildtype and 
mutant biofilms contained less catalase activity, they were more resistant to hydrogen 
peroxide treatment than their respective planktonic counterparts. Also, while catalase was 
implicated as an important factor in biofilm resistance to hydrogen peroxide insult, other 
unknown factors seemed potentially important, as PAI mutant biofilm sensitivity appeared not 
to be incrementally correlated to catalase levels (Hassett et al., 1999). In this connection, it is 
important to recall the highly autoaggegative and biofilm forming nature of the SCV 20265 as 
compared to the free-living planktonic nature of WT 20265.  Thus independent of the levels 
of catalase activities and its expression, SCV 20265 could still be more resistant to hydrogen 
peroxide compared to the Wildtype employing some unknown factors one of which could be 
the probable peroxidase PA3529 whose expression was markedly increased in response to 
H2O2 treatment. There are also host of other peroxidases like the ahpC whose role in oxidative 
stress resistance is not to be undermined. 
 
It has been described Britigan et al., (2001), that clinical P. aeruginosa isolates vary little in 
FeSOD and catalase expression. Some strains produce a newly described MnSOD variant, 
whereas some deficient in MnSOD production. The absence of MnSOD expression in a P. 
aeruginosa strain causing invasive human disease indicates that MnSOD is probably not 
essential for P. aeruginosa virulence (Britigan et al., 2001). From the proteome analysis of 
hydrogen peroxide treated cells, the FeSOD expression was not found to be significantly 
different between the WT and SCV. But a differential expression of MnSOD was observable. 
This is in good correlation with the observations of Britigan et al., (2001). Also since both the 
SCV and WT 20265 come from the same habitat, namely the CF lung, it’s possible that the 
expression of their basic core enzymes is more or less the same.    
 
Polack et al., (1996) have shown that MnSOD may participate in the adaptation of mucoid 
strains of P. aeruginosa to the stationary phase of growth in the lungs of CF patients. The 
sodA mutant exhibited an increased sensitivity to oxidative stress generated by paraquat and 
was less resistant to oxidative stress in the stationary phase of growth compared with its 
parental strain (Polack et al., 1996).  So it is possible that there might be some mutations in 
the key enzymes that render them functionally in active even though their expression levels 
might not be affected. These mutations are difficult to be detected in a proteome analysis. 
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Salunkhe et al., (2003) have shown that one operon encoding four proteins of previously 
unknown function (PA0939–PA0942) was 20–200-fold up-regulated in all three analyzed 
strains in response to paraquat induced oxidative stress in their study. This operon, the 
constitutively highly expressed manganese-dependent superoxide dismutase SodA, the 
catalase KatA, and the alkylhydroperoxide reductase AhpC were speculated to confer the 
most resistance to paraquat-induced stress in P. aeruginosa (Salunkhe et al., 2003). The 
resistance to paraquat induced oxidative stress is also greatly influenced by many regulatory 
proteins like the OxyR and SoxRS. One inherent disadvantage of the Proteomics approach is 
its difficulty to resolve more than a thousand spots each representing a gene product. Even 
among these, most of the prominent spots are often house keeping enzymes. The low 
abundant regulatory proteins such as the transcriptional regulators are often masked or not 
detectable in a complex mixture and hence need several rounds of enrichment before they can 
be detected.  
 
The role of the blue copper protein azurin and cytochrome c(551) as the possible electron 
donors to nitrite reductase in the dissimilatory nitrate reduction pathway in Pseudomonas 
aeruginosa have been investigated by Vijgenboom et al., (1997). It was shown by an in vivo 
approach with mutant strains of P. aeruginosa deficient in one or both of these electron-
transfer proteins, that cytochrome c(551), but not azurin, is functional in this pathway. 
Expression studies demonstrated the presence of azurin in both aerobic and anaerobic 
cultures. A sharp increase in azurin expression was observed when cultures were shifted from 
exponential to stationary phase. The stationary-phase sigma factor, sigma(s), was shown to be 
responsible for this induction. In addition, one of the two promoters transcribing the azu gene 
was regulated by the anaerobic transcriptional regulator ANR. An azurin deficient mutant was 
more sensitive to hydrogen peroxide and paraquat than the wild-type P. aeruginosa. These 
results suggest a physiological role of azurin in stress situations like those encountered in the 
transition to the stationary phase (Vijgenboom, Busch, and Canters, 1997). In SCV 20265 and 
WT 20265 azurin has been shown to be differentially expressed (refer figure 3.1.8). Thus we 
may speculate that azurin levels could also contribute for the observed differences in 
sensitivities of SCV 20265 and WT 20265 to hydrogen peroxide induced oxidative stress on 
plates. OxyR-recG locus is essential for the oxidative stress defense and for DNA repair 
(Ochsner et al., 2000). Therefore it is important to analyze the expression of this locus in the 
future studies.  
 
                                                                                                                  Results and Discussion 
125 
Even though the precise molecular causes for the observed differences in sensitivities of the 
SCV and WT 20265 to oxidative stress, is yet to be determined, the present investigation with 
proteome analysis and functional assays on plates and broth has clearly confirmed the 
occurrence of intraclonal variation in response to oxidative stress. Secondly, this throws some 
light on the complex interactions of the different metabolic labyrinths pertaining to iron 
homeostasis, anerobiosis and oxidative stress. Oxidative stress in the CF lungs, like iron 
limitation might also be speculated to select for clonal variants like the SCV 20265, which 
shows enhanced resistance to the oxidative stress compared to its wildtype.  
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3.3 Differential response of  morphotypes to anaerobic growth conditions 
 
3.3.1 Differential growth of  morphotypes under anaerobic conditions 
Recent evidence suggests the occurrence of anaerobic/microaerobic conditions within the CF 
lung habitat and the ability of P.aeruginosa to grow and form robust biofilms in the hypoxic 
mucous (Yoon et al., 2002). The fitness and differential growth of the clonal morphotypes 
was tested under anaerobic growth conditions in the presence of potassium nitrate as a source 
of nitrate. To achieve maximum oxygen depletion from the medium, vogel bonner medium 
was bubbled with nitrogen gas for two hours. The medium was quickly filled up to brim in 
culture tubes. It is known that in the presence of nitrate in the medium, the bacterial ability to 
sense oxygen gradient is paralysed and therefore they take to an anaerobic mode of growth 
utilizing nitrate as the terminal electron acceptor instead of oxygen. 
 
To achieve optimal anaerobic environment during incubation, the culture tubes were left 
unshaken in a commercially available anaerobic jar (Merck). Special oxygen depletion packs 
obtained from the manufacturer were put inside the jars to deplete the oxygen within and to 
ensure the availability of an anaerobic environment.  Special colour indicator strips provided 
by the manufacturer were placed in the jars in order to visualize and monitor the depletion of 
oxygen within, during the entire period of incubation.  
 
 
 
 
 
 
 
 
 
 
Figure 3.3.1 Aanerobic growth of morphotypes of 20265 in Vogel Bonner (VB) medium bubbled with N2 gas 
and tubes incubated at 37° C in Anerocult (Merck) anaerobic jar after 96 hours of growth. Note the higher 
growth (as seen by high protein concentration) of SCV 20265. Error bars represent standard deviations of three 
independent cultures.  
 
1% KNO3 was used as described in as a source of nitrate Yoon et al., (2002). A negative 
control of Vogel Bonner medium without any nitrate supplementation was also included. 
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Figure 3.3.1 shows the growth of the SCV and WT of strain 20265 measured as the function 
of protein concentration. Protein concentration of the medium was chosen as a measure of 
growth because of the growth of the bacteria as aggregates and any representative sampling 
for Optical density measurement or serial dilution for CFU counting was not possible. 
Additionally, in order to avoid any aeration during sampling, several parallel cultures were 
grown and whole culture tubes were used for sampling at various time points. The SCV 
20265 shows clearly more growth than WT 20265 under these anaerobic growth conditions 
utilizing nitrate.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.2 Growth of morphotypes of strain 20265 under microaerobic growth in the presence of 1% 
KNO3 followed over a period of time. Growth has been measured as a function of protein concentration in the 
culture. The error bars represent strandard deviation of three independent experiments.  
 
The growth of the SCV 20265 and WT 20265 was followed from the time of inoculation over 
a period of 150 hours (refer Fig. 3.3.2). Interestingly, the SCV 20265 was growing much 
better and faster than the Wildtype 20265. A comparison of the growth curve under normal 
vogel bonner medium   (refer Fig. 3.1.1) shows the marked difference in the pattern of growth 
of the SCV and WT under these two different conditions of growth. 
 
The slow growing SCV grows faster than the WT under this specialized growth condition in 
the dearth of oxygen and availability of an alternative electron acceptor. The proteome profile 
of the morphotypes under these conditions have been investigated to gain insight into the 
possible differences at a protein level. These are discussed in section 3.3.2. The ability of 
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these morphotypes to form biofilms under these conditions must be investigated further to see 
if these growth differences under anaerobic conditions are also translated as differences in 
nature and size of the biofilms they form under such conditions. These results are consistent 
with our working hypothesis of the small colony variants being a clonal variant specially 
adapted to specific niches in the CF lung that have specific stresses such as the redox stress, 
iron limitation, anaerobic stress or a combination of these. 
  
3.3.2 Proteome analysis of anaerobically grown bacteria 
SCV 20265 and WT 20265 were grown for 48 to 72 hours in the presence of 1 % KNO3 in 
nitrogen bubbled VB medium in special anaerobic jars (Merck) with culture vessels filled up 
to the brim without any shaking as described above. The cells were quickly harvested and 
lysed for extraction of cellular proteins. Figure 3.3.3 shows the cellular extracts of SCV 
20265 and WT 20265 grown anaerobically. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.3 Proteome analysis of anaerobically grown SCV 20265 and WT 20265 in the presence of 1% 
KNO3 supplement in VB medium. Total cellular extract of the cells were resolved on a 12- 15% linear gradient 
gel and IPG strips with pH 4–7 and stained with Colloidal Coomassie. SCV 20265 (A) and WT 20265 (B).  Inset 
boxes show regions of differential expression. 
 
Some of the differentially expressed proteins detected include Chain A Pseudomonas 
aeruginosa Cd1 Nitrite reductase reduced cyanide complex, Ferripyochelin receptor FptA, 
Catalase (Kat A), Chain A Catabolic ornithine carbamyl transferase, D-3-Phosphoglycerate 
dehydrogenase. Anaerobically induced low affinity iron transporter OprG was also expressed 
in slightly higher levels in the SCV. Figure 3.3.4 shows the positions of some of these 
differentially expressed spots and other major protein spots that were detected on 2D gels that 
were used to resolve the total cellular extract of anaerobically grown SCV 20265. Figure 
A B
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3.3.5 shows the 3D visualisation of the differential expression of a particular protein spot 
identified as a DsbG (PA2476) - a thiol: disulfide interchange protein using image analysis 
software ProteomeWeaver. DsbG has a Thioredoxin family active site and belongs to the 
DsbC subfamily of chaperones. DsbG was one of the few proteins that were consistently 
expressed in high levels by WT 20265 while its expression was hardly detectable in the SCV 
20265 cultures. Under anaerobic conditions of growth also DsbG was consistently expressed 
only in the WT 20265 in levels much higher than that of the SCV 20265.  
 
 
                                                                                                                                                                                                        Results and Discussion 
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.4. 2D gel prepared from SCV 20265 anaerobically grown in the presence of 1% KNO3 supplement in VB medium. Total cellular protein extract of the
bacterial cells was resolved on a 12-15% linear gradient gel with pH 4–7. Some of the differentially expressed proteins include those that are involved in iron uptake and
nitrate respiration.   
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Fig 3.3.5. 3D visualization of differential expression of DsbG in WT 20265 (a&c) and SCV 20265 (b&d) using Proteome weaver image analysis
software. DsbG is one of the few proteins that was consistently expressed only by the WT 20265 cultures but absent in the SCV 20265 irrespective of the
growing conditions. This differential expression was observable in the anaerobically grown cultures too. 
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3.3.3 Discussion 
Recent evidence indicates that Pseudomonas aeruginosa residing as biofilms in airway mucus 
of cystic fibrosis (CF) patients is undergoing anaerobic metabolism, a form of growth 
requiring gene products that are not utilized during aerobic growth. The outer membrane 
protein, OprF, and the rhl quorum sensing circuit are two previously unrecognized cellular 
factors that are now known to be required for optimal anaerobic biofilm viability. Without 
OprF, bacteria grow extremely poorly because they lack nitrite reductase activity while 
lacking rhlR or rhlI forces bacteria to undergo metabolic suicide by overproduction of nitric 
oxide. Furthermore, anaerobic growth seems to favor maintenance of the mucoid, alginate-
overproducing phenotype. Thus, with increasing age of CF patients, mucoid populations 
predominate, indicating that anaerobic bacteria reside in the inspissated airway mucus. The 
role of anaerobic respiration in Pseudomonas pathogenesis in CF lungs is gaining so much 
importance that it has recently been proposed to develop of new drugs to combat anaerobic 
metabolism by P. aeruginosa for more effective treatment of chronic CF lung infections 
(Hassett et al., 2002). 
 
The major components of nitrate respiration apparatus in Pseudomonas aeruginosa are 
presented in the figure1.6.1. Cd-1 nitrite reductase catalyzes the conversion of nitrite to NO in 
denitrifying bacteria (Cutruzzola et al., 2001). Interestingly, there was a significantly higher 
expression of the Cd1- nitrite reductase in SCV 20265 anaerobically grown cultures. One 
other component of the anaerobic respiration machinery namely the OprC was also found to 
be expressed higher in the SCV 20265 compared to the WT 20265. These observations 
together with the better growth of SCV 20265 under anaerobic growth conditions (refer 
Figure 3.3.1 and 3.3.2) lead us to speculate the better adaptation of SCV 20265 in the 
anaerobic mucous of the CF lung.  
 
Additionally, in all the conditions of growth analysed so far, it has been a general observation 
that OprF, whose crucial role in anaerobic respiration has been emphasised repeatedly by 
several workers (Hassett et al., 2002, Yoon et al., 2002), was produced in very high levels by 
both the morphotypes. This reconfirms the ability of both these morphotypes to survive 
anaerobically. Thus the differential growth of SCV and WT 20265 under anaerobic conditions 
in the presence of nitrate supplement can be explained on the basis of differential expression 
of other components of the nitrate metabolism such as the nitrite reductase and OprC, which 
have been identified in the proteome analysis. However, these represent only a small piece of 
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a complex puzzle and therefore these observations can be interpreted as mere starting points 
for further experiments and cannot be claimed as anything conclusive. Since the role of 
quorum sensing system rhl is also known to be vital for optimal anaerobic growth, further 
investigations of the expression of the components of this system are also needed. 
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3.4 Polyadenylation of mRNA in Pseudomonas aeruginosa 
 
3.4.1 Polyadenylation of mRNA in Pseudomonas aeruginosa 
During the synthesis of cDNA from P. aeruginosa 20265 morphotypes, for the real time PCR 
analysis of feoB described in section 3.1.6, an attempt was made to prepare cDNA of the total 
mRNA using oligo (dT) primed reverse transcription. Generally the cDNAs of bacterial 
mRNA complement are generated with random hexamer primers. The use of oligo (dT) 
primers are largely restricted to the preparation of cDNA from eukaryotic mRNAs which are 
known to invariably have long poly (A) tracts at their 3’end. It is widely believed that such 
poly (A) tails are rare in the prokaryotic world whose RNAs undergo little or no processing 
after transcription. However, there is growing evidence about the occurrence of 
polyadenylated mRNAs in a variety of prokaryotes (Sarkar, 1997).  
 
Total RNA was isolated as described in the relevant materials and methods section. DNAse 
was used to remove any traces of genomic DNA. The quality of the mRNA was checked on 
the formaldehyde agarose gel. Figure 3.4.1 shows the purity of the total RNA isolation used 
for the study from P. aeruginosa 20265 morphotypes on a 1.5 % (w/v) agarose gel. 
 
 
 
 
 
 
 
 
 
Fig 3.4.1 Total RNA from P. aeruginosa 20265 separated by non denaturing agarose gel electrophoresis (1.5 % 
w/v) and stained with 0.5 µg ethidium bromide per ml. 100 bp DNA ladder (1); RNA (2 µg) purified from P. 
aeruginosa PAO1 (2).  
 
cDNA was prepared in the presence and absence of oligo (dT). A cDNA preparation with 
random hexamer primers was used as a positive control and a cDNA reaction mix without 
mRNA was used as a negative control. The cDNA was then analyzed on 0.8 % agarose gel 
and visualized under UV light after staining with ethidium bromide. A continuous smear of 
cDNA could be observed and no bands were observed in the negative controls. 
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Specific mRNA transcripts of rpoD were amplified with gene specific primers (refer 
Appendix) using cDNA of the morphotypes of 20265 P. aeruginosa. As expected, a 359 bp 
sequence corresponding to the rpoD product was observed (refer figure 3.4.2, lanes 3,4,5). It 
was confirmed that the amplification of rpoD using cDNA prepared in presence of oligo (dT) 
was identical to that obtained with genomic DNA amplification and the random hexamer 
primer generated cDNA. This was done by sequencing the eluted PCR products from these 
three reactions (data not shown). 
 
 
 
 
 
 
Figure 3.4.2. Electrophoresis of cDNA corresponding to rpoD mRNA transcript amplified by RT-PCR 
with gene specific primers from WT 20265 Pseudomonas aeruginosa. cDNA preparation without RT (1); 
cDNA preparation without oligo(dT) or random primers (2); Genomic DNA amplified rpoD (3); cDNA 
preparation with random primers (4); cDNA preparation with oligo(dT) (5);  Standard 3000 -100bp size (6). 
 
Further, mRNA transcript of feoB homologue in P. aeruginosa, namely PA4358 was 
amplified by RT-PCR (data not shown) using the gene specific primers shown in Appendix I, 
and transcripts could be detected in cDNA preparations made in presence of oligo (dT). 
Again, the size and sequence identity of the RT-PCR product was found to match that 
amplified from the genomic DNA. Thus the ability to synthesize cDNA using oligo (dT) 
primers was clearly demonstrated which confirmed the occurrence of polyadenylation in 
mRNAs of P. aeruginosa.  
 
 
 
 
 
Figure 3.4.3. Electrophoresis of cDNA corresponding to rpoD mRNA transcript amplified by RT-PCR 
with gene specific primers from Pseudomonas aeruginosa PAO1 and TB. cDNA preparation without RT (1); 
cDNA preparation without oligo (dT) or random primers (2); Genomic DNA amplified rpoD from strain TB (3); 
cDNA preparation with  random primers for strain TB (4); cDNA preparation with oligo (dT) for strain TB 
(5);Genomic DNA amplified rpoD from strain PAO1 (6); cDNA preparation with random primers for strain 
PAO1 (7);  cDNA preparation with oligo (dT) for strain PAO1 (8);  Standard (3000bp – 100 bp) (9).  
 
In order to determine if the phenomenon of polyadenylation itself was widespread among the 
different isolates of P. aeruginosa or if it was restricted only to the clinical isolate 20265 used 
in this study, rpoD was amplified from cDNA synthesised with oligo (dT) primers from 
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strains PAO1 (Genome sequenced strain) and a clinical isolate TB. The results are presented 
in figure 3.4.3. The amplification of a similar gene product corresponding to rpoD, which was 
identical to the amplification products amplified from strain 20265, clearly demonstrated the 
occurrence of polyadenylation in these isolates of Pseudomonas aeruginosa too.  
 
In order to confirm and evaluate the extent of polyadenylation of P. aeruginosa mRNA, P. 
aeruginosa PAO1 (genome sequenced strain) RNA isolated from cells (in exponential phase 
of growth) grown in Vogel Bonner (VB) medium, was reverse transcribed with either the 
oligo (dT) primer or the random hexamer primers. As shown in figure 3.4.4, a continuous 
smear of P. aeruginosa PAO1 cDNA could be observed with oligo (dT) primers as well as 
with random hexamer primers whereas no bands were observed in the negative controls 
lacking RNA or oligo (dT) primers. The yield of cDNA prepared using oligo (dT) primed 
reaction was approximately five times less than that prepared using random primed reactions 
for the same amount of RNA used, as determined by UV absorption using a 
spectrophotometer. Both the resultant cDNAs were separately hybridized to P. aeruginosa 
PAO1 GeneChip (Affymetrix).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.4 cDNA synthesis in the presence of oligo (dT) primers or random hexamer primers using RNA 
isolated from PAO1. Marker 100 bp DNA ladder (1); cDNA mix without RNA (negative control) (2); cDNA 
mix without oligo (dT) primers (negative control) (3); cDNA preparation using oligo (dT) primers (4); cDNA 
preparation with random hexamer primers (positive control) (5); Marker 100 bp DNA ladder (6). The gel was 
run on 2 % agarose gel and stained with sybr green. 
 
This DNA oligonucleotide array comprises of oligonucleotide probes for 5549 coding 
sequences (CDS), 18 tRNA genes, one rRNA operon and 199 probe sets corresponding to all 
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intergenic regions selected from the annotated genome of strain PAO1, as well as 117 genes 
found in other P. aeruginosa strains. The comparative DNA microarray analysis was used to 
identify the specific genes whose RNA transcripts were polyadenylated giving some estimates 
about the extent of polyadenylation and the type of transcripts that were polyadenylated. 
Accordingly, a total of 2739 genes were detected with significant (according to statistical 
algorithms of MAS 5.0) signal intensities using random primed cDNA synthesis. This 
represents 49.3 % of the total 5549 P. aeruginosa PAO1 CDS on the chip (Table 3.4.1). Out 
of these 2739, 1199 genes representing 21.6 % of the 5549 CDS, were found to have 
polyadenylation of their mRNA transcripts because they were also detected in cDNA 
preparations made from oligo (dT) primed reactions (Table 3.4.1).  
 
Table 3.4.1 Number of genes and the respective percentages for which signals could be detected on a P. 
aeruginosa GeneChip using cDNAs prepared from either oligo (dT) primers or random hexamer primers. 
 
 Number of 
genes 
Percentage 
 
Total number of genes (CDS) on the GeneChip 
 
Total number of genes detected in the GeneChip 
                Genes detected 
using random primers  
 
using oligo (dT) primers  
 
using oligo (dT) primers and not with random 
primers                   
 
using random primers and not with oligo (dT) 
primers  
 
by both random primers and oligo (dT) primers   
 
Genes not detected 
 
5549 
 
2755 
 
2739 
 
1215 
 
 
16 
 
 
1540 
 
1199 
 
2794 
 
100% 
 
49.6% 
 
49.3% 
 
21.8% 
 
 
0.1% 
 
 
27.7% 
 
21.6% 
 
50.3% 
 
Thus, 43.7 % of the genes detected using random primed cDNA synthesis showed 
polyadenylation of their corresponding mRNAs. 16S rRNA, 23S rRNA and several tRNA 
species were polyadenylated too. Signals for only 16 genes were detected exclusively using 
oligo (dT) primed cDNA. All these 16 genes were not detected in random primed cDNA 
preparations in the present study and interestingly almost all of them belonged to the 
functional class of hypothetical proteins. However, the DNA microarray results of two earlier 
works which used random primed cDNA of strain 20265 (von Götz et al., 2004) and strain 
PAO1 (Salunkhe et al., 2003) were compared to the results of the present study. The detection 
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of the 16 genes (that were detected exclusively using the oligo (dT) primed cDNA in the 
present study) was found to be highly variable. Detection of signals for these genes was 
scrutinized in several independent GeneChips hybridized with random primed cDNA 
prepared from strain 20265 RNA, harvested under similar culture conditions (data not shown) 
and several independent GeneChips hybridized with random primed cDNA prepared from 
strain PAO1 RNA, harvested under different culture conditions (data not shown). None of the 
16 genes in question were absent in all the hybridisations indicating that cDNAs for these 
genes were not exclusively primed by oligo (dT) only as revealed by the present study.         
 
 
Figure 3.4.5 gives a comparison of numbers of genes whose mRNA transcripts were 
polyadenylated, non-polyadenylated and total number of genes detected by random primed 
cDNA synthesis belonging to different functional classes. mRNAs of genes belonging to 
almost all the 26 major functional classes enlisted in figure 3.4.5 were polyadenylated. Little 
or no polyadenylation was observed in the mRNAs corresponding to genes belonging to two 
component regulatory systems, phage related proteins and putative enzymes. A high 
proportion of polyadenylated mRNAs corresponded to genes belonging to the functional 
classes of translation and posttranslational modification, energy metabolism and genes coding 
hypothetical protein. The proportion of polyadenylated mRNAs exceeded the non-
polyadenylated mRNAs in the functional classes of motility and attachment, protein secretion 
and export and nucleotide biosynthesis genes, adaptation and protection, amino acid 
biosynthesis, cell division, cell wall / capsule / LPS, chaperones and heat shock, energy 
metabolism, transcription and translation and post-translational processing. 
 
rpoD and feoB, whose transcripts were found to be polyadenylated in the RT PCR, were also 
were detected as polyadenylated genes in the DNA microarray analysis. As a further evidence 
for the occurrence of polyadenylation in P. aeruginosa, expression signals of pnp (PA4740), 
rne (PA2976) and pcnB (PA4727), putative enzymes involved in the mRNA degradation and 
polyadenylation could be detected in the array analysis. In addition the putative poly (A) 
binding protein PA3162 (ribosomal protein S1) was also detected in high levels. PA4944 
(hfq) was yet another gene with a possible involvement in polyadenylation, whose transcripts 
were detected with significant signal intensities (data not shown).  
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Figure 3.4.5. Comparison of numbers of genes whose mRNA transcripts were polyadenylated or non-
polyadenylated as detected by GeneChip analysis. The genes analysed are categorized into functional classes 
based on the annotation available from the Pseudomonas genome sequence. Inset bar graph shows shows the 
relative number of genes for the functional class Hypothetical, unclassified proteins. Category ‘Combined’ in the 
figure legend represents the combined total of polyadenylated and non-polyadenylated transcripts identified in 
each functional class. 
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3.4.2 Discussion  
mRNA polyadenylation now appears to be a common property of all living cells, but until 
recently it had been extensively studied only in eukaryotes (Colgan et al., 1997; Sachs et al., 
1997; Wickens et al., 1997). In eubacteria mRNAs have been detected in both gram positive 
and gram-negative organisms (Sarkar, 1996; Sarkar, 1997). In Mycobacteria, the oligo(dT) 
primed synthesis of cDNA by reverse transcriptase has been reported (Rindi et al., 1998; 
Adilakshmi et al., 2000). Unlike the poly (A) tracts in eukaryotic mRNA which range from 80 
to 200 nucleotides, poly (A) tracts in prokaryotes range between 14 and 60 nucleotides and, 
moreover, polyadenylation occurs at all unprotected RNA 3’termini irrespective of their 
secondary structure. The functions of bacterial RNA polyadenylation are quiet diverse, 
ranging from the control of plasmid replication to the modulation of mRNA stability, as well 
as a possible role in mRNA translation (Sarkar, 1997). Polyadenylation of transcripts in 
bacteria is believed to be involved in the regulation of gene expression by influencing the 
efficiency of mRNA degradation (Jasiecki, et al., 2003). Polyadenylation is now emerging as 
a process that plays an important role in maintaining the momentum of exonucleolytic 
degradation by adding single-stranded extensions to the 3’ ends of mRNAs and their decay 
intermediates, thereby facilitating further exonuclease digestion (Steege, 2000). Much of our 
knowledge about bacterial polyadenylation has been derived from works in E. coli (Sarkar, 
1996).  To the best of our knowledge there has been no report demonstrating the occurrence 
of polyadenylation in any Pseudomonad. DNA microarray analysis had been used to 
demonstrate the extent of polyadenylation of mycobacterial mRNAs (Lakey, et al., 2002). A 
similar DNA microarray approach was employed in this study to confirm and evaluate the 
extent of polyadenylation in P. aeruginosa. The GeneChip hybridisation revealed the oligo 
(dT) primed cDNA synthesis for only 1215 genes, whereas the priming with random primers 
yielded hybridisation signals for 2739 genes. It is possible that the number of mRNAs primed 
by oligo (dT) was underestimated because the large amounts of polyadenylated rRNA may 
depress cDNA synthesis from mRNA templates. Indeed there were intense signals for the 
rRNA genes too when the GeneChips were hybridized with oligo (dT) primed cDNAs (data 
not shown). Priming efficiency of the random hexamer primers to generate representative 
cDNAs was unrivalled by the oligo (dT) primers. Therefore use of oligo (dT) primers to 
generate representative cDNA of total RNA preparation is largely relevant in the context of 
detecting the polyadenylated species of RNAs among a heterogenous mixture of total RNA 
preparation and not to complement detection using random hexamer primed cDNA.  
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The chief enzymes that are responsible for the polyadenylation are poly (A) polymerases. 
Even though the poly (A) polymerases of E. coli have been well studied, their counterparts in 
P. aeruginosa have been annotated purely based on their sequence homologies. pcnB encodes 
the major poly (A) polymerase (PAP I) in E. coli. Poly (A) polymerase (ATP: 
polyribonucleotide adenylyltransferase) catalyzes the template–independent sequential 
addition of adenylate residues to the 3’hydroxyl termini of RNA molecules.  pnp encodes a 
3’-exonuclease, polynucleotide phosphorylase (PNPase) and rne encodes an endonuclease 
RNase E, both of which are implicated in the turnover of poly(A) tracts and the in vivo 
modulation of polyadenylation in E. coli (Mohanty, et al., 2000). It is known that S1 
ribosomal protein is a poly (A) binding protein in E. coli (Kalapos, et al., 1997). hfq is known 
to stimulate elongation of poly (A) tails by poly (A) polymerase I in E. coli (Hajnsdorf,  et al., 
2000). Detection of signals, for the putative counterparts of these poly (A) tail-related genes 
in our array analysis is an additional evidence for the occurrence of polyadenylation in P. 
aeruginosa. Our study also indicates that polyadenylation seems to occur in the mRNAs of all 
the major functional classes of genes and is not restricted to any one or few of them. 
 
Polyadenylation depends on growth rate (Jasiecki, et al., 2003) and growth phase (Cao, et al., 
1997) in E. coli with increased polyadenylation observed in slowly growing cells. Levels of 
poly (A) polymerase, PAP I, was reported to be higher in slowly growing cells cultivated in 
media supporting high growth rates (Jasiecki, et al., 2003). It remains to be investigated 
whether there exist any differences in polyadenylation with respect to growth phases in P. 
aeruginosa also and if the polyadenylation in P. aeruginosa has the same functions as 
described in E. coli i.e. marking mRNA transcripts for degradation by ribonucleases, which is 
important for maintaining an equilibrium of the normal RNA turnover, or if it has some novel 
functions. 
 
The experimental demonstration of the occurrence of polyadenylation to an appreciable extent 
in the P. aeruginosa transcripts is significant in many respects. Firstly, it proves the 
occurrence of a basic biological phenomenon in P. aeruginosa, which has only been 
speculative so far. Secondly, it opens our views to possible new means of post-transcriptional 
regulation of gene expression in P. aeruginosa. It also underlines the importance of the need 
to further study polyadenylation and therefore mRNA stability in the biology of P. 
aeruginosa.  It might be reasonable to speculate that the polyadenylation might be even more 
widespread and may be found in other species of Pseudomonas too. To our knowledge, 
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nothing is known about the post-transcriptional processing through polyadenylation in 
Pseudomonas aeruginosa. In this context, understanding the role of this phenomenon and the 
enzymes involved in these processes and their impact on the overall gene expression will be 
important. 
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4.  Summary and Conclusion  
 
The role of SCVs isolated from chronically infected CF lungs, in pathogenesis is still unclear. 
The objectives of the present study were to determine if the SCV 20265 and WT 20265 (the 
paradigm strain of a subgroup of hyperpiliated, autoaggregative and cytotoxic SCVs) 
displayed a differential growth response to some typical stress conditions like iron limitation, 
oxidative stress and anaerobic/microaerobic mode of growth and follow up the possible 
molecular causes of such differentially responses at a proteome level using Proteomics 
technologies encompassing mass spectrometry, as major investigation tool.  
 
Previous works in our laboratory have accomplished some Transcriptome analysis (von Götz 
2003) and Proteome analysis (Wehmhöner, 2002) of the strain 20265 with no specific 
attention to these stress conditions. Additionally, other SCV related works from our 
laboratory have demonstrated the enhanced virulence of SCV 20265 and some other 
hyperpiliated and autoaggregative SCVs using killing assays in mice and worm (C.elegans) 
models.  It is in this context that the present study began with testing the hypothesis that SCV 
20265 may represent a clonal variant that is better adapted than its clonal wildtype WT 20265 
to cope up with stresses like iron limitation stress, oxidative stress and anaerobic stress which 
are likely to be encountered in the various niches of the CF lung that they colonise. Several 
functional assays to demonstrate the relative fitness of these morphotypes and morphotypes of 
the few other strains, to the above mentioned stress conditions were standardized. It was 
clearly demonstrated on plate assays and liquid assays that the SCV 20265 was indeed better 
adapted to cope up with 2,2-Dipyridyl induced iron limitation. The distribution of this special 
trait was variable. Not all SCVs are well adapted to iron stress better than their clonal WT and 
vice versa. This was also true of the response of the morphotypes to oxidative stress induced 
by hydrogen peroxide. Not all SCVs were fitter than their corresponding clonal wildtypes to 
survive an oxidative insult. SCV 20265 was however unique in its ability to adapt to these 
diverse stress consitions better than its clonal WT. 
 
The ability to grow well under an anaerobic/microaerobic mode of growth was tested in the 
SCV 20265 and WT 20265. The results revealed that SCV 20265 was indeed outgrowing the 
WT 20265 under anaerobic mode of growth using a supplemented nitrate source. Extensive 
proteome analysis was also performed on the morphotypes of 20265 grown under the 
different stress conditions. The differential expression of several iron acquisition related 
proteins, oxidative stress combat proteins and proteins involved in nitrate respiration could be 
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detected and correlated well with the differential responses of SCV 20265 on functional 
assays. One interesting aspect of this study was the detailed investigation of the membrane 
and supernatant subproteome using a gel-less nanoflow LC/MS approach. The challenges of 
analysing the membrane subproteome with conventional gel based systems like the 16-BAC 
separation have been done away with the greater ease, precision and high-throughput of 
LC/MS approach. These were some areas that were not well explored before in the previous 
studies. Careful analysis of the LC/MS protein identifications revealed the reproducible 
differential expression of one probable ferrous iron transporter – a feoB homolog (PA4358). 
Using real time PCR, expression level of the probable Ferrous iron transporter (feoB), 
PA4358 was followed at an mRNA level and its higher expression by SCV 20265 was 
confirmed. The role of feoB in pathogenesis or iron acquisition of P. aeruginosa is hitherto 
unknown. This offers a good prospect for future investigations in this line. This clearly 
illustrated that one could apply gel-less LC/MS approach for a initial round of screening for 
candidates of differential expression in a comparative proteome analysis such as this study 
and subsequently identify potential genes whose expression can be followed with other 
sensitive specific approaches. This approach is particularly useful for analysing challenging 
subproteomes such as that of the membrane subproteome. Also the greater ease in handling 
several samples and the number of significant protein identifications obtained are unrivalled 
by the cumbersome gel based conventional approaches. However, one sure disadvantage of 
this LC/MS approach was that the inability to provide quantitative information on the relative 
abundance of any protein between the subjects compared.    
 
One unexpected outcome of the present study was the discovery of the phenomenon of 
polyadenylation of mRNAs in P. aeruginosa. Even though, genome sequencing and 
annotation of the genome sequence has hinted at existence of Poly (A) polymerase enzyme, 
the chief enzyme responsible for polyadenylation of mRNA transcripts, there has been no 
experimental proof for the occurrence of polyadenylation in P. aeruginosa so far. Much of 
what we know about polyadenylation in bacteria is from the studies undertaken in E.coli. 
Since any extrapolation of observations in E.coli to P.  aeruginosa must be backed by strong 
experimental proof, the present study investigated the phenomenon of polyadenylation in P. 
aeruginosa. During the real time PCR analysis of feoB transcripts an attempt was made to 
synthesise cDNA using oligo (dT) primer (that binds only to Poly (A) sequences on mRNA). 
Surprisingly, it was possible to prepare cDNA using oligo (dT) primer. Subsequently, the 
occurrence of polyadenylation was confirmed using independent approaches on several 
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strains of P.aeruginosa. Using RT PCR specific transcripts of rpoD were amplified from 
cDNA synthesised using both random primers and oligo (dT) primers. Additionally the 
specific amplification products from the different cDNA sources were compared with the 
PCR products of rpoD amplified using genomic DNA as template. All the products were 
found to match. To gain broader understanding of the type of genes and the number of genes 
that were polyadenylated, a genome wide analysis of PAO1 genome was undertaken using 
DNA microarrays. Interestingly, as high as 43% of the expressed genes of PAO1 were found 
to be polyadenylated during log phase. The discovery of polyadenylation in P. aeruginosa and 
the high level of polyadenylation among the transcripts, surely hint at the possible role for 
post transcriptional processing in the control of gene expression in P. aeruginosa. Future 
studies in this direction must be able to provide more insight into role of polyadenylation in 
Pseudomonas gene expression and its biology in general.   
 
The present study has to a large extent accomplished many of its fore set goals. The study has 
clearly answered that SCV 20265 is fitter than its clonal WT in surviving harsher stress 
conditions like those of iron limitation, oxidative stress and ability to grow under anaerobic 
condition using nitrate. Proteomics provided a great deal of information on several proteins of 
the iron acquisition systems, Superoxide dismutases and other oxidative stress combat 
proteins, membrane proteins, nitrate utilization and anaerobic respiration proteins. In many 
cases the differential expression of these proteins could be correlated with the observed 
differential responses of the morphotypes to the various stress conditions. However, the 
picture obtained with the proteome data was far from complete because of the inherent 
difficulty of the proteomics approach to look at all of the expressed proteins in a single 
experiment unlike the DNA microarray approach. Henceforth, it is important that in order to 
gain a complete picture, both the approaches must be used in parallel to complement the 
findings from each other. It is therefore worth investigating the iron limitation stress response, 
oxidative stress response and anaerobic mode of growth using nitrate supplements, of the 
SCV and WT pairs of strain 20265 using DNA microarrays to obtain some trancriptome 
analysis of these responses in order to evolve well directed future proteomics studies. Once a 
short list of proteins to be investigated, has been generated using the transcriptome analysis, it 
is much easier to follow the protein level expression of these genes on 2D gels using special 
enrichment and prefractionation strategies and a combination of different pH IPG strips.   
From the present study, there are some candidates that can be suggested for further focussed 
investigation and it might be even worth generating isogenic mutants of these genes in order 
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to ascertain their role in the pathogenicity of Pseudomonas aeruginosa and perhaps even in 
the inter clonal variations. These include the feoB homologue (PA4358), dsbG (PA2476), 
dsbA (PA5489), hasAp (PA 3407), minD (PA3244), mexE (PA2493), czaA (PA2520) and 
ostA (PA0595). Many of these proteins have been differentially expressed in the SCV or WT 
and might have some role to play in pathogenicity or basic biology. But for most of these the 
functions have been assigned purely using in silico bioinformatic analysis based on sequence 
similarity to homologues in E. coli or other related bacteria. Therefore, any functional 
demonstration of the accuracy of their present annotations is lacking at the moment. It must 
be emphasised here that this list is not exhaustive and more such candidates could be picked 
upon careful data analysis in combination with other future experiments like the ones 
proposed above. 
 
In conclusion, SCV 20265 represents a highly adapted clonal variant with a slow growing 
phenotype that can tackle iron limitation, oxidative stress and anaerobic stress better than its 
clonal wildtype. This exemplifies clonal variation as a means of adaptation to the harsh CF 
lung habitat where such stress conditions are likely to occur. It is possible that similar 
adaptation occurs in variants of other isolates too even though it may not necessarily be the 
rule for very SCV. Overall the situation represents a complex bacterial adaptation to the 
plethora of changing niches of a complex habitat such as the CF lung. Studies such as this will 
surely help in understanding the basic mechanisms of adaptation of this versatile pathogenic 
bacteria and help in evolving novel therapeutic strategies and diagnostic methods that can 
improve the conditions of patients suffereing from infections.          
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6. Appendix  
 
Primers used for real time PCR of rpoD and  feoB homologue (PA4358) described in section 
3.1.7.  
 
Gene Primer sequence Binding 
region in 
the Coding 
sequence 
Melting 
Temperature 
GC 
% 
 
rpoD 
 
Forward Primer 
5’-GGG GAT CAA CGT ATT CGA GA-3’ 
 
Reverse Primer 
5’-TCA TCG GGA TCG ATA TAG CC-3’ 
 
 
    159-178 
 
 
496-515 
 
57.3°C 
 
 
57.3°C 
 
50% 
 
 
50% 
 
feoB 
 
Forward Primer 
5’-TGT ACC ATG TGC CAC ACC TT -3’ 
 
Reverse Primer 
5’-GGT CGT AGC CTT CGT AGT CG -3’ 
 
 
1463-1482 
 
 
1800-1819 
 
57.3°C 
 
 
61.4°C 
 
50% 
 
 
50% 
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